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Reports of tuberculosis (TB) cases are submitted
to the Division of TB Elimination (DTBE), Centers
for Disease Control and Prevention (CDC), by 60
reporting areas (the 50 states, the District of
Columbia, New York City, Puerto Rico, and seven
other jurisdictions in the Pacific and Caribbean).  In
January 1993, an expanded system was developed
to collect additional information for each reported
TB case in order to better monitor trends in TB
and TB control.  A software package (SURVS-
TB) for data entry, analysis, and transmission of
case reports to CDC was designed and
implemented as part of the expanded TB
surveillance system.  In 1998, the Tuberculosis
Information Management System (TIMS) replaced
SURVS-TB.
This publication, Reported Tuberculosis in the
United States, 2005, presents summary data for
TB cases reported to DTBE, verified, and counted
in 2005.  It is similar to previous publications (see
page xi, #19) and contains six major sections.  The
first section presents trends in the overall TB case
counts and case rates by selected demographic
and clinical characteristics.  The second section
presents overall case counts and case rates for the
United States by selected demographic
characteristics for 2005.  In the third section, TB
case counts and case rates are presented by state
and other jurisdictions with tables of selected
demographic and clinical characteristics.  In the
fourth section, data collected as part of the
expanded system (e.g., initial drug resistance, HIV
status) are presented by reporting area.  The fifth
section provides TB case counts and case rates by
metropolitan statistical areas (MSAs: see Technical
Notes, page 9, for further details) with tables of
selected demographic and clinical characteristics.
The sixth section provides TB counts and case
rates by sex and age for the U.S.-affiliated Pacific
Island jurisdictions (USAPI). These jurisdictions
include Guam and American Samoa, the
Commonwealth of the Northern Marianas Islands,
the three U.S.-affiliated nations: the Republic of
Palau, the Federated States of Micronesia, and the
Republic of the Marshall Islands. Finally, the seventh
section presents figures from the annual surveillance
slide set, which emphasize key recent trends in TB
epidemiology in the United States.  The slides with
accompanying text can also be viewed and
downloaded from the Division home page, which is
accessible via the Internet at http://www.cdc.gov/
nchstp/tb/.
To help interpret the data, an Executive
Commentary (page 3) and Technical Notes (page 9)
have been included.  In addition, the current case
definition (MMWR 1997;46 [No. RR 10]:40-41)
and “Recommendations for Counting Reported
Tuberculosis Cases” are provided in Appendices A
and B, respectively (page 131).  The
recommendations for counting TB cases, which
update the original January 1977 recommendations,
were first published in Reported Tuberculosis in the
United States, 1996.
After the publication of updated Guidelines for
Targeted Tuberculin Testing and Treatment of
Latent Tuberculosis Infection in April 2000,1
the Division of Tuberculosis Elimination (DTBE),
CDC, began receiving reports of serious adverse
events (i.e., hospitalization or death) related to the
use of a 2-month course of rifampin and
pyrazinamide (RZ) for treatment of latent
tuberculosis infection (TLTBI).  Subsequently,
DTBE requested and received reports and
conducted on-site investigations of liver injury in
persons on TLTBI, and treatment guidelines were
revised accordingly.2
Severe adverse events among persons receiving
TLTBI continue to be a public health concern, and
data on the annual number and trends of such events
are needed.  To this end, DTBE organized a
working group on TLTBI adverse events in
September 2003.  This working group was charged
with the development of a national surveillance
system with the following objectives:
x
• To assist public health officials, policy
makers, and healthcare providers in the
prevention of adverse events, and
• To serve as the basis for periodic
evaluation of guidelines for TLTBI and
revision of these guidelines as needed.
Development of the National System for Severe
Adverse Events Associated with Treatment of
LTBI is underway, and will include formal
collaborations among CDC, FDA, and other
participating agencies to ensure interagency
notification of serious adverse events. Mechanisms
for quality assurance and timely dissemination of
data are also under development.
At present, DTBE urges health departments,
hospices, hospitals, jails, prisons, and private
medical offices to report all severe adverse events
(e.g., liver injury, metabolic acidosis, anaphylaxis,
seizure, and severe dermatitis) leading to
hospitalization or death of a person receiving
TLTBI that occurred after January 1, 2004, to
DTBE by telephone (404) 639-8401 or e-mail
(LManangan@cdc.gov).
References
1. ATS/CDC. Targeted tuberculin testing and
treatment of latent tuberculosis infection. Am J
Respir Crit Care Med 2000;161:S221-S247.
2. American Thoracic Society/CDC.  Update:
Adverse event data and revised American Thoracic
Society/CDC recommendations against the use of
rifampin and pyrazinamide for treatment of latent
tuberculosis infection—United States, 2003.
MMWR 2003;52(31):735-9.
xi
Previous Statistical Reports in this Series:
  1. Special Tuberculosis Projects, 1961–1965. Atlanta:  CDC; 1966.
  2. Special Tuberculosis Projects, December 1965. Atlanta:  CDC; 1966.
  3. Special Tuberculosis Projects, June 1966. Atlanta:  CDC; 1967.
  4. Special Tuberculosis Projects, December 1966. Atlanta:  CDC; 1967.
  5. Summary Report. Atlanta:  CDC; 1967.
  6. Special Tuberculosis Projects, June 1967. Atlanta:  CDC; 1968.
  7. Tuberculosis Program Reports, December 1967. Atlanta:  CDC; 1968.
  8. Tuberculin testing during 1966–1967 school year. In:  Tuberculosis Program Reports. Atlanta:
CDC; 1968.
  9. Tuberculosis Program Reports: Six Month Period Ending June 1968. Atlanta:  CDC; 1969.
10. Program Performance Analyses, June–December 1968. In: Tuberculosis Program Reports.
Atlanta: CDC; 1970.
11. Tuberculin testing data, 1967–1968 school year. In: Tuberculosis Program Reports.
Atlanta:  CDC; 1970.
12. The project years, 1961–1969, In: Tuberculosis Program Reports. Atlanta:  CDC; 1970.
13. Tuberculosis programs (for years 1970–1973). In: Tuberculosis Program Reports. Atlanta:
CDC; 1971–1974.
14. Reported Tuberculosis Data (for years 1962–1973). Atlanta:  CDC; 1963–1974.
15. Tuberculosis Statistics: States and Cities (for years 1974–1985). Atlanta:  CDC; 1971–1986.
16. Tuberculosis in the United States (for years 1974–1986). Atlanta:  CDC; 1976–1987.
17. Tuberculosis program management in the United States, 1984. In:  Tuberculosis Program
Reports. Atlanta: CDC; 1986.
18. Tuberculosis Statistics in the United States (for years 1987–1992). Atlanta:  CDC: 1989–1993.
19. Reported Tuberculosis in the United States (for years 1993–2004). Atlanta:  CDC: 1994–2005.
Reports from 1999 through 2005 are available on the Internet at
http://www.cdc.gov/nchstp/tb/surv/surv.htm.
xii






















































*As reported to CDC by U.S. reporting area TB programs as of July 2006. Includes responses from the reporting areas of  New York





Previous Statistical Reports in This Series ................................................................................................ xi
State TB Statistics on the Internet ........................................................................................................... xii
Executive Commentary ........................................................................................................................... 3
Technical Notes ...................................................................................................................................... 9
Morbidity Trend Tables, United States
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per
100,000 Population, and Percent Change:  United States, 1953–2005 ....................................... 15
Table 2.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic
Ethnicity and non-Hispanic Race: United States, 1993–2005 ...................................................... 16
Table 3.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Race Only:
United States, 1993–2005 ......................................................................................................... 17
Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age Group:
United States, 1993–2005 ......................................................................................................... 18
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of Birth:
United States, 1993–2005 ......................................................................................................... 18
Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons by the Top 30 Countries
by Origin of Birth: United States, 2001–2005 ............................................................................. 19
Table 7.  Tuberculosis Cases and Percentages Among Adult Foreign-born Persons by Country of
Origin and Years in the United States Before TB Diagnosis, Top 30 Countries: United States, 2005
and 1995 .................................................................................................................................. 20
Table 8.  Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease:
United States, 1993–2005 ......................................................................................................... 21
Table 9.  Pulmonary Tuberculosis Cases and Percentages by Sputum Smear and Sputum Culture
Results: United States, 1993–2005 ............................................................................................ 21
Table 10. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug Resistance in
Persons with No Previous TB, by Origin of Birth: United States, 1993–2005 .............................. 22
Table 11. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug Resistance in
Persons with Previous TB, by Origin of Birth: United States, 1993–2005 .................................... 22
xiv
Table 12.  Percentages of TB Cases by Initial Drug Regimen, Use of Directly Observed Therapy
(DOT), and Completion of Therapy (COT): United States, 1993–2005 ..................................... 23
Table 13.  Tuberculosis Cases and Percentages in Persons with HIV Test Results and with HIV
Coinfection by Age Group: United States, 1993–2004 ............................................................... 23
Table 14.  Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Stopped: United
States, 1993–2003 .................................................................................................................... 24
Morbidity Tables, United States, 2005
Table 15.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group:
United States, 2005 .................................................................................................................. 27
Table 16.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-Hispanic
Race, Sex, and Age Group: United States, 2005 ....................................................................... 28
Table 17.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic Race,
Sex, and Age Group: United States, 2005 ................................................................................. 29
Table 18.  Tuberculosis Cases in Foreign-born Persons by Hispanic Ethnicity and Non-Hispanic Race,
Sex, and Age Group: United States, 2005 ................................................................................. 30
Table 19. Tuberculosis Cases by Country of Origin: United States, 2005 ......................................... 32
Morbidity Tables, States, 2005
Table 20. Tuberculosis Cases and Case Rates per 100,000 Population: States, 2005 and 2004 ....... 37
Table 21. Tuberculosis Cases and Percentages by Age Group: Reporting Areas, 2005 ..................... 38
Table 22. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Report-
ing Areas, 2005 ........................................................................................................................ 40
Table 23. Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons: States, 2005 42
Table 24. Tuberculosis Cases and Percentages in Foreign-born Persons by Country of Origin: States,
2005 ........................................................................................................................................ 44
Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons by Number of Years in the
United States: States, 2005 ....................................................................................................... 46
Table 26. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease: Reporting
Areas, 2005 ............................................................................................................................. 47
Table 27. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: Reporting Areas,
2005 ........................................................................................................................................ 48
xv
Table 28.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by
Number of Cases: States and the District of Columbia, 2004 and 2005 ...................................... 50
Morbidity Tables, Reporting Areas, 2005 and 2003
Table 29. Tuberculosis Cases and Percentages by Residence in Correctional Facilities,  Age >15:
Reporting Areas, 2005 .............................................................................................................. 53
Table 30. Tuberculosis Cases and Percentages by Homeless Status,  Age >15:  Reporting Areas, 2005
................................................................................................................................................ 54
Table 31. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,  Age >15:
Reporting Areas, 2005 .............................................................................................................. 55
Table 32. Tuberculosis Cases and Percentages by Injecting Drug Use,  Age >15: Reporting Areas,
2005 ........................................................................................................................................ 56
Table 33. Tuberculosis Cases and Percentages by Noninjecting Drug Use,  Age >15: Reporting Areas,
2005..........................................................................................................................................57
Table 34. Tuberculosis Cases and Percentages by Excess Alcohol Use,  Age >15: Reporting Areas,
2005 ........................................................................................................................................ 58
Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen: Reporting Areas, 2005 ....... 59
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results, by
Resistance to INH or Multidrug Resistance: Reporting Areas, 2005 ........................................... 60
Table 37. Tuberculosis Cases and Percentages Among Persons Aged 25–44 by HIV Status: Reporting
Areas, 2005 ............................................................................................................................. 61
Table 38. Tuberculosis Cases and Percentages by Occupation,  Age >15: Reporting Areas, 2005 .... 62
Table 39. Tuberculosis Cases and Percentages by Type of Health Care Provider: Reporting Areas,
2003 ........................................................................................................................................ 63
Table 40. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): Reporting
Areas, 2003 ............................................................................................................................. 64
Table 41. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy (COT): Report-
ing Areas, 2003 ........................................................................................................................ 65
Table 42. Tuberculosis Cases and Percentages by Reason Therapy Stopped: Reporting Areas,
      2003......................................................................................................................................... 66
Table 43. Completion of Tuberculosis Therapy (COT) Cases and Percentages by Hispanic Ethnicity
and Non-Hispanic Race: Reporting Areas, 2003 ....................................................................... 67
Table 44. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom Therapy Was
Indicated for One Year or Less: States, Reporting Areas, 1999–2003 ........................................ 68
xvi
Morbidity Tables, Cities and Metropolitan Statistical Areas, 2005
Table 45. Tuberculosis Cases in Selected Cities: 2005 and 2004 ...................................................... 71
Table 46. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical Areas
with >500,000 Population, 2005 and 2004 ................................................................................ 72
Table 47. Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: Metropolitan Statistical
Areas with >500,000 Population, 2005 ..................................................................................... 74
Table 48. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000 Population,
2005 ......................................................................................................................................... 76
Table 49. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statistical
Areas with >500,000 Population, 2005 ..................................................................................... 78
Table 50. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Persons: Metro-
politan Statistical Areas with >500,000 Population, 2005 ........................................................... 80








Appendix A: Tuberculosis Case Definition for Public Health Surveillance ........................................ 131





Highlights of 2005 Report
Since 1953, through the cooperation of state and local health departments, CDC has collected
information on the numbers of newly reported cases of TB disease in the United States.  Currently,
each individual TB case report (Report of Verified Case of Tuberculosis, or RVCT) is submitted
electronically to CDC’s DTBE.  The highlights of the 2005 report include
1. Updated case counts for each year from 1993 through 2004
2. Change in calculation of case rates for 2005 using unrounded figures
3. A new section of the report that was created this year contains information on U.S.-affiliated
Pacific Island jurisdictions.
4. Case counts: 14,097 TB cases were reported to CDC from the 50 states and the District of
Columbia, representing a 2.9% decrease from 2004
o 20 states reported increases in case counts (Table 28)
o California, New York, Texas, and Florida accounted for 48% of the overall 2005
national case total (Table 28)
o For the second consecutive year, Hispanics (29%) exceeded non-Hispanic blacks
(28%) as the racial/ethnic group with the largest percentage of total cases (Table 2)
o Blacks or African-Americans represented 45% of TB cases in U.S.-born persons and
accounted for more than one fifth of the overall national case total (Tables 17, 18)
o Hispanics and Asians each represented 40% of TB cases in foreign-born persons and
together accounted for almost 45% of the overall national case total (Tables 17, 18)
5. Case rates: The TB case rate declined from 4.9 to 4.8 per 100,000 population, representing a
3.8% decrease from 2004
o 12 states and DC reported rates above the national average (Table 20)
o 26 states met the definition for low incidence (<3.5 cases per 100,000 population)
(Table 20)
o The TB case rate was 2.5 per 100,000 for U.S.-born persons and 21.9 for foreign-born
persons (Table 5)
o Asians and Native Hawaiians or Other Pacific Islanders continue to have the highest
case rate among all racial and ethnic groups (Table 2)
6. Burden in the foreign-born: The proportion of all cases occurring in foreign-born persons was
55%
o 22 states had >50% of total cases among foreign-born persons (Table 23)
o 6 states had >70% of total cases among foreign-born persons (Table 23)
o The top five countries of origin of foreign-born persons with TB were Mexico, the
Philippines, Vietnam, India, and China (Table 6)
7. Drug resistance: The proportion of cases with primary multidrug-resistant TB remained
approximately 1.0% (Table 10)
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Tuberculosis in the United States
The 14,097 TB cases reported to CDC for 2005
represented a 2.9% decrease from 2004 and a
47% decrease from 1992, when the number of
cases and the case rate peaked during a
resurgence in the United States.  Compared with
2004, the TB case rate in 2005 declined 3.8% to
4.8 per 100,000.  The decrease in the percent
change of the annual case rate has slowed, from
an annual average of 5.6% for 1993 through
2002 to an average of 3.1% for 2003 through
2005 (Table 1).
The proportion of total cases occurring in
foreign-born persons has been increasing since
1993.  In 2005, the proportion of total cases
occurring in the foreign-born was 55%,
constituting a majority of cases for the fourth
consecutive year.  Additionally, the case rate
among foreign-born persons was more than eight
times higher than among U.S.-born persons
(Table 5).
Tuberculosis deaths decreased 6.9%, from 711
deaths in 2003 to 662 deaths in 2004. (Table 1).
Age and Race/Ethnicity
TB case rates, which have been declining since
1993, varied by factors such as age, race/
ethnicity, and nativity.  The largest declines
occurred in children under 15 years of age (from
2.9 per 100,000 in 1993 to 1.4 in 2005), as well
as in adults aged 25 to 44 years (from 11.5 to
5.6), 45 to 64 years (from 12.4 to 5.7), and 65
years and older (from 17.7 to 7.7), each group’s
rate having decreased approximately 50%.  The
case rate declined by 27% in those 15 to 24 years
of age (from 5.0 to 3.7) (Table 4).
In 2003, the race/ethnicity category, “non-
Hispanic, Asian or Pacific Islander,” was split
into two categories:  “non-Hispanic Asian” and
“non-Hispanic Native Hawaiian or Other Pacific
Islander.”  In 2005, non-Hispanic Asians had the
highest TB rate, 25.8 per 100,000, which was
down from 29.6 in 2003; non-Hispanic native
Hawaiians and other Pacific Islanders had the
second-highest TB case rate (13.8), down from
16.4 in 2003 (Table 2).
TB rates declined at least 50% from 1993
through 2005 in the other racial/ethnic groups:
among non-Hispanic whites from 3.6 to 1.3,
among non-Hispanic blacks from 28.5 to 10.9,
among Hispanics from 19.9 to 9.5, and among
non-Hispanic American Indians and Alaska
Natives from 13.9 to 6.9 (Table 2).
Nativity
In 1993, 69% of reported cases were among
U.S.-born persons (7.4 cases per 100,000),
whereas 29% were in foreign-born persons (34.0
per 100,000).  In comparison, in 2005, 55% of
reported cases occurred among foreign-born
persons, and the respective case rates were 2.5
per 100,000 for U.S.-born persons and 21.9 per
100,000 for foreign-born persons (Table 5).
Cases among persons born in the United States
decreased by 63%, from 17,422 in 1993 to 6,371
in 2005.  However, among foreign-born persons,
the annual case count has fluctuated between
7,404 and 7,989 during the same time period.
The number of states that have >50% of their
annual total of reported TB cases among foreign-
born persons increased from five in 1993 to 22 in
2005.  Of these 22 states, six (California,
Hawaii, Massachusetts, Minnesota, New
Hampshire, and Utah) had >70% of their annual
state case totals among foreign-born persons in
2005, a decrease from 11 states in 20031 (Table
23).
Country of Origin and World Region
From 2001 through 2005, the top five countries
of origin of foreign-born persons with TB were
Mexico, the Philippines, Vietnam, India, and
China (Table 6).  However, fluxes in
immigration patterns are leading to changes in
the distribution of TB cases by global region of
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origin.2  In 2005, of the 7,693 cases of TB in
foreign-born persons, 45% occurred among
persons from the Americas (Central and South
America or the Caribbean), and 29% were in
persons from the Western Pacific.  During 1993
through 2005, the proportion of cases among
persons from the Eastern Mediterranean
increased (3% in 1993 and 5% in 2005) and
almost doubled among persons from Southeast
Asia (6% in 1993 and 11% in 2005), while the
proportion of cases among persons from Africa
more than tripled (2% in 1993 and 7% in 2005)
(Table 19).
Multidrug-Resistant TB
Since 1993, when the case report was expanded
to include drug-susceptibility results, the
proportion of patients with primary MDR TB (no
previous TB and multidrug resistant, defined as
resistance to at least isoniazid and rifampin) has
decreased from 2.5% to 1.0%.  Among the 95
MDR TB cases reported for 2005, 18 were in
U.S.-born persons.  Since 1998, the percentage
of U.S.-born patients with MDR TB has
remained <0.7%.  However, of the total number
of reported primary MDR TB cases, the
proportion occurring in foreign-born persons
increased from 26% (105 of 410) in 1993 to 80%
(76 of 95) in 2005 (Table 10).
Tuberculosis Therapy
The proportion of TB patients placed on an
initial treatment regimen of three or more drugs
increased during 1993 through 2005 (Table 12).
The proportions of patients who completed
treatment within 1 year and of persons who were
treated with directly observed therapy (at least
for a portion of treatment) also increased from
1993 through 2003, the latest year for which
complete outcome data are available (Table 12).
Summary
Essential elements for controlling TB in the
United States include sufficient local resources,
interventions targeted to populations with the
highest TB rates, and continued collaborative
efforts with other nations to reduce TB globally.3
During 1993 through 2005, TB case rates in the
United States decreased for U.S.-born and
foreign-born persons; however, the decrease
among foreign-born persons was less substantial.
Despite the decreased case rate among foreign-
born persons, more than half of the TB cases in
the United States in 2005 occurred in this
population, and the case rate was more than eight
times greater in this population than among U.S.-
born persons.  To address the high rate, CDC is
collaborating with other national and
international public health organizations to 1)
improve overseas screening of immigrants and
refugees by systematically monitoring and
evaluating the screening process; 2) strengthen
the current notification system that alerts local
health departments about the arrival of
immigrants or refugees who have suspected TB
to enhance the evaluation and treatment of such
persons; 3) improve coordination of TB control
activities between the United States and Mexico
to ensure completion of treatment among TB
patients who cross the border; 4) test recent
arrivals from high-incidence countries for latent
TB infection and treat them to completion; and
5) survey foreign-born TB patients in the United
States to determine opportunities for improving
prevention and control interventions.  In
addition, CDC continues to strengthen
collaborations with international partners,
including the Stop TB Partnership of the World
Health Organization, to improve TB control in
high-incidence countries.3
Accelerating progress in national TB elimination
activities, however, will require broader
prevention efforts in other population risk groups
such as African or Asian Americans, persons
living with HIV, and persons living in poverty
with limited access to medical care and adequate
housing and nutrition.
In addition, low-incidence areas in the United
States need continued support to ensure they
maintain the capacity and expertise needed to
6
respond to cases when they occur.4  CDC has
recently updated its comprehensive national
action plan to reflect the alignment of its
priorities with the 2000 Institute of Medicine
report on TB5 and updated major TB
guidelines.5,6,7,8,9  These updates also ensure that
priority prevention activities are undertaken with
optimal collaboration and coordination among
national and international public health
partners.10
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1Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of
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National Surveillance for Tuberculosis
All reporting areas (i.e., the 50 states, the District
of Columbia, New York City, Puerto Rico, and
other U.S. jurisdictions in the Pacific and
Caribbean) report tuberculosis (TB) cases to
CDC using a standard case report form, Report
of Verified Case of Tuberculosis (RVCT).1
Reported TB cases are verified according to the
TB case definition for public health surveillance
(MMWR 1997;46[No. RR-10]:40–41).
Cases may be verified using the laboratory or the
clinical case definition.  A case may be verified
by the laboratory case definition either by 1)
isolation of Mycobacterium tuberculosis from a
clinical specimen, OR 2) demonstration of acid-
fast bacilli (AFB) in a clinical specimen when a
culture has not been or cannot be obtained.
A case may be verified by the clinical case
definition in the presence of ALL of the
following clinical criteria: 1) a positive
tuberculin skin test result, 2) other signs and
symptoms compatible with TB, such as an
abnormal, unstable (worsening or improving)
chest radiograph, or clinical evidence of current
disease, 3) treatment with two or more
antituberculosis medications, and 4) a completed
diagnostic evaluation.  When patients are
diagnosed with TB but do not meet the case
definition (e.g., anergic patients with a clinical
picture consistent with TB but without laboratory
evidence of M. tuberculosis), reporting areas also
have the option of verifying TB cases based on
provider diagnosis.
In January 1993, in conjunction with state and
local health departments, CDC implemented an
expanded surveillance system for TB that would
collect additional data to better monitor and
target groups at risk for TB disease, to estimate
and follow the extent of drug-resistant TB, and
to evaluate outcomes of TB cases.  The RVCT
form for reporting TB cases was revised to
collect information on occupation, the initial
drug regimen, human immunodeficiency virus
(HIV) test results, history of substance abuse and
homelessness, and residence in correctional or
long term-care facilities at the time of diagnosis.
RVCT Follow Up Report-1 was added to collect
drug susceptibility results for the initial
M.tuberculosis isolate from patients with
culture-positive disease.
To evaluate the outcomes of TB therapy, RVCT
Follow Up Report-2 was added to collect
information on the reason and date therapy was
stopped, the type of health care provider, sputum
culture conversion, the use of directly observed
therapy (DOT), and the results of drug-
susceptibility testing for the final M. tuberculosis
isolate from patients with culture-positive
disease.
Since 1993, RVCT data have been reported to
CDC using software specifically developed for
expanded TB surveillance (i.e., SURVS-TB,
1993–1997; TIMS, 1998–present).  The
instructions for completing the RVCT forms and
the definitions for all data items were included in
the software user’s guide.  The summary data
presented in this publication for 2005 (and for
2003, Tables 39–44) and the trend data for 1993–
2005 (Tables 1–14) were received at CDC by
April 1, 2006.
Completion of Tuberculosis Therapy
Tables 12, 41, 43, and 44 present rates of
completion of TB therapy (COT).  Data collected
by RVCT Follow Up Report-2 on date and
reason therapy stopped (e.g., patient completed
therapy, moved, was lost) were used to calculate
rates of COT.  Cases were stratified by the




Society of America treatment guidelines2 in
effect during the period covered, and the
patient’s initial drug susceptibility test results,
age, and site of disease.  The adequacy of the
treatment regimen (e.g., the sufficiency of the
duration of therapy, the appropriateness of the
prescribed TB drugs) was not evaluated in this
analysis. Acquired drug resistance during therapy
with the need for a longer duration of therapy
was also not considered in this analysis.
In Table 41, the first column shows the total
number of cases reported during 2003.  The
remaining columns are grouped under three
headings: therapy of 1 year or less indicated,
therapy greater than 1 year indicated, and overall.
For patients with an initial isolate resistant to
rifampin and for pediatric patients (those under
15 years of age) with meningeal, bone or joint, or
miliary disease, data were included under the
category of greater than 1 year of therapy
indicated.  For all other patients, including those
with culture-negative disease, those with an
unknown culture status, and those with culture-
positive disease but unknown initial drug-
susceptibility test results, data were included
under the category of 1 year or less of therapy
indicated.  Table 12 presents data only for the
category of therapy of 1 year or less indicated.
In Table 41, each group under an indicated
length of therapy has an initial column showing
the number of cases in persons who were alive at
diagnosis and prescribed an initial regimen of
one or more drugs, and who did not die during
therapy.  This number was used as the
denominator in COT rate calculations.
COT rates, shown as percentages, were only
calculated for areas reporting reason therapy
stopped for at least 90% of cases shown in the
overall column. For the group with an indicated
length of therapy of 1 year or less, rates are
shown for both COT in 1 year or less (COT <1
year) and for COT, regardless of duration (i.e.,
duration of therapy <1 year, >1 year, or
unknown).  For COT <1 year, the numerator
included only those patients completing therapy
in <365 days (based on the dates therapy started
and stopped).  Patients with missing dates were
classified as “treatment not completed” for this
calculation.
Rates of COT, regardless of duration, were
calculated by dividing the number of patients
reported as having completed therapy by the
number of total eligible patients.  Patients with
an outcome other than completed therapy (i.e.,
moved, lost, refused treatment, and other) were
classified as “treatment not completed.”  Patients
with an unknown outcome were also classified
as “treatment not completed.”  For the remaining
two groups of indicated therapy length (greater
than 1 year and overall), only rates of COT,
regardless of duration, are presented.  Table 12
provides rates for COT <1 year and for COT,
regardless of duration, only for the group with an
indicated therapy of 1 year or less.  Table 43
presents rates of COT by ethnicity and non-
Hispanic race, and by state for those in whom
therapy less than 1 year was indicated.
Site of TB Disease
Miliary disease is classified as both an
extrapulmonary and a pulmonary form of TB
(Tables 8, 9, 26, 27, and 47).  In publications
prior to 1997, miliary disease was classified as
extrapulmonary TB unless pulmonary disease
was reported as the major site of TB disease.
Reporting of HIV Status
Table 37 shows information on HIV status for
persons with TB aged 25–44 years, the age group
in which 73% of AIDS cases occur (CDC. HIV/
AIDS Surveillance Report 2003; 15).  The
information on HIV status for TB cases reported
in 2005 is incomplete.  Reasons for incomplete
reporting of HIV test results to the national TB
surveillance system include concerns about
confidentiality, which may limit the exchange of
data between TB and HIV/AIDS programs; laws
2CDC.  Treatment of Tuberculosis, American Thoracic Society, CDC, and the Infectious Diseases Society of America.  MMWR
2003;52(No.RR-11):1-77.
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and regulations in certain states and local
jurisdictions that have been interpreted as
prohibiting the HIV/AIDS program from sharing
the HIV status of TB patients with the TB
program, or from reporting patients with TB and
AIDS to the TB program; and reluctance by
health care providers to report HIV test results to
the TB surveillance program staff.  In addition,
health care providers may not offer HIV
counseling, testing, and referral to some TB
patients because of a lack of resources or of
appropriately trained staff, or due to the
perception that selected patients (e.g., foreign-
born persons) are not at risk for HIV infection.
Data on the HIV-infection status of reported TB
cases should be interpreted with caution.  These
data are not representative of all TB patients with
HIV infection.  HIV testing is performed after a
patient receives counseling and gives informed
consent.  Since testing is voluntary, some TB
patients may decline HIV testing.  TB patients
who are tested anonymously may choose not to
share the results of HIV testing with their health
care provider.  TB patients managed in the
private sector may receive confidential HIV
testing, but results may not be reported to the TB
program in the health department.  In addition,
many factors may influence HIV testing of TB
patients, including the extent to which testing is
targeted or routinely offered to specific groups
(e.g., 25- to 44-year-old males, injecting drug
users, homeless persons), and the availability of
and access to HIV testing services.  These data
may overrepresent or underrepresent the
proportion of TB patients known to be HIV
infected in a reporting area.
Tabulation and Presentation of TB Data
This report primarily presents summary data for
TB cases reported to CDC in 2005.  Data from
the RVCT Follow Up Report-2 (i.e., completion
of therapy, use of directly observed therapy, and
type of health care provider) are presented for
cases reported in 2003.  In addition, trend data
are presented in Tables 1 through 14.  TB cases
are tabulated by the year in which the reporting
area verified that the patient had TB and
included the patient in its official annual TB case
count.  In contrast to previous annual summaries,
in which TB case counts for preceding years
were not updated, the current summary reflects
updated information on the numbers of cases of
confirmed TB for each year from 1993 to 2004.
Therefore, case counts for these years differ from
those reported in the annual summaries
previously published.  Totals for the United
States only include data from the 50 states, the
District of Columbia, and New York City.  Age
group tabulations are based on the patient’s age
in the month and year the patient was reported to
the health department as a suspected TB case.
State or metropolitan area data tabulations are
based on the patient’s residence at diagnosis of
TB (see Appendix B: “Recommendations for
Counting Reported Tuberculosis Cases”).
Tables 46 through 50 present data by
metropolitan statistical areas (MSAs) with an
estimated 2005 population of 500,000 or more.
MSAs are defined by the federal Office of
Management and Budget, and the definitions
effective as of December 2004 were used for this
publication (www.census.gov/population/www/
estimates/metrodef.html).  The MSA definitions
apply to all areas except the six New England
states; for these states, the New England County
Metropolitan Areas (NECMAs) are used.  MSAs
are named for a central city in the MSA or
NECMA, may include several cities and
counties, and may cross state boundaries.  For
example, the TB cases and case rates presented
for the District of Columbia in Table 20 include
only persons residing within the geographic
boundaries of the District.  However, the TB
cases and case rates for the Washington, D.C.,
MSA (Table 46) include persons residing within
the several counties in the metropolitan area,




Rates are expressed as the number of cases
reported each calendar year per 100,000
population.  Population denominators used in
calculating TB rates were based on official
census and midyear (July 1) postcensal estimates
from the U.S. Census Bureau.  Specifically, in
Tables 1 and 20, the U.S. total populations for
2000 to 2005 were obtained from the Annual
Estimates of the Population for the United States
and States, and for Puerto Rico (July 1, 2000–
July 1, 2005).3 In 2003, two modifications were
made to the RVCT form: 1) entries for multiple
race (two or more races reported for a person)
were allowed, and 2) the previous category of
Asian/Pacific Islander was divided into “Asian”
and “Native Hawaiian or Other Pacific Islander.”
To calculate rates in Tables 2 and 3,
denominators for 2000 to 2005 were obtained
from the Annual Estimates of the Population by
Sex, Race, and Hispanic or Latino Origin for the
United States: April 1, 2000, to July 1, 2005.4 To
calculate rates for Table 4, denominators were
obtained from the Annual Estimates of the
Population by Sex and Five-Year Age Groups for
the United States: April 1, 2000, to July 1, 2005.5
Denominators for computing 2005 rates in Table
16 were obtained from U.S. Census Bureau
Monthly Postcensal Resident Population, by
single year of age, sex, race, and Hispanic origin:
July 1, 2005.6 In 2004, the method for
calculating the annual percentage change in the
TB case rate was modified.  In contrast to
methods used in previous summaries, unrounded
figures are now applied to calculate the
percentage change in the case rate, providing a
greater degree of precision and accuracy than in
the past. Percent change in tuberculosis death
rates continues to be calculated with rounded
figures, as provided by the National Center for
Health Statistics, CDC.
In Table 5, the populations for U.S.-born and
foreign-born persons for 1993 and 1994 were
obtained from Quarterly Estimates of the United
States Foreign-born and Native Resident
Populations: April 1, 1990, to July 1, 1999.7
Denominators for computing the 1995–2005
rates were based on extrapolations from the U.S.
Census Current Population Survey (March
Supplement).
Mortality Data
Official TB mortality statistics for the United
States are compiled by the National Center for
Health Statistics (NCHS), CDC.  The annual
mortality rate is calculated as the number of
deaths due to TB in that year, divided by the
estimated population for the year, multiplied by
100,000 (Table 1).  The number of deaths for
2004 (preliminary) was obtained from the
National Center for Health Statistics, National
Vital Statistics Report, Vol. 54, No. 19, June 28,
2006.  For previous years, official tuberculosis
mortality statistics were compiled by the
National Center for Health Statistics, CDC. The
number of deaths for 2005 was not available at









1953  84,304 52.6 19,707 12.4
1954 79,775 48.9 - 5.4 - 7.0 16,527 10.2 -16.1 -17.7
1955 77,368 46.6 - 3.0 - 4.7 15,016 9.1 - 9.1 -10.8
1956 69,895 41.4 - 9.7 -11.2 14,137 8.4 - 5.9 - 7.7
1957 67,149 39.0 - 3.9 - 5.8 13,390 7.8 - 5.3 - 7.1
1958 63,534 36.3 - 5.4 - 6.9 12,417 7.1 - 7.3 - 9.0
1959 57,535 32.4 - 9.4 -10.7 11,474 6.5 - 7.6 - 8.5
1960 55,494 30.7 - 3.5 - 5.2 10,866 6.0 - 5.3 - 7.7
1961 53,726 29.2 - 3.2 - 4.9 9,938 5.4 - 8.5 -10.0
1962 53,315 28.6 - 0.8 - 2.1 9,506 5.1 - 4.3 - 5.6
1963 54,042 28.6 + 1.4 0.0 9,311 4.9 - 2.1 - 3.9
1964 50,874 26.5 - 5.9 - 7.3 8,303 4.3 -10.8 -12.2
1965 49,016 25.2 - 3.7 - 4.9 7,934 4.1 - 4.4 - 4.7
1966 47,767 24.3 - 2.5 - 3.6 7,625 3.9 - 3.9 - 4.9
1967 45,647 23.0 - 4.4 - 5.3 6,901 3.5 - 9.5 -10.3
1968 42,623 21.2 - 6.6 - 7.8 6,292 3.1 - 8.8 -11.4
1969 39,120 19.3 - 8.2 - 9.0 5,567 2.8 -11.5 - 9.7
1970 37,137 18.1 - 5.1 - 6.2 5,217 2.6 - 6.3 - 7.1
1971 35,217 17.0 - 5.2 - 6.1 4,501 2.2 -13.7 -15.4
1972 32,882 15.7 - 6.6 - 7.6 4,376 2.1 - 2.8 - 4.5
1973 30,998 14.6 - 5.7 - 7.0 3,875 1.8 -11.4 -14.5
1974 30,122 14.1 - 2.8 - 3.4 3,513 1.7 - 9.3 - 5.6
1975 33,989 15.7 3,333 1.6 - 5.1 - 5.9
1976 32,105 14.7 - 5.5 - 6.4 3,130 1.5 - 6.1 - 6.3
1977 30,145 13.7 - 6.1 - 6.8 2,968 1.4 - 5.2 - 6.7
1978 28,521 12.8 - 5.4 - 6.6 2,914 1.3 - 1.8 - 7.1
1979 27,669 12.3 - 3.0 - 3.9 2,007.1 0.91 -31.11 30.81
1980 27,749 12.2 + 0.3 - 0.8 1,978 0.9 - 1.4 0.0
1981 27,373 11.9 - 1.4 - 2.5 1,937 0.8 - 2.1 -11.1
1982 25,520 11.0 - 6.8 -7.6 1,807 0.8 - 6.7 0.0
1983 23,846 10.2 - 6.6 - 7.3 1,779 0.8 - 1.5 0.0
1984 22,255 9.4 - 6.7 - 7.8 1,729 0.7 - 2.8 -12.5
1985 22,201 9.3 - 0.2 - 1.1 1,752 0.7 + 1.3 0.0
1986 22,768 9.5 + 2.6 + 2.2 1,782 0.7 + 1.7 0.0
1987 22,517 9.3 - 1.1 - 2.1 1,755 0.7 - 1.5 0.0
1988 22,436 9.2 - 0.4 - 1.1 1,921 0.8 + 9.5 +14.3
1989 23,495 9.5 + 4.7 + 3.3 1,970 0.8 + 2.6 0.0
1990 25,701 10.3 + 9.4 + 8.4 1,810 0.7 - 8.1 -12.5
1991 26,283 10.4 + 2.3 + 1.0 1,713 0.7 - 5.4 0.0
1992 26,673 10.4 + 1.5 + 0.1 1,705 0.7 - 0.5 0.0
1993 25,108 9.7 - 5.9 - 7.1 1,631 0.6 - 4.3 -14.3
1994 24,205 9.2 - 3.6 - 4.8 1,478 0.6 - 9.4 0.0
1995 22,727 8.5  - 6.1 - 7.2 1,336 0.5 - 9.6 -16.7
1996 21,210 7.9 - 6.7 - 7.8 1,202 0.5 -10.0 0.0
1997 19,751 7.2 - 6.9 - 8.0 1,166 0.4 - 3.0 -20.0
1998 18,287 6.6 - 7.4 - 8.5 1,112  0.4  - 4.6  0.0
1999 17,501 6.3 - 4.3 - 5.4 930 0.3 -16.4 -25.0
2000 16,309 5.8 - 6.8 - 7.9 776 0.3 -16.6 0.0
2001 15,946 5.6 -2.2 -3.2 764 0.3 -1.5 0.0
2002 15,056 5.2 -5.6 -6.5 784 0.3 +2.6 0.0
2003 14,840 5.1 -1.4 -2.4 711 0.2 -9.3 -33.3
2004 14,515 4.9 -2.2 -3.1 662.2 0.22 -6.92 0.02
2005 14,097 4.8 -2.9 -3.8 ... ... ... ...
1The large decrease in death rate in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleurisy
with effusion (without mention of cause) are no longer included in tuberculosis deaths.
2Preliminary data obtained from National Center for Health Statistics, National Vital Statistics Report, Vol. 54, No. 19, June 28, 2006.
For previous years, official tuberculosis mortality statistics were compiled by the National Center for Health Statistics, CDC. Percent
change in tuberculosis death rates is calculated with rounded figures. See Technical Notes (page 9).
Note: 1993 to 2005 tuberculosis case counts and rates updated as of March 29, 2006, using Bridged-Race 1990–1999 Intercensal
Population Estimates for 1990–1999 (ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/
documentationbridgedintercena1.doc) (accessed June 6, 2006) and Annual Estimates of the Population for the United States and
States, and for Puerto Rico (July 1, 2000– July 1, 2005)  (www.census.gov/popest/states/tables/NST-EST2005-01.xls) (accessed
June 6, 2006).  Percentage change results reported to one decimal. Ellipses indicate data not available. Case data after 1974 are
not comparable to prior years due to changes in the surveillance case definition that became effective in 1975.  See Surveillance
Slides #2 and #3.
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates
per 100,000 Population, and Percent Change:  United States, 1953–2005
Tuberculosis Cases Tuberculosis Deaths
Percent ChangePercent Change
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1993 25,108 1663 (7) 2.9 1,823 (7) 5.0 9,586 (38) 11.5 6,197 (25) 12.4 5,820 (23) 17.7 19 (0)
1994 24,205 1659 (7) 2.9 1,833 (8) 5.0 9,043 (37) 10.7 6,125 (25) 11.9 5,539 (23) 16.6 6 (0)
1995 22,727 1536 (7) 2.6 1,698 (7) 4.6 8,201 (36) 9.7 5,960 (26) 11.3 5,327 (23) 15.8 5 (0)
1996 21,210 1356 (6) 2.3 1,637 (8) 4.4 7,564 (36) 8.9 5,572 (26) 10.2 5,076 (24) 14.9 5 (0)
1997 19,751 1250 (6) 2.1 1,675 (8) 4.5 6,885 (35) 8.0 5,277 (27) 9.4 4,663 (24) 13.6 1 (0)
1998 18,287 1077 (6) 1.8 1,542 (8) 4.1 6,335 (35) 7.4 4,956 (27) 8.5 4,377 (24) 12.6 0 (0)
1999 17,501 1039 (6) 1.7 1,518 (9) 3.9 6,063 (35) 7.1 4,858 (28) 8.0 4,020 (23) 11.6 3 (0)
2000 16,309 964 (6) 1.6 1,617 (10) 4.1 5,575 (34) 6.6 4,636 (28) 7.4 3,516 (22) 10.0 1 (0)
2001 15,946 929 (6) 1.5 1,597 (10) 4.0 5,609 (35) 6.6 4,516 (28) 7.0 3,293 (21) 9.3 2 (0)
2002 15,056 944 (6) 1.6 1,496 (10) 3.7 5,287 (35) 6.3 4,182 (28) 6.3 3,143 (21) 8.8 4 (0)
2003 14,840 913 (6) 1.5 1,572 (11) 3.8 5,074 (34) 6.0 4,283 (29) 6.2 2,995 (20) 8.3 3 (0)
2004 14,515 959 (7) 1.6 1,602 (11) 3.8 4,942 (34) 5.9 4,195 (29) 5.9 2,816 (19) 7.8 1 (0)
2005 14,097 863 (6) 1.4 1,542 (11) 3.7 4,743 (34) 5.6 4,133 (29) 5.7 2,816 (20) 7.7 0 (0)
Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age




0–14 15–24 25–44 45–64 >65 Unk.1
.No. No. No. No. No. No. (%)(%)(%)(%)(%)(%) Rate Rate Rate Rate Rate
1Includes unknown and missing.
Note: Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates
(http://www.cdc.gov/nchs/about/major/dvs/popbridge/popridge.htm) (accessed June 1, 2006). Denominators for computing 2000–2005
case rates were obtained from the Annual Estimates of the Population by Sex and Five-Year Age Groups for the United States: April 1,
2000, to July 1, 2005  (http://www.census.gov/popest/national/asrh/NC-EST2005/NC-EST2005-01.xls) (accessed June 1, 2006).
Data for all years updated through March 29, 2006.
See Technical Notes (page 9).
Zero % (0) denotes <1%.
See Surveillance Slides #5 and #6.
1993 25,108 17,422 (69) 7.4 7,404 (29) 34.0 282 (1)
1994 24,205 16,171 (67) 6.8 7,741 (32) 34.6 293 (1)
1995 22,727 14,646 (64) 6.2 7,987 (35) 32.6 94 (0)
1996 21,210 13,315 (63) 5.6 7,726 (36) 31.5 169 (1)
1997 19,751 11,879 (60) 4.9 7,742 (39) 30.0 130 (1)
1998 18,287 10,632 (58) 4.4 7,599 (42) 28.9 56 (0)
1999 17,501 9,806 (56) 4.0 7,602 (43) 28.7 93 (1)
2000 16,309 8,670 (53) 3.5 7,596 (47) 25.3 43 (0)
2001 15,946 7,891 (49) 3.2 7,989 (50) 25.1 66 (0)
2002 15,056 7,298 (48) 2.9 7,700 (51) 23.7 58 (0)
2003 14,840 6,881 (46) 2.7 7,911 (53) 23.6 48 (0)
2004 14,515 6,670 (46) 2.6 7,820 (54) 22.8 25 (0)
2005 14,097 6,371 (45) 2.5 7,693 (55) 21.9 33 (0)
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000




U.S.-born Persons Foreign-born Persons1 Unknown or Missing
No. (%)No. (%) RateNo. (%) Rate
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia,
Guam, the Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana
Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific
islands.
Note:  Denominators for computing rates for years 1993–1994 were obtained from Quarterly Estimates of the
United States Foreign-born and Native Resident Populations: April 1, 1990–July 1, 1999, located at         http:/
/www.census.gov/population/estimates/nation/nativity/fbtab001.txt (accessed June 7, 2006).  Denominators
for computing the 1995–2005 rates are based on the Current Population Survey (March Supplement).
Denominators for 1993–2002 were provided by the Ethnic and Hispanic Statistics Branch, Populations
Division, U.S. Bureau of the Census Current Population Survey.  Denominators for 2003–2005 were provided
by the U.S. Census Bureau, Current Population Survey, Annual Social and Economic Supplement, Immigra-
tion Statistics Staff, Population Division.
Data for all years updated through March 29, 2006.
Zero % (0) denotes <1%.
See Surveillance Slides #11 through #16.
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Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by
the Top 30 Countries2 of Origin of Birth: United States, 2001–2005
Country of Origin
2005 2004 2003 2002 2001
Year
No. No. No. No. No.(%) (%) (%) (%) (%)
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the
Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
2The top 30 countries were selected based on their ranked 5-year average number of TB cases.
3 Includes Not Specified for Country of Origin.  Excludes missing.
Note: Zero (0) denotes <1%.
Data for all years updated through March 29, 2006.
Total Cases 7693 (100) 7820 (100) 7911 (100) 7700 (100) 7989 (100)
Mexico 1,942 (25) 1,987 (25) 2,028 (26) 1,897 (25) 1,865 (23)
Philippines 829 (11) 828 (11) 914 (12) 868 (11) 911 (11)
Vietnam 577 (8) 619 (8) 661 (8) 657 (9) 631 (8)
India 567 (7) 561 (7) 603 (8) 584 (8) 613 (8)
China 392 (5) 350 (4) 372 (5) 356 (5) 434 (5)
Haiti 238 (3) 248 (3) 264 (3) 264 (3) 254 (3)
Korea, Rep. 173 (2) 219 (3) 194 (2) 210 (3) 208 (3)
Guatemala 209 (3) 191 (2) 172 (2) 149 (2) 139 (2)
Ecuador 155 (2) 159 (2) 159 (2) 149 (2) 164 (2)
Peru 154 (2) 159 (2) 157 (2) 151 (2) 143 (2)
Ethiopia 154 (2) 169 (2) 142 (2) 131 (2) 161 (2)
Somalia 147 (2) 139 (2) 105 (1) 142 (2) 165 (2)
El Salvador 142 (2) 125 (2) 116 (1) 152 (2) 158 (2)
Honduras 165 (2) 112 (1) 124 (2) 135 (2) 137 (2)
Cambodia 107 (1) 107 (1) 118 (1) 75 (1) 83 (1)
Dominican Republic 76 (1) 104 (1) 96 (1) 91 (1) 91 (1)
Lao, PDR 84 (1) 88 (1) 73 (1) 89 (1) 102 (1)
Pakistan 77 (1) 89 (1) 91 (1) 80 (1) 93 (1)
Kenya 65 (1) 68 (1) 79 (1) 80 (1) 83 (1)
Colombia 37 (0) 68 (1) 58 (1) 52 (1) 70 (1)
Cuba 55 (1) 56 (1) 49 (1) 58 (1) 58 (1)
Thailand 73 (1) 62 (1) 45 (1) 33 (0) 44 (1)
Indonesia 57 (1) 36 (0) 54 (1) 53 (1) 52 (1)
Nigeria 36 (0) 51 (1) 56 (1) 55 (1) 54 (1)
Liberia 64 (1) 54 (1) 30 (0) 26 (0) 44 (1)
Burma 39 (1) 41 (1) 31 (0) 38 (0) 40 (1)
Russia 43 (1) 28 (0) 30 (0) 38 (0) 47 (1)
Sudan 33 (0) 45 (1) 32 (0) 23 (0) 49 (1)
Bangladesh 34 (0) 38 (0) 29 (0) 34 (0) 45 (1)
Nepal 32 (0) 48 (1) 39 (0) 28 (0) 26 (0)



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9.  Pulmonary Tuberculosis Cases and Percentages by Sputum Smear and Sputum











No. (%) No. (%) No. No. No. No.(%) (%) (%) (%)
1Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
Note:  Data for all years updated through March 29, 2006.
1993 21158 9428 (45) 7915 (37) 3815 (18) 14878 (70) 2814 (13) 3466 (16)
1994 20316 8964 (44) 7912 (39) 3440 (17) 14210 (70) 2806 (14) 3300 (16)
1995 18887 8093 (43) 7712 (41) 3082 (16) 13281 (70) 2626 (14) 2980 (16)
1996 17387 7454 (43) 7351 (42) 2582 (15) 12268 (71) 2560 (15) 2559 (15)
1997 16239 6935 (43) 6916 (43) 2388 (15) 11568 (71) 2259 (14) 2412 (15)
1998 14799 6624 (45) 6037 (41) 2138 (14) 10485 (71) 2138 (14) 2176 (15)
1999 14068 6275 (45) 5663 (40) 2130 (15) 9820 (70) 2098 (15) 2150 (15)
2000 13086 5884 (45) 5342 (41) 1860 (14) 9251 (71) 1947 (15) 1888 (14)
2001 12724 5651 (44) 5320 (42) 1753 (14) 8903 (70) 2009 (16) 1812 (14)
2002 11901 5438 (46) 4793 (40) 1670 (14) 8329 (70) 1837 (15) 1735 (15)
2003 11808 5366 (45) 4875 (41) 1567 (13) 8209 (70) 1972 (17) 1627 (14)
2004 11537 5251 (46) 4877 (42) 1409 (12) 8026 (70) 2014 (17) 1497 (13)
2005 11128 5089 (46) 4680 (42) 1359 (12) 7634 (69) 1992 (18) 1502 (13)
1993 25108 20308 (81) 185 (1) 3086 (12) 1529 (6) 21158 (84) 3941 (16)
1994 24205 19506 (81) 189 (1) 2899 (12) 1611 (7) 20316 (84) 3887 (16)
1995 22727 18266 (80) 189 (1) 2727 (12) 1545 (7) 18887 (83) 3835 (17)
1996 21210 17152 (81) 131 (1) 2601 (12) 1326 (6) 17387 (82) 3814 (18)
1997 19751 15979 (81) 155 (1) 2405 (12) 1212 (6) 16239 (82) 3509 (18)
1998 18287 14790 (81) 155 (1) 2252 (12) 1090 (6) 14799 (81) 3485 (19)
1999 17501 13996 (80) 172 (1) 2100 (12) 1233 (7) 14068 (80) 3430 (20)
2000 16309 13013 (80) 148 (1) 1950 (12) 1198 (7) 13086 (80) 3211 (20)
2001 15946 12750 (80) 123 (1) 1887 (12) 1186 (7) 12724 (80) 3218 (20)
2002 15056 11976 (80) 104 (1) 1819 (12) 1157 (8) 11901 (79) 3148 (21)
2003 14840 11695 (79) 115 (1) 1780 (12) 1250 (8) 11808 (80) 3021 (20)
2004 14515 11319 (78) 85 (1) 1808 (12) 1303 (9) 11537 (79) 2975 (21)
2005 14097 10943 (78) 119 (1) 1754 (12) 1281 (9) 11128 (79) 2968 (21)
Table 8.  Tuberculosis Cases and Percentages by Case Verification Criterion and Site of















No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
1Based on the public health surveillance case definition for tuberculosis:  CDC. Case definitions for infectious conditions under public
health surveillance.  MMWR 1997:46(No. RR-10):40–41.  See Appendix A.
2Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
3Includes cases among persons with extrapulmonary TB disease only.
4Excludes missing and unknowns.
Note: See Technical Notes (page 9) for a description of national TB surveillance.
Data for all years updated through March 29, 2006.
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Table 10. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug
Resistance1 in Persons with No Previous History of TB, by Origin of Birth: United
States, 1993–2005
1Resistance to at least isoniazid and rifampin
2Isolates may be resistant to other drugs.
3All cases were culture positive, and initial drug susceptibility testing done.
4Includes persons of unknown country of birth.
5Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands.
6Includes Not Specified for Country of Origin.  Excludes missing.
Note:  Data for all years updated through March 29, 2006.
Percentages are of total cases for given year with no previous history of TB, culture positive, and initial drug susceptibility testing done
(total cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
See Surveillance Slides #19 through #22.
1993 1401 (8.4) 805 (6.8) 580 (12.3) 410 (2.5) 302 (2.5) 105 (2.2)
1994 1360 (8.3) 711 (6.4) 635 (12.0) 353 (2.1) 238 (2.2) 110 (2.1)
1995 1174 (7.3) 555 (5.4) 618 (11.0) 254 (1.6) 169 (1.6) 85 (1.5)
1996 1136 (7.4) 494 (5.1) 639 (11.3) 206 (1.3) 104 (1.1) 101 (1.8)
1997 1079 (7.4) 435 (5.0) 640 (11.2) 155 (1.1) 76 (0.9) 79 (1.4)
1998 1012 (7.5) 367 (4.7) 643 (11.3) 131 (1.0) 55 (0.7) 75 (1.3)
1999 899 (7.0) 283 (4.0) 614 (10.9) 127 (1.0) 39 (0.6) 88 (1.6)
2000 892 (7.5) 268 (4.3) 621 (11.0) 121 (1.0) 38 (0.6) 83 (1.5)
2001 803 (7.0) 243 (4.3) 559 (9.5) 115 (1.0) 34 (0.6) 81 (1.4)
2002 819 (7.6) 204 (4.0) 614 (10.8) 125 (1.2) 35 (0.7) 90 (1.6)
2003 814 (7.7) 210 (4.4) 601 (10.4) 91 (0.9) 24 (0.5) 67 (1.2)
2004 796 (7.7) 207 (4.5) 589 (10.4) 102 (1.0) 26 (0.6) 76 (1.3)
2005 721 (7.3) 179 (4.1) 537 (9.8) 95 (1.0) 18 (0.4) 76 (1.4)
Year
Resistance to Isoniazid2 Resistance to Isoniazid and Rifampin2
Total Cases3,4 Foreign-born5,6U.S.-born Total Cases3,4 U.S.-born Foreign-born5,6
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
1Resistance to at least isoniazid and rifampin
2Isolates may be resistant to other drugs.
3All cases were culture positive, and initial drug susceptibility testing done.
4Includes persons of unknown country of birth.
5Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands.
6 Includes Not Specified for Country of Origin.  Excludes missing.
Note:  Data for all years updated through March 29, 2006.
Percentages are of total cases for given year with previous history of TB, culture positive, and initial drug susceptibility testing done
(total cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
Table 11. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug
Resistance1 in Persons with Previous History  of TB, by Origin of Birth: United
States, 1993–2005
1993 164 (16.5) 85 (12.6) 76 (24.8) 75 (7.6) 30 (4.5) 45 (14.7)
1994 176 (17.0) 81 (11.6) 94 (27.9) 74 (7.1) 35 (5.0) 38 (11.3)
1995 168 (17.6) 77 (13.0) 91 (25.1) 70 (7.3) 28 (4.7) 42 (11.6)
1996 142 (16.4) 67 (12.0) 74 (24.3) 43 (5.0) 20 (3.6) 22 (7.2)
1997 109 (14.7) 35 (7.7) 74 (25.8) 44 (5.9) 12 (2.6) 32 (11.1)
1998 98 (13.0) 38 (7.8) 60 (22.7) 23 (3.1) 6 (1.2) 17 (6.4)
1999 82 (12.2) 25 (6.5) 55 (19.3) 28 (4.2) 6 (1.6) 22 (7.7)
2000 82 (12.9) 22 (6.0) 60 (22.1) 24 (3.8) 2 (0.5) 22 (8.1)
2001 85 (13.5) 28 (8.6) 57 (18.9) 31 (4.9) 7 (2.2) 24 (8.0)
2002 79 (14.0) 23 (7.6) 56 (21.5) 25 (4.4) 3 (1.0) 22 (8.5)
2003 65 (12.5) 17 (6.8) 48 (17.7) 20 (3.8) 3 (1.2) 17 (6.3)
2004 62 (11.9) 15 (5.6) 47 (18.4) 25 (4.8) 4 (1.5) 21 (8.2)
2005 71 (14.6) 21 (9.1) 50 (19.7) 23 (4.7) 3 (1.3) 20 (7.9)
Year
Resistance to Isoniazid2 Resistance to Isoniazid and Rifampin2
Total Cases3,4 Foreign-born5,6U.S.-born Total Cases3,4 U.S.-born Foreign-born5,6
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
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Table 13.  Tuberculosis Cases and Percentages in Persons with HIV Test Results and with
HIV Coinfection by Age Group: United States, 1993–2004
Year





No. No. No. No.(%) (%) (%) (%)
1993 4375 (46) 2788 (29) 7455 (30) 3681 (15)
1994 4442 (49) 2667 (29) 7883 (33) 3599 (15)
1995 4277 (52) 2172 (26) 8178 (36) 3038 (13)
1996 4366 (58) 1856 (25) 8831 (42) 2615 (12)
1997 4143 (60) 1473 (21) 8771 (44) 2092 (11)
1998 3861 (61) 1240 (20) 8290 (45) 1831 (10)
1999 3811 (63) 1175 (19) 8420 (48) 1726 (10)
2000 3524 (63) 955 (17) 8110 (50) 1464 (9)
2001 3566 (64) 911 (16) 8036 (50) 1406 (9)
2002 3485 (66) 844 (16) 7940 (53) 1389 (9)
2003 3424 (67) 807 (16) 8103 (55) 1320 (9)
2004 3306 (67) 683 (14) 8111 (56) 1187 (8)
1Includes persons with positive, negative, or indeterminate HIV test results and persons from California also reported with AIDS.  Rhode
Island reported HIV test results in 1998–2001. HIV test results were not reported from California.  However, California provided HIV
status for TB cases reported during 1993–2004 in persons with AIDS (i.e., HIV positive). Percentages based on all reported TB cases.
2Includes cases in persons with HIV-positive test results and California cases in persons also reported with AIDS.  Percentages based
on all reported TB cases.
Note:  Data for all years updated through March 29, 2006.
See Surveillance Slides #23 and #24.
1993 (13.0) (31.2) (40.9) (40.4) (21.7) (14.4) (64.1) (87.5)
1994 (7.1) (23.3) (56.4) (55.8) (28.1) (20.5) (69.0) (87.8)
1995 (5.2) (20.3) (63.4) (62.7) (37.2) (21.5) (73.2) (89.6)
1996 (4.2) (17.5) (67.9) (67.4) (42.5) (22.4) (75.8) (90.4)
1997 (3.2) (15.1) (72.5) (72.0) (46.9) (23.8) (77.9) (91.2)
1998 (2.6) (12.9) (74.7) (74.3) (47.7) (26.6) (80.3) (92.5)
1999 (2.2) (11.3) (77.2) (76.9) (49.4) (27.6) (80.0) (92.4)
2000 (2.0) (10.4) (78.7) (78.5) (52.5) (25.9) (81.0) (92.6)
2001 (1.7) (9.6) (80.2) (79.9) (53.7) (27.5) (81.0) (92.4)
2002 (1.8) (8.9) (80.5) (80.3) (55.4) (27.7) (81.4) (92.2)
2003 (1.4) (8.1) (81.5) (81.4) (56.6) (28.4) (81.5) (92.2)
2004 (1.5) (6.3) (82.4) (82.2) ... ... ... ...
2005 (1.2) (5.5) (83.6) (83.5) ... ... ... ...
Table 12.  Percentages of TB Cases by Initial Drug Regimen, Use of Directly Observed




Therapy <1 Year Indicated4
IRZ IRZ, E/S DOT Only
Both DOT and Self-
Administered COT <1 Year COTI R
1Includes persons alive at diagnosis.
2I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.  Excludes cases with no information on initial drug regimen;
1% received no initial drug therapy, less than 1% were started on one drug, and approximately 9% had an initial multidrug regimen other
than IR, IRZ, or IRZ,E/S.
3Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy.  Excludes
persons with initial isolate resistant to rifampin and pediatric (aged <15) cases with meningeal, bone or joint, or miliary disease.  See
Technical Notes (page 9) for description of COT calculation.
Note: Ellipses indicate data not available.
Data for all years updated through March 29, 2006.
See Surveillance Slides #25 and #26.
IRZE
24
Table 14.  Tuberculosis (TB) Cases and Percentages by Reason Tuberculosis Therapy
Stopped: United States, 1993–2003
1993 23741 18042 (76) 1121 (5) 1087 (5) 223 (1) 3051 (13) 217 (1)
1994 23051 17761 (77) 1194 (5) 739 (3) 183 (1) 2743 (12) 431 (2)
1995 21711 17285 (80) 970 (5) 563 (3) 155 (1) 2390 (11) 348 (2)
1996 20297 16510 (81) 783 (4) 520 (3) 156 (1) 1991 (10) 337 (2)
1997 18930 15653 (83) 668 (4) 434 (2) 119 (1) 1755 (9) 301 (2)
1998 17584 14773 (84) 534 (3) 400 (2) 104 (1) 1578 (9) 195 (1)
1999 16863 14238 (84) 457 (3) 356 (2) 104 (1) 1439 (9) 269 (2)
2000 15785 13401 (85) 410 (3) 390 (3) 112 (1) 1294 (8) 178 (1)
2001 15410 13187 (86) 373 (2) 364 (2) 96 (1) 1114 (7) 276 (2)
2002 14556 12415 (85) 333 (2) 366 (3) 86 (1) 1069 (7) 287 (2)
2003 14382 12328 (86) 324 (2) 353 (3) 83 (1) 982 (7) 312 (2)
Year
Total
Cases1 Completed Therapy Moved Lost Refused Died2 Unknown3
1Includes all cases in persons reported as alive at diagnosis and taking one or more TB drugs.
2Died = died of any cause (not only TB).
3Includes cases in persons reporting reason therapy stopped = Other, Missing, or Unknown.
Note: Data for all years are updated through March 29, 2006.
Data complete through 2003 only.  See Technical Notes (page 9) for details.




Table 15.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age
Group: United States, 2005
1Persons of Hispanic or Latino ethnicity may be of any race or multiple race.
2Indicates two or more races reported for a person. Category first reported in 2003.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or
Other Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple
Race does not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slides #6 and #9.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
Total Cases 14,097 480 383 1,542 4,743 4,133 2,816 0
  Male 8,715 246 194 882 2,858 2,836 1,699 0
  Female 5,382 234 189 660 1,885 1,297 1,117 0
  Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino1 4,043 239 158 665 1,612 888 481 0
  Male 2,648 122 90 440 1,109 606 281 0
  Female 1,395 117 68 225 503 282 200 0
  Unknown 0 0 0 0 0 0 0 0
Non-Hispanic
 American Indian or Alaska Native 153 9 3 9 43 64 25 0
  Male 97 6 0 6 32 36 17 0
  Female 56 3 3 3 11 28 8 0
  Unknown 0 0 0 0 0 0 0 0
 Asian 3,209 52 52 271 1,140 892 802 0
  Male 1,734 24 18 126 542 533 491 0
  Female 1,475 28 34 145 598 359 311 0
  Unknown 0 0 0 0 0 0 0 0
 Black or African American 3,954 131 133 465 1,347 1,315 563 0
  Male 2,442 68 65 240 798 931 340 0
  Female 1,512 63 68 225 549 384 223 0
  Unknown 0 0 0 0 0 0 0 0
 Native Hawaiian or Other Pacific Islander 56 2 4 14 15 11 10 0
  Male 33 2 2 6 8 8 7 0
  Female 23 0 2 8 7 3 3 0
  Unknown 0 0 0 0 0 0 0 0
 White 2,581 42 27 110 551 933 918 0
  Male 1,700 19 16 61 348 702 554 0
  Female 881 23 11 49 203 231 364 0
  Unknown 0 0 0 0 0 0 0 0
 Multiple Race 2 46 5 4 5 17 11 4 0
  Male 28 5 2 2 9 8 2 0
  Female 18 0 2 3 8 3 2 0
  Unknown 0 0 0 0 0 0 0 0
 Unknown 55 0 2 3 18 19 13 0
  Male 33 0 1 1 12 12 7 0
  Female 22 0 1 2 6 7 6 0
  Unknown 0 0 0 0 0 0 0 0
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Table 16.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2005
1Persons of Hispanic or Latino origin may be of any race or multiple race.
2Indicates two or more races reported for a person. Category first reported in 2003.
Note: Denominators for computing case rates were obtained from the U.S. Census Bureau Monthly Postcensal Resident Population,
by single year of age, sex, race, and Hispanic origin: July 1, 2005 (http://www.census.gov/popest/national/asrh/files/NC_EST2005-
ALLDATA-R-File12.txt) (Accessed June 1, 2006).
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race
does not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slide #10.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45 –64 >65
Total Rate 4.8 2.4 0.9 3.7 5.6 5.7 7.7
Male 6.0 2.4 0.9 4.1 6.7 8.0 11.0
Female 3.6 2.4 1.0 3.2 4.5 3.5 5.2
Hispanic or Latino1 9.5 5.3 2.0 9.2 11.3 13.4 21.1
 Male 12.0 5.3 2.3 11.5 14.5 18.4 29.0
 Female 6.8 5.3 1.8 6.7 7.7 8.4 15.2
Non-Hispanic
 American Indian or Alaska Native 6.9 5.2 0.8 2.2 6.8 13.1 15.0
  Male 8.8 6.8 0.0 2.9 10.1 15.3 23.3
  Female 5.0 3.5 1.7 1.5 3.4 11.0 8.5
 Asian 25.8 6.2 3.4 16.3 25.7 31.0 72.9
  Male 28.8 5.6 2.3 14.9 25.1 39.8 104.2
  Female 23.0 6.9 4.5 17.9 26.3 23.4 49.5
 Black or African American 10.9 4.5 2.2 7.7 12.7 16.9 18.5
  Male 14.1 4.6 2.2 7.8 15.9 26.3 29.2
  Female 7.9 4.4 2.3 7.5 9.9 9.1 11.9
 Native Hawaiian or Other Pacific Islander 13.8 7.4 6.3 19.9 11.1 13.4 37.1
  Male 16.1 14.3 6.1 16.6 11.7 19.6 57.7
  Female 11.5 0.0 6.4 23.4 10.6 7.3 20.2
 White 1.3 0.4 0.1 0.4 1.0 1.7 3.1
  Male 1.7 0.3 0.1 0.5 1.3 2.6 4.4
  Female 0.9 0.4 0.1 0.4 0.8 0.8 2.1
 Multiple Race 2 1.2 0.9 0.4 0.7 1.9 1.9 1.9
  Male 1.4 1.8 0.4 0.5 2.1 2.9 2.2
  Female 0.9 0.0 0.4 0.8 1.7 1.0 1.7
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Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
Table 17.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic
Race, Sex, and Age Group: United States, 2005
1Persons of Hispanic or Latino origin may be of any race or multiple race.
2Indicates two or more races reported for a person. Category first reported in 2003.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or
Other Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple
race does not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slide #13.
Total Cases 6,371 405 212 449 1,560 2,273 1,472 0
Male 4,125 210 109 230 979 1,678 919 0
Female 2,246 195 103 219 581 595 553 0
Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino1 982 206 87 123 223 215 128 0
 Male 593 105 48 64 143 157 76 0
 Female 389 101 39 59 80 58 52 0
 Unknown 0 0 0 0 0 0 0 0
Non-Hispanic
 American Indian or Alaska Native 146 9 3 9 41 62 22 0
  Male 92 6 0 6 31 34 15 0
  Female 54 3 3 3 10 28 7 0
  Unknown 0 0 0 0 0 0 0 0
 Asian 131 35 13 15 26 19 23 0
  Male 70 18 2 9 11 14 16 0
  Female 61 17 11 6 15 5 7 0
  Unknown 0 0 0 0 0 0 0 0
 Black or African American 2,887 114 80 223 848 1,126 496 0
  Male 1,850 60 41 106 516 821 306 0
  Female 1,037 54 39 117 332 305 190 0
  Unknown 0 0 0 0 0 0 0 0
 Native Hawaiian or Other Pacific Islander 40 2 3 12 12 7 4 0
  Male 22 2 2 4 6 5 3 0
  Female 18 0 1 8 6 2 1 0
  Unknown 0 0 0 0 0 0 0 0
 White 2,146 34 22 66 404 830 790 0
  Male 1,469 14 13 41 266 636 499 0
  Female 677 20 9 25 138 194 291 0
  Unknown 0 0 0 0 0 0 0 0
 Multiple Race 2 21 5 3 1 4 5 3 0
  Male 17 5 2 0 4 4 2 0
  Female 4 0 1 1 0 1 1 0
  Unknown 0 0 0 0 0 0 0 0
 Unknown 18 0 1 0 2 9 6 0
  Male 12 0 1 0 2 7 2 0
  Female 6 0 0 0 0 2 4 0
  Unknown 0 0 0 0 0 0 0 0
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Table 18.  Tuberculosis Cases in Foreign-born Persons1 by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2005
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands.
2Persons of Hispanic or Latino ethnicity may be of any race or multiple race.
3Indicates two or more races reported for a person. Category first reported in 2003.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or
Other Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple
race does not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slide #13.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
Total Cases 7,693 75 170 1,092 3,178 1,844 1,334 0
Male 4,564 36 84 651 1,874 1,148 771 0
Female 3,129 39 86 441 1,304 696 563 0
Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino2 3,044 33 70 541 1,386 667 347 0
 Male 2,040 17 41 375 963 444 200 0
 Female 1,004 16 29 166 423 223 147 0
 Unknown 0 0 0 0 0 0 0 0
Non-Hispanic
 American Indian or Alaska Native 7 0 0 0 2 2 3 0
  Male 5 0 0 0 1 2 2 0
  Female 2 0 0 0 1 0 1 0
  Unknown 0 0 0 0 0 0 0 0
 Asian 3,074 17 39 256 1,113 872 777 0
  Male 1,660 6 16 117 530 518 473 0
  Female 1,414 11 23 139 583 354 304 0
  Unknown 0 0 0 0 0 0 0 0
 Black or African American 1,063 17 53 242 499 186 66 0
  Male 589 8 24 134 282 108 33 0
  Female 474 9 29 108 217 78 33 0
  Unknown 0 0 0 0 0 0 0 0
 Native Hawaiian or Other Pacific Islander 16 0 1 2 3 4 6 0
  Male 11 0 0 2 2 3 4 0
  Female 5 0 1 0 1 1 2 0
  Unknown 0 0 0 0 0 0 0 0
 White 434 8 5 44 147 102 128 0
  Male 230 5 3 20 82 65 55 0
  Female 204 3 2 24 65 37 73 0
  Unknown 0 0 0 0 0 0 0 0
 Multiple Race 3 25 0 1 4 13 6 1 0
  Male 11 0 0 2 5 4 0 0
  Female 14 0 1 2 8 2 1 0
  Unknown 0 0 0 0 0 0 0 0
 Unknown 30 0 1 3 15 5 6 0
  Male 18 0 0 1 9 4 4 0
  Female 12 0 1 2 6 1 2 0
  Unknown 0 0 0 0 0 0 0 0
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Table 19. Tuberculosis Cases by Country of Origin1: United States, 2005
Algeria 2 Gabon 0 Nigeria 36
Angola 4 Gambia 13 Rwanda 3
Benin 0 Ghana 15 Sao Tome and Principe 0
Botswana 4 Guinea 20 Senegal 13
Burkina Faso 2 Guinea-Bissau 0 Seychelles 0
Burundi 2 Kenya 65 Sierra Leone 24
Cameroon 22 Lesotho 1 South Africa 9
Cape Verde 10 Liberia 64 Swaziland 0
Central African Republic 1 Madagascar 0 Tanzania, UR 5
Chad 0 Malawi 0 Togo 7
Comoros 0 Mali 6 Uganda 10
Congo, Republic of 18 Mauritania 5 Zambia 22
Côte d’Ivoire 14 Mauritius 0 Zimbabwe 15
DR Congo 1 Mozambique 0
Equatorial Guinea 0 Namibia 3
Ethiopia 154 Niger 2
Anguilla 0 Cuba 55 Panama 6
Antigua and Barbuda 3 Dominica 2 Paraguay 0
Argentina 7 Dominican Republic 76 Peru 154
Bahamas 5 Ecuador 155 Puerto Rico 68
Barbados 5 El Salvador 142 St. Kitts and Nevis 0
Belize 4 Grenada 1 St. Lucia 2
Bermuda 1 Guatemala 209 St. Vincent & Grenadines 4
Bolivia 24 Guyana 29 Suriname 1
Brazil 37 Haiti 238 Trinidad and Tobago 12
British Virgin Islands 1 Honduras 165 Turks and Caicos Islands 0
Canada 6 Jamaica 27 Uruguay 6
Cayman Islands 0 Mexico 1942 U.S. Virgin Islands 1
Chile 2 Montserrat 0 United States of America 6273
Colombia 37 Netherland Antilles 0 Venezuela 6
Costa Rica 5 Nicaragua 20
Afghanistan 23 Lebanon 2 Sudan 33
Bahrain 0 Libyan Arab Jamahiriya 1 Syrian Arab Republic 3
Djibouti 2 Morocco 14 Tunisia 1
Egypt 6 Oman 0 United Arab Emirates 0
Iran, Islamic Republic of 19 Pakistan 77 West Bank and Gaza 0
Iraq 6 Qatar 0 Yemen 8
Jordan 3 Saudi Arabia 2








Albania 1 Greece 4 Poland 31
Andorra 1 Hungary 8 Portugal 9
Armenia 13 Iceland 0 Romania 15
Austria 1 Ireland 2 Russian Federation 43
Azerbaijan 2 Israel 3 San Marino 0
Belarus 1 Italy 10 Serbia 3
Belguim 0 Kazakhstan 7 Slovakia 0
Bosnia and Herzegovina 28 Kyrgyzstan 1 Slovenia 0
Bulgaria 5 Latvia 0 Spain 6
Croatia 2 Lithuania 3 Sweden 1
Cyprus 0 Luxembourg 0 Switzerland 1
Czech Republic 0 Macedonia, TFYR 2 Tajikistan 0
Denmark 2 Malta 0 Turkey 12
Estonia 0 Moldova, Republic of 0 Turkmenistan 0
Finland 1 Monaco 0 Ukraine 20
France 4 Montenegro 0 United Kingdom 8
Georgia 0 Netherlands 0 Uzbekistan 3
Germany 14 Norway 0 Yugoslavia 11
Bangladesh 34 Korea, DPR 21 Sri Lanka 2
Bhutan 2 Maldives 0 Thailand 73
India 567 Myanmar 39 Timor-Leste 0
Indonesia 57 Nepal 32
American Samoa 0 Korea, Rep. 173 Philippines 829
Australia 0 Lao, PDR 84 Samoa 2
Brunei Darussalam 0 Malaysia 4 Singapore 2
Cambodia 107 Marshall Islands, Republic of 12 Solomon Islands 0
China 392 Micronesia, Federated States of 7 Tokelau 0
China, Hong Kong SAR 30 Mongolia 7 Tonga 2
China, Macao SAR 1 Nauru 0 Tuvalu 0
Cook Islands 0 New Caledonia 0 Vanuatu 0
Fiji 2 New Zealand 0 Vietnam 577
French Polynesia 0 Niue 0 Wallis and Futuna 0
Guam 9 N. Mariana Islands, Commonwealth of 0
Japan 22 Palau, Republic of 1
Kiribati 0 Papua New Guinea 0
1Country as reported by patient.
2Includes country codes currently reported via the National Tuberculosis Surveillance System that are not represented by WHO member
states.
Note:  Regional composition of countries based on  WHO 2006 Report Global Tuberculosis Control, Surveillance, Planning, Financing,
World Health Organization  (WHO/HTM/TB/2006.362) (http://www.who.int/tb/publications/global_report/en/).
















Table 20. Tuberculosis Cases and Case Rates per 100,000 Population: States, 2005 and 2004
1Not ranked with the states. See Table 28, page 50, for District of Columbia ranking among states.
2Not included in U.S. totals.
Note: Denominators for computing 2004 and 2005 rates for states, the District of Columbia, and Puerto Rico were obtained from Annual
Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2005 (NST-EST2005-01)
(accessed June 1, 2006)  (http://www.census.gov/popest/states/tables/NST-EST2005-01.xls); for all other areas, from IDB Summary
Demographic Data (http://www.census.gov/ipc/www/idbsum.html).
Ellipses indicate data not available.
See Surveillance Slide #4.
United States 14,097 14,515 4.8 4.9 — — 296,410,404
Alabama 216 211 4.7 4.7 13 17 4,557,808
Alaska 59 43 8.9 6.5 1 5 663,661
Arizona 281 272 4.7 4.7 14 14 5,939,292
Arkansas 114 132 4.1 4.8 20 13 2,779,154
California 2,904 2,992 8.0 8.3 3 2 36,132,147
Colorado 101 127 2.2 2.8 35 30 4,665,177
Connecticut 95 101 2.7 2.9 29 29 3,510,297
Delaware 26 32 3.1 3.9 26 26 843,524
District of Columbia1 56 81 10.2 14.6 — — 550,521
Florida 1,094 1,075 6.1 6.2 6 6 17,789,864
Georgia 505 539 5.6 6.0 9 7 9,072,576
Hawaii 112 116 8.8 9.2 2 1 1,275,194
Idaho 23 11 1.6 0.8 41 49 1,429,096
Illinois 596 568 4.7 4.5 16 18 12,763,371
Indiana 146 128 2.3 2.1 32 37 6,271,973
Iowa 55 47 1.9 1.6 40 42 2,966,334
Kansas 60 62 2.2 2.3 34 33 2,744,687
Kentucky 124 127 3.0 3.1 27 27 4,173,405
Louisiana 257 249 5.7 5.5 8 11 4,523,628
Maine 17 20 1.3 1.5 44 43 1,321,505
Maryland 283 314 5.1 5.6 11 8 5,600,388
Massachusetts 265 283 4.1 4.4 19 20 6,398,743
Michigan 246 272 2.4 2.7 31 31 10,120,860
Minnesota 199 199 3.9 3.9 23 25 5,132,799
Mississippi 103 119 3.5 4.1 25 22 2,921,088
Missouri 108 127 1.9 2.2 39 36 5,800,310
Montana 10 15 1.1 1.6 47 41 935,670
Nebraska 35 39 2.0 2.2 38 34 1,758,787
Nevada 112 95 4.6 4.1 17 23 2,414,807
New Hampshire 4 24 0.3 1.8 49 39 1,309,940
New Jersey 485 482 5.6 5.5 10 10 8,717,925
New Mexico 39 42 2.0 2.2 37 35 1,928,384
New York 1,289 1,360 6.7 7.1 5 4 19,254,630
North Carolina 329 381 3.8 4.5 24 19 8,683,242
North Dakota 6 4 0.9 0.6 48 50 636,677
Ohio 260 219 2.3 1.9 33 38 11,464,042
Oklahoma 144 178 4.1 5.1 22 12 3,547,884
Oregon 103 106 2.8 3.0 28 28 3,641,056
Pennsylvania 325 328 2.6 2.6 30 32 12,429,616
Rhode Island 47 51 4.4 4.7 18 15 1,076,189
South Carolina 261 233 6.1 5.6 7 9 4,255,083
South Dakota 16 11 2.1 1.4 36 45 775,933
Tennessee 298 277 5.0 4.7 12 16 5,962,959
Texas 1,535 1,683 6.7 7.5 4 3 22,859,968
Utah 29 36 1.2 1.5 46 44 2,469,585
Vermont 8 6 1.3 1.0 45 48 623,050
Virginia 355 329 4.7 4.4 15 21 7,567,465
Washington 256 245 4.1 3.9 21 24 6,287,759
West Virginia 28 24 1.5 1.3 42 46 1,816,856
Wisconsin 78 95 1.4 1.7 43 40 5,536,201
Wyoming 0 5 0.0 1.0 50 47 509,294
American Samoa1,2 5 3 8.6 5.2 — — 57,881
Fed. States of Micronesia1,2 74 8 68.5 7.4 — — 108,105
Guam1,2 64 51 38.0 30.7 — — 168,564
Marshall Islands1,2 66 41 111.7 71.0 — — 59,071
N. Mariana Islands1,2 56 55 69.7 70.3 — — 80,362
Puerto Rico1,2 113 123 2.9 3.2 — — 3,912,054
Republic of Palau1,2 10 5 49.3 25.0 — — 20,303
U.S. Virgin Islands1,2 ... ... ... ... — — 108,708
State
Cases Case Rates Rank According to Rate Population Estimates


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands. See Surveillance Slide #14.




Cases No. No. No.(%) (%) (%)
U.S.-born Persons Foreign-born Persons1 Unknown Origin
United States 14,097 6,371 (45.2) 7,693 (54.6) 33 (0.2)
Alabama 216 176 (81.5) 40 (18.5) 0 (0.0)
Alaska 59 42 (71.2) 17 (28.8) 0 (0.0)
Arizona 281 109 (38.8) 169 (60.1) 3 (1.1)
Arkansas 114 86 (75.4) 28 (24.6) 0 (0.0)
California 2,904 655 (22.6) 2,229 (76.8) 20 (0.7)
Colorado 101 42 (41.6) 59 (58.4) 0 (0.0)
Connecticut 95 32 (33.7) 63 (66.3) 0 (0.0)
Delaware 26 9 (34.6) 17 (65.4) 0 (0.0)
District of Columbia 56 34 (60.7) 22 (39.3) 0 (0.0)
Florida 1,094 609 (55.7) 485 (44.3) 0 (0.0)
Georgia 505 319 (63.2) 186 (36.8) 0 (0.0)
Hawaii 112 30 (26.8) 82 (73.2) 0 (0.0)
Idaho 23 12 (52.2) 11 (47.8) 0 (0.0)
Illinois 596 328 (55.0) 267 (44.8) 1 (0.2)
Indiana 146 86 (58.9) 60 (41.1) 0 (0.0)
Iowa 55 25 (45.5) 30 (54.5) 0 (0.0)
Kansas 60 29 (48.3) 31 (51.7) 0 (0.0)
Kentucky 124 93 (75.0) 31 (25.0) 0 (0.0)
Louisiana 257 232 (90.3) 25 (9.7) 0 (0.0)
Maine 17 9 (52.9) 8 (47.1) 0 (0.0)
Maryland 283 110 (38.9) 173 (61.1) 0 (0.0)
Massachusetts 265 60 (22.6) 205 (77.4) 0 (0.0)
Michigan 246 148 (60.2) 98 (39.8) 0 (0.0)
Minnesota 199 26 (13.1) 173 (86.9) 0 (0.0)
Mississippi 103 88 (85.4) 15 (14.6) 0 (0.0)
Missouri 108 70 (64.8) 38 (35.2) 0 (0.0)
Montana 10 10 (100.0) 0 (0.0) 0 (0.0)
Nebraska 35 14 (40.0) 21 (60.0) 0 (0.0)
Nevada 112 34 (30.4) 78 (69.6) 0 (0.0)
New Hampshire 4 0 (0.0) 4 (100.0) 0 (0.0)
New Jersey 485 163 (33.6) 322 (66.4) 0 (0.0)
New Mexico 39 21 (53.8) 18 (46.2) 0 (0.0)
New York 1,289 384 (29.8) 898 (69.7) 7 (0.5)
North Carolina 329 219 (66.6) 110 (33.4) 0 (0.0)
North Dakota 6 5 (83.3) 1 (16.7) 0 (0.0)
Ohio 260 156 (60.0) 104 (40.0) 0 (0.0)
Oklahoma 144 109 (75.7) 34 (23.6) 1 (0.7)
Oregon 103 40 (38.8) 63 (61.2) 0 (0.0)
Pennsylvania 325 174 (53.5) 151 (46.5) 0 (0.0)
Rhode Island 47 15 (31.9) 31 (66.0) 1 (2.1)
South Carolina 261 243 (93.1) 18 (6.9) 0 (0.0)
South Dakota 16 10 (62.5) 6 (37.5) 0 (0.0)
Tennessee 298 234 (78.5) 64 (21.5) 0 (0.0)
Texas 1,535 797 (51.9) 738 (48.1) 0 (0.0)
Utah 29 7 (24.1) 22 (75.9) 0 (0.0)
Vermont 8 6 (75.0) 2 (25.0) 0 (0.0)
Virginia 355 136 (38.3) 219 (61.7) 0 (0.0)
Washington 256 85 (33.2) 171 (66.8) 0 (0.0)
West Virginia 28 24 (85.7) 4 (14.3) 0 (0.0)
Wisconsin 78 26 (33.3) 52 (66.7) 0 (0.0)
Wyoming 0 0 — 0 — 0 —
43














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Number of Years




1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands.
See Surveillance Slide #18.
<1 Year 1–4 5–9 10–19 >20 Unknown orMissing
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
United States 7,693 1,472 (19.1) 1,695 (22.0) 1,104 (14.4) 1,257 (16.3) 1,274 (16.6) 891 (11.6)
Alabama 40 15 (37.5) 11 (27.5) 7 (17.5) 5 (12.5) 2 (5.0) 0 (0.0)
Alaska 17 7 (41.2) 0 (0.0) 5 (29.4) 1 (5.9) 3 (17.6) 1 (5.9)
Arizona 169 39 (23.1) 33 (19.5) 22 (13.0) 20 (11.8) 25 (14.8) 30 (17.8)
Arkansas 28 5 (17.9) 7 (25.0) 7 (25.0) 7 (25.0) 2 (7.1) 0 (0.0)
California 2,229 404 (18.1) 321 (14.4) 268 (12.0) 449 (20.1) 518 (23.2) 269 (12.1)
Colorado 59 15 (25.4) 12 (20.3) 4 (6.8) 11 (18.6) 7 (11.9) 10 (16.9)
Connecticut 63 10 (15.9) 22 (34.9) 11 (17.5) 12 (19.0) 8 (12.7) 0 (0.0)
Delaware 17 5 (29.4) 5 (29.4) 2 (11.8) 4 (23.5) 1 (5.9) 0 (0.0)
District of Columbia 22 5 (22.7) 8 (36.4) 4 (18.2) 4 (18.2) 1 (4.5) 0 (0.0)
Florida 485 83 (17.1) 141 (29.1) 70 (14.4) 59 (12.2) 85 (17.5) 47 (9.7)
Georgia 186 43 (23.1) 59 (31.7) 29 (15.6) 26 (14.0) 14 (7.5) 15 (8.1)
Hawaii 82 21 (25.6) 5 (6.1) 4 (4.9) 21 (25.6) 25 (30.5) 6 (7.3)
Idaho 11 4 (36.4) 4 (36.4) 1 (9.1) 1 (9.1) 1 (9.1) 0 (0.0)
Illinois 267 51 (19.1) 63 (23.6) 43 (16.1) 46 (17.2) 27 (10.1) 37 (13.9)
Indiana 60 13 (21.7) 12 (20.0) 13 (21.7) 4 (6.7) 1 (1.7) 17 (28.3)
Iowa 30 8 (26.7) 10 (33.3) 9 (30.0) 2 (6.7) 1 (3.3) 0 (0.0)
Kansas 31 9 (29.0) 6 (19.4) 5 (16.1) 3 (9.7) 6 (19.4) 2 (6.5)
Kentucky 31 8 (25.8) 10 (32.3) 4 (12.9) 7 (22.6) 2 (6.5) 0 (0.0)
Louisiana 25 5 (20.0) 4 (16.0) 3 (12.0) 3 (12.0) 6 (24.0) 4 (16.0)
Maine 8 0 (0.0) 2 (25.0) 3 (37.5) 0 (0.0) 3 (37.5) 0 (0.0)
Maryland 173 42 (24.3) 49 (28.3) 32 (18.5) 23 (13.3) 23 (13.3) 4 (2.3)
Massachusetts 205 45 (22.0) 50 (24.4) 36 (17.6) 41 (20.0) 28 (13.7) 5 (2.4)
Michigan 98 15 (15.3) 34 (34.7) 13 (13.3) 17 (17.3) 18 (18.4) 1 (1.0)
Minnesota 173 63 (36.4) 42 (24.3) 22 (12.7) 6 (3.5) 7 (4.0) 33 (19.1)
Mississippi 15 1 (6.7) 7 (46.7) 3 (20.0) 3 (20.0) 1 (6.7) 0 (0.0)
Missouri 38 5 (13.2) 18 (47.4) 8 (21.1) 4 (10.5) 3 (7.9) 0 (0.0)
Montana 0 0 — 0 — 0 — 0 — 0 — 0 —
Nebraska 21 5 (23.8) 8 (38.1) 4 (19.0) 3 (14.3) 1 (4.8) 0 (0.0)
Nevada 78 13 (16.7) 13 (16.7) 21 (26.9) 16 (20.5) 15 (19.2) 0 (0.0)
New Hampshire 4 1 (25.0) 0 (0.0) 3 (75.0) 0 (0.0) 0 (0.0) 0 (0.0)
New Jersey 322 42 (13.0) 77 (23.9) 33 (10.2) 31 (9.6) 24 (7.5) 115 (35.7)
New Mexico 18 4 (22.2) 1 (5.6) 5 (27.8) 2 (11.1) 6 (33.3) 0 (0.0)
New York 898 120 (13.4) 239 (26.6) 130 (14.5) 168 (18.7) 143 (15.9) 98 (10.9)
North Carolina 110 20 (18.2) 31 (28.2) 19 (17.3) 18 (16.4) 8 (7.3) 14 (12.7)
North Dakota 1 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0)
Ohio 104 34 (32.7) 29 (27.9) 16 (15.4) 8 (7.7) 10 (9.6) 7 (6.7)
Oklahoma 34 7 (20.6) 6 (17.6) 2 (5.9) 9 (26.5) 10 (29.4) 0 (0.0)
Oregon 63 21 (33.3) 7 (11.1) 4 (6.3) 5 (7.9) 6 (9.5) 20 (31.7)
Pennsylvania 151 26 (17.2) 34 (22.5) 40 (26.5) 27 (17.9) 17 (11.3) 7 (4.6)
Rhode Island 31 7 (22.6) 2 (6.5) 0 (0.0) 1 (3.2) 1 (3.2) 20 (64.5)
South Carolina 18 5 (27.8) 7 (38.9) 3 (16.7) 2 (11.1) 1 (5.6) 0 (0.0)
South Dakota 6 0 (0.0) 2 (33.3) 0 (0.0) 3 (50.0) 1 (16.7) 0 (0.0)
Tennessee 64 19 (29.7) 20 (31.3) 19 (29.7) 2 (3.1) 3 (4.7) 1 (1.6)
Texas 738 131 (17.8) 152 (20.6) 107 (14.5) 119 (16.1) 156 (21.1) 73 (9.9)
Utah 22 7 (31.8) 6 (27.3) 2 (9.1) 3 (13.6) 4 (18.2) 0 (0.0)
Vermont 2 1 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (50.0) 0 (0.0)
Virginia 219 51 (23.3) 78 (35.6) 32 (14.6) 33 (15.1) 25 (11.4) 0 (0.0)
Washington 171 19 (11.1) 37 (21.6) 20 (11.7) 25 (14.6) 23 (13.5) 47 (27.5)
West Virginia 4 2 (50.0) 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Wisconsin 52 16 (30.8) 9 (17.3) 16 (30.8) 3 (5.8) 1 (1.9) 7 (13.5)
Wyoming 0 0 — 0 — 0 — 0 — 0 — 0 —
47









No. No. No. No.(%) (%) (%)
1Includes cases with pulmonary listed as major site of disease and no additional site of disease.
2Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major
site of disease.
3Includes miliary cases.
4Not included in U.S. totals.
Note:  1 case had missing and/or unknown site of disease.
Ellipses indicate data not available.
United States 14,097 9,908 (70.3) 2,968 (21.1) 1,220 (8.7) 260
Alabama 216 175 (81.0) 33 (15.3) 8 (3.7) 1
Alaska 59 52 (88.1) 6 (10.2) 1 (1.7) 0
Arizona 281 231 (82.2) 35 (12.5) 15 (5.3) 2
Arkansas 114 90 (78.9) 18 (15.8) 6 (5.3) 0
California 2,904 2,025 (69.7) 623 (21.5) 255 (8.8) 46
Colorado 101 58 (57.4) 31 (30.7) 12 (11.9) 3
Connecticut 95 60 (63.2) 29 (30.5) 6 (6.3) 0
Delaware 26 16 (61.5) 7 (26.9) 3 (11.5) 0
District of Columbia 56 37 (66.1) 15 (26.8) 4 (7.1) 2
Florida 1,094 875 (80.0) 182 (16.6) 37 (3.4) 9
Georgia 505 370 (73.3) 103 (20.4) 32 (6.3) 7
Hawaii 112 99 (88.4) 8 (7.1) 5 (4.5) 0
Idaho 23 16 (69.6) 5 (21.7) 2 (8.7) 1
Illinois 596 433 (72.7) 145 (24.3) 18 (3.0) 6
Indiana 146 105 (71.9) 28 (19.2) 13 (8.9) 5
Iowa 55 35 (63.6) 18 (32.7) 2 (3.6) 0
Kansas 60 40 (66.7) 15 (25.0) 5 (8.3) 0
Kentucky 124 99 (79.8) 19 (15.3) 6 (4.8) 2
Louisiana 257 213 (82.9) 31 (12.1) 13 (5.1) 6
Maine 17 11 (64.7) 4 (23.5) 2 (11.8) 0
Maryland 283 186 (65.7) 63 (22.3) 34 (12.0) 7
Massachusetts 265 145 (54.7) 77 (29.1) 43 (16.2) 18
Michigan 246 152 (61.8) 83 (33.7) 11 (4.5) 1
Minnesota 199 94 (47.2) 83 (41.7) 22 (11.1) 1
Mississippi 103 83 (80.6) 14 (13.6) 6 (5.8) 1
Missouri 108 69 (63.9) 29 (26.9) 10 (9.3) 2
Montana 10 8 (80.0) 1 (10.0) 1 (10.0) 1
Nebraska 35 22 (62.9) 12 (34.3) 1 (2.9) 0
Nevada 112 77 (68.8) 26 (23.2) 9 (8.0) 0
New Hampshire 4 2 (50.0) 2 (50.0) 0 (0.0) 0
New Jersey 485 319 (65.8) 109 (22.5) 57 (11.8) 7
New Mexico 39 27 (69.2) 8 (20.5) 4 (10.3) 1
New York 1,289 856 (66.4) 288 (22.3) 145 (11.2) 5
North Carolina 329 228 (69.3) 72 (21.9) 29 (8.8) 13
North Dakota 6 3 (50.0) 1 (16.7) 2 (33.3) 0
Ohio 260 171 (65.8) 63 (24.2) 26 (10.0) 3
Oklahoma 144 98 (68.1) 21 (14.6) 25 (17.4) 3
Oregon 103 71 (68.9) 21 (20.4) 11 (10.7) 1
Pennsylvania 325 228 (70.2) 68 (20.9) 29 (8.9) 7
Rhode Island 47 26 (55.3) 17 (36.2) 4 (8.5) 3
South Carolina 261 169 (64.8) 47 (18.0) 45 (17.2) 10
South Dakota 16 8 (50.0) 6 (37.5) 2 (12.5) 1
Tennessee 298 206 (69.1) 64 (21.5) 28 (9.4) 6
Texas 1,535 1,114 (72.6) 259 (16.9) 162 (10.6) 59
Utah 29 19 (65.5) 7 (24.1) 3 (10.3) 2
Vermont 8 6 (75.0) 2 (25.0) 0 (0.0) 0
Virginia 355 261 (73.5) 69 (19.4) 25 (7.0) 10
Washington 256 147 (57.4) 75 (29.3) 34 (13.3) 4
West Virginia 28 24 (85.7) 3 (10.7) 1 (3.6) 0
Wisconsin 78 49 (62.8) 23 (29.5) 6 (7.7) 4
Wyoming 0 0 — 0 — 0 — 0
American Samoa4 5 5 (100.0) 0 (0.0) 0 (0.0) 0
Fed. States of Micronesia4 74 53 (71.6) 15 (20.3) 6 (8.1) 0
Guam4 64 52 (81.3) 9 (14.1) 3 (4.7) 3
Marshall Islands4 66 55 (83.3) 11 (16.7) 0 (0.0) 0
N. Mariana Islands4 56 50 (89.3) 5 (8.9) 1 (1.8) 0
Puerto Rico4 113 96 (85.0) 16 (14.2) 1 (0.9) 0
Republic of Palau4 10 10 (100.0) 0 (0.0) 0 (0.0) 0




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































>400 cases in 2005
.California 2904 8.0 2992 8.3 -2.9 -3.7 4
.Texas 1535 6.7 1683 7.5 -8.8 -10.3 5
.New York1 1289 6.7 1360 7.1 -5.2 -5.1 5
.Florida 1094 6.1 1075 6.2 1.8 -0.5 7
.Illinois 596 4.7 568 4.5 4.9 4.5 14
.Georgia 505 5.6 539 6.0 -6.3 -7.9 10
.New Jersey 485 5.6 482 5.5 0.6 0.2 10
100-399 cases in 2005
.Virginia 355 4.7 329 4.4 7.9 6.7 14
.North Carolina 329 3.8 381 4.5 -13.6 -15.1 25
.Pennsylvania 325 2.6 328 2.6 -0.9 -1.2 31
.Tennessee 298 5.0 277 4.7 7.6 6.3 13
.Maryland 283 5.1 314 5.6 -9.9 -10.5 12
.Arizona 281 4.7 272 4.7 3.3 -0.2 14
.Massachusetts 265 4.1 283 4.4 -6.4 -6.2 20
.South Carolina 261 6.1 233 5.6 12.0 10.5 7
.Ohio 260 2.3 219 1.9 18.7 18.6 33
.Louisiana 257 5.7 249 5.5 3.2 2.8 9
.Washington 256 4.1 245 3.9 4.5 3.1 20
.Michigan 246 2.4 272 2.7 -9.6 -9.7 32
.Alabama 216 4.7 211 4.7 2.4 1.6 14
.Minnesota 199 3.9 199 3.9 0.0 -0.7 24
.Indiana 146 2.3 128 2.1 14.1 13.2 33
.Oklahoma 144 4.1 178 5.1 -19.1 -19.7 20
.Kentucky 124 3.0 127 3.1 -2.4 -3.1 28
.Arkansas 114 4.1 132 4.8 -13.6 -14.5 20
.Hawaii 112 8.8 116 9.2 -3.4 -4.4 3
.Nevada 112 4.6 95 4.1 17.9 13.9 18
.Missouri 108 1.9 127 2.2 -15.0 -15.6 40
.Mississippi 103 3.5 119 4.1 -13.4 -14.0 26
.Oregon 103 2.8 106 3.0 -2.8 -4.2 29
.Colorado 101 2.2 127 2.8 -20.5 -21.6 35
<100 cases in 2005
.Connecticut 95 2.7 101 2.9 -5.9 -6.2 30
.Wisconsin 78 1.4 95 1.7 -17.9 -18.4 44
.Kansas 60 2.2 62 2.3 -3.2 -3.6 35
.Alaska 59 8.9 43 6.5 37.2 36.0 2
.District of Columbia 56 10.2 81 14.6 -30.9 -30.4 1
.Iowa 55 1.9 47 1.6 17.0 16.5 40
.Rhode Island 47 4.4 51 4.7 -7.8 -7.5 19
.New Mexico 39 2.0 42 2.2 -7.1 -8.4 38
.Nebraska 35 2.0 39 2.2 -10.3 -10.8 38
.Utah 29 1.2 36 1.5 -19.4 -21.0 47
.West Virginia 28 1.5 24 1.3 16.7 16.4 43
.Delaware 26 3.1 32 3.9 -18.8 -20.0 27
.Idaho 23 1.6 11 0.8 109.1 104.1 42
.Maine 17 1.3 20 1.5 -15.0 -15.4 45
.South Dakota 16 2.1 11 1.4 45.5 44.5 37
.Montana 10 1.1 15 1.6 -33.3 -34.0 48
.Vermont 8 1.3 6 1.0 33.3 32.9 45
.North Dakota 6 0.9 4 0.6 50.0 49.9 49
.New Hampshire 4 0.3 24 1.8 -83.3 -83.5 50
.Wyoming 0 0.0 5 1.0 -100.0 -100.0 51
Total 14097 4.8 14515 4.9 -2.9 -3.8
Table 28.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and
Grouped by Number of Cases: States and the District of Columbia, 2004 and 2005
State
2005 2004 2004–2005 % Change




1Includes New York City.
Note: Denominators for computing 2004 and 2005 rates for states and the District of Columbia were obtained from Annual
Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2005 (NST-
EST2005-01)  (http://www.census.gov/popest/states/tables/NST-EST2005-01.xls) (accessed June 1, 2006).




Table 29. Tuberculosis Cases and Percentages by Residence in Correctional Facilities, Age >




Cases with Information on Residence
 in Correctional Facilities
Cases Reported As Residents
 of Correctional Facilities1
No. No.(%) (%)
1Resident of correctional facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 13,225 (99.9) 534 (4.0)
Alabama 201 201 (100.0) 7 (3.5)
Alaska 52 52 (100.0) 1 (1.9)
Arizona 244 243 (99.6) 40 (16.5)
Arkansas 105 105 (100.0) 2 (1.9)
California 2,753 2,750 (99.9) 65 (2.4)
Colorado 84 84 (100.0) 7 (8.3)
Connecticut 93 93 (100.0) 0 (0.0)
Delaware 25 25 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 1 (1.8)
Florida 1,037 1,037 (100.0) 74 (7.1)
Georgia 463 462 (99.8) 25 (5.4)
Hawaii 109 109 (100.0) 0 (0.0)
Idaho 21 20 (95.2) 0 (0.0)
Illinois 550 549 (99.8) 14 (2.6)
Indiana 137 137 (100.0) 4 (2.9)
Iowa 51 51 (100.0) 0 (0.0)
Kansas 57 57 (100.0) 2 (3.5)
Kentucky 118 118 (100.0) 7 (5.9)
Louisiana 241 241 (100.0) 21 (8.7)
Maine 16 16 (100.0) 0 (0.0)
Maryland 266 266 (100.0) 6 (2.3)
Massachusetts 252 252 (100.0) 3 (1.2)
Michigan 238 238 (100.0) 1 (0.4)
Minnesota 179 179 (100.0) 4 (2.2)
Mississippi 100 99 (99.0) 4 (4.0)
Missouri 105 105 (100.0) 5 (4.8)
Montana 10 10 (100.0) 1 (10.0)
Nebraska 35 35 (100.0) 2 (5.7)
Nevada 107 107 (100.0) 0 (0.0)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 461 (100.0) 2 (0.4)
New Mexico 39 38 (97.4) 1 (2.6)
New York State2 287 287 (100.0) 7 (2.4)
New York City 943 943 (100.0) 22 (2.3)
North Carolina 309 309 (100.0) 8 (2.6)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 241 241 (100.0) 3 (1.2)
Oklahoma 125 125 (100.0) 9 (7.2)
Oregon 99 99 (100.0) 4 (4.0)
Pennsylvania 312 312 (100.0) 3 (1.0)
Rhode Island 44 44 (100.0) 0 (0.0)
South Carolina 235 235 (100.0) 4 (1.7)
South Dakota 16 16 (100.0) 0 (0.0)
Tennessee 277 277 (100.0) 13 (4.7)
Texas 1,424 1,424 (100.0) 149 (10.5)
Utah 25 25 (100.0) 1 (4.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 330 330 (100.0) 6 (1.8)
Washington 247 247 (100.0) 5 (2.0)
West Virginia 27 27 (100.0) 0 (0.0)
Wisconsin 72 72 (100.0) 1 (1.4)
Wyoming 0 0 — — —
American Samoa3 5 5 (100.0) 0 (0.0)
Fed. States of Micronesia3 63 63 (100.0) 0 (0.0)
Guam3 53 53 (100.0) 1 (1.9)
Marshall Islands3 60 60 (100.0) 0 (0.0)
N. Mariana Islands3 55 55 (100.0) 0 (0.0)
Puerto Rico3 108 108 (100.0) 5 (4.6)
Republic of Palau3 9 9 (100.0) 0 (0.0)










Table 30. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: Reporting
Areas, 2005
1Homeless within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the District of
Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 13,126 (99.2) 795 (6.1)
Alabama 201 201 (100.0) 11 (5.5)
Alaska 52 52 (100.0) 3 (5.8)
Arizona 244 227 (93.0) 21 (9.3)
Arkansas 105 103 (98.1) 0 (0.0)
California 2,753 2,721 (98.8) 179 (6.6)
Colorado 84 83 (98.8) 6 (7.2)
Connecticut 93 93 (100.0) 5 (5.4)
Delaware 25 25 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 5 (9.1)
Florida 1,037 1,031 (99.4) 83 (8.1)
Georgia 463 463 (100.0) 41 (8.9)
Hawaii 109 109 (100.0) 1 (0.9)
Idaho 21 18 (85.7) 3 (16.7)
Illinois 550 543 (98.7) 23 (4.2)
Indiana 137 137 (100.0) 5 (3.6)
Iowa 51 51 (100.0) 3 (5.9)
Kansas 57 57 (100.0) 5 (8.8)
Kentucky 118 118 (100.0) 9 (7.6)
Louisiana 241 236 (97.9) 15 (6.4)
Maine 16 16 (100.0) 0 (0.0)
Maryland 266 266 (100.0) 13 (4.9)
Massachusetts 252 250 (99.2) 10 (4.0)
Michigan 238 237 (99.6) 6 (2.5)
Minnesota 179 179 (100.0) 4 (2.2)
Mississippi 100 100 (100.0) 11 (11.0)
Missouri 105 105 (100.0) 6 (5.7)
Montana 10 10 (100.0) 2 (20.0)
Nebraska 35 35 (100.0) 2 (5.7)
Nevada 107 107 (100.0) 8 (7.5)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 461 (100.0) 14 (3.0)
New Mexico 39 39 (100.0) 5 (12.8)
New York State2 287 286 (99.7) 8 (2.8)
New York City 943 919 (97.5) 52 (5.7)
North Carolina 309 309 (100.0) 20 (6.5)
North Dakota 6 5 (83.3) 0 (0.0)
Ohio 241 240 (99.6) 15 (6.3)
Oklahoma 125 125 (100.0) 12 (9.6)
Oregon 99 99 (100.0) 8 (8.1)
Pennsylvania 312 311 (99.7) 5 (1.6)
Rhode Island 44 44 (100.0) 2 (4.5)
South Carolina 235 235 (100.0) 16 (6.8)
South Dakota 16 16 (100.0) 1 (6.3)
Tennessee 277 277 (100.0) 32 (11.6)
Texas 1,424 1,423 (99.9) 70 (4.9)
Utah 25 25 (100.0) 1 (4.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 330 330 (100.0) 8 (2.4)
Washington 247 246 (99.6) 40 (16.3)
West Virginia 27 27 (100.0) 1 (3.7)
Wisconsin 72 70 (97.2) 5 (7.1)
Wyoming 0 0    —    —    —
American Samoa3 5 5 (100.0) 0 (0.0)
Fed. States of Micronesia3 63 63 (100.0) 0 (0.0)
Guam3 53 53 (100.0) 0 (0.0)
Marshall Islands3 60 57 (95.0) 0 (0.0)
N. Mariana Islands3 55 55 (100.0) 0 (0.0)
Puerto Rico3 108 108 (100.0) 2 (1.9)
Republic of Palau3 9 9 (100.0) 0 (0.0)





Cases with Information on
Residence in Long-term Care Facilities
Cases Reported As Residents of
Long-term Care Facilities
No. No.(%) (%)
Table 31. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,1
Age >15: Reporting Areas, 2005
1Resident of long-term care facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 13,221 (99.9) 319 (2.4)
Alabama 201 201 (100.0) 9 (4.5)
Alaska 52 52 (100.0) 0 (0.0)
Arizona 244 243 (99.6) 7 (2.9)
Arkansas 105 105 (100.0) 1 (1.0)
California 2,753 2,749 (99.9) 55 (2.0)
Colorado 84 84 (100.0) 4 (4.8)
Connecticut 93 93 (100.0) 2 (2.2)
Delaware 25 25 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 0 (0.0)
Florida 1,037 1,037 (100.0) 19 (1.8)
Georgia 463 462 (99.8) 7 (1.5)
Hawaii 109 109 (100.0) 3 (2.8)
Idaho 21 20 (95.2) 1 (5.0)
Illinois 550 550 (100.0) 11 (2.0)
Indiana 137 137 (100.0) 4 (2.9)
Iowa 51 51 (100.0) 2 (3.9)
Kansas 57 57 (100.0) 2 (3.5)
Kentucky 118 118 (100.0) 5 (4.2)
Louisiana 241 241 (100.0) 3 (1.2)
Maine 16 16 (100.0) 0 (0.0)
Maryland 266 266 (100.0) 10 (3.8)
Massachusetts 252 252 (100.0) 6 (2.4)
Michigan 238 238 (100.0) 6 (2.5)
Minnesota 179 179 (100.0) 1 (0.6)
Mississippi 100 98 (98.0) 4 (4.1)
Missouri 105 104 (99.0) 7 (6.7)
Montana 10 10 (100.0) 0 (0.0)
Nebraska 35 35 (100.0) 2 (5.7)
Nevada 107 107 (100.0) 1 (0.9)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 461 (100.0) 11 (2.4)
New Mexico 39 37 (94.9) 1 (2.7)
New York State2 287 287 (100.0) 6 (2.1)
New York City 943 942 (99.9) 11 (1.2)
North Carolina 309 309 (100.0) 15 (4.9)
North Dakota 6 6 (100.0) 0 (0.0)
Ohio 241 241 (100.0) 14 (5.8)
Oklahoma 125 125 (100.0) 5 (4.0)
Oregon 99 99 (100.0) 1 (1.0)
Pennsylvania 312 312 (100.0) 15 (4.8)
Rhode Island 44 44 (100.0) 1 (2.3)
South Carolina 235 235 (100.0) 8 (3.4)
South Dakota 16 16 (100.0) 1 (6.3)
Tennessee 277 277 (100.0) 13 (4.7)
Texas 1,424 1,424 (100.0) 33 (2.3)
Utah 25 25 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 0 (0.0)
Virginia 330 330 (100.0) 4 (1.2)
Washington 247 247 (100.0) 4 (1.6)
West Virginia 27 27 (100.0) 1 (3.7)
Wisconsin 72 72 (100.0) 3 (4.2)
Wyoming 0 0    —    — —
American Samoa3 5 5 (100.0) 0 (0.0)
Fed. States of Micronesia3 63 63 (100.0) 0 (0.0)
Guam3 53 53 (100.0) 0 (0.0)
Marshall Islands3 60 60 (100.0) 0 (0.0)
N. Mariana Islands3 55 55 (100.0) 0 (0.0)
Puerto Rico3 108 108 (100.0) 3 (2.8)
Republic of Palau3 9 9 (100.0) 0 (0.0)





Cases with Information on
Injecting Drug Use
Cases Reporting Injecting Drug Use
No. No.(%) (%)
Table 32. Tuberculosis Cases and Percentages by Injecting Drug Use,1 Age >15: Reporting
Areas, 2005
1Injecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 12,938 (97.8) 282 (2.2)
Alabama 201 201 (100.0) 1 (0.5)
Alaska 52 52 (100.0) 0 (0.0)
Arizona 244 225 (92.2) 11 (4.9)
Arkansas 105 105 (100.0) 1 (1.0)
California 2,753 2,679 (97.3) 64 (2.4)
Colorado 84 81 (96.4) 1 (1.2)
Connecticut 93 93 (100.0) 4 (4.3)
Delaware 25 25 (100.0) 1 (4.0)
District of Columbia 55 55 (100.0) 1 (1.8)
Florida 1,037 1,029 (99.2) 22 (2.1)
Georgia 463 446 (96.3) 6 (1.3)
Hawaii 109 72 (66.1) — —
Idaho 21 18 (85.7) 0 (0.0)
Illinois 550 505 (91.8) 5 (1.0)
Indiana 137 137 (100.0) 9 (6.6)
Iowa 51 51 (100.0) 0 (0.0)
Kansas 57 57 (100.0) 1 (1.8)
Kentucky 118 118 (100.0) 2 (1.7)
Louisiana 241 230 (95.4) 13 (5.7)
Maine 16 16 (100.0) 0 (0.0)
Maryland 266 266 (100.0) 7 (2.6)
Massachusetts 252 244 (96.8) 1 (0.4)
Michigan 238 236 (99.2) 4 (1.7)
Minnesota 179 178 (99.4) 0 (0.0)
Mississippi 100 100 (100.0) 1 (1.0)
Missouri 105 103 (98.1) 0 (0.0)
Montana 10 10 (100.0) 0 (0.0)
Nebraska 35 35 (100.0) 1 (2.9)
Nevada 107 107 (100.0) 4 (3.7)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 460 (99.8) 12 (2.6)
New Mexico 39 37 (94.9) 2 (5.4)
New York State2 287 286 (99.7) 2 (0.7)
New York City 943 898 (95.2) 21 (2.3)
North Carolina 309 308 (99.7) 1 (0.3)
North Dakota 6 5 (83.3) 0 (0.0)
Ohio 241 239 (99.2) 5 (2.1)
Oklahoma 125 125 (100.0) 12 (9.6)
Oregon 99 95 (96.0) 4 (4.2)
Pennsylvania 312 312 (100.0) 6 (1.9)
Rhode Island 44 44 (100.0) 1 (2.3)
South Carolina 235 234 (99.6) 4 (1.7)
South Dakota 16 16 (100.0) 1 (6.3)
Tennessee 277 277 (100.0) 0 (0.0)
Texas 1,424 1,423 (99.9) 34 (2.4)
Utah 25 25 (100.0) 1 (4.0)
Vermont 7 7 (100.0) 1 (14.3)
Virginia 330 330 (100.0) 5 (1.5)
Washington 247 241 (97.6) 9 (3.7)
West Virginia 27 27 (100.0) 0 (0.0)
Wisconsin 72 71 (98.6) 0 (0.0)
Wyoming 0 0 — — —
American Samoa3 5 5 (100.0) 0 (0.0)
Fed. States of Micronesia3 63 32 (50.8) — —
Guam3 53 53 (100.0) 1 (1.9)
Marshall Islands3 60 60 (100.0) 0 (0.0)
N. Mariana Islands3 55 55 (100.0) 0 (0.0)
Puerto Rico3 108 108 (100.0) 17 (15.7)
Republic of Palau3 9 9 (100.0) 0 (0.0)





Cases with Information on
Noninjecting Drug Use
Cases Reporting Noninjecting Drug Use
No. No.(%) (%)
Table 33. Tuberculosis Cases and Percentages by Noninjecting Drug Use,1 Age >15: Report-
ing Areas, 2005
1Noninjecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and
the District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 12,915 (97.6) 1,004 (7.8)
Alabama 201 201 (100.0) 8 (4.0)
Alaska 52 52 (100.0) 2 (3.8)
Arizona 244 225 (92.2) 20 (8.9)
Arkansas 105 105 (100.0) 0 (0.0)
California 2,753 2,683 (97.5) 165 (6.1)
Colorado 84 81 (96.4) 5 (6.2)
Connecticut 93 93 (100.0) 5 (5.4)
Delaware 25 25 (100.0) 0 (0.0)
District of Columbia 55 55 (100.0) 4 (7.3)
Florida 1,037 1,027 (99.0) 145 (14.1)
Georgia 463 446 (96.3) 54 (12.1)
Hawaii 109 70 (64.2) — —
Idaho 21 17 (81.0) 1 (5.9)
Illinois 550 498 (90.5) 50 (10.0)
Indiana 137 137 (100.0) 21 (15.3)
Iowa 51 51 (100.0) 0 (0.0)
Kansas 57 57 (100.0) 4 (7.0)
Kentucky 118 118 (100.0) 8 (6.8)
Louisiana 241 224 (92.9) 44 (19.6)
Maine 16 16 (100.0) 0 (0.0)
Maryland 266 266 (100.0) 11 (4.1)
Massachusetts 252 246 (97.6) 7 (2.8)
Michigan 238 236 (99.2) 13 (5.5)
Minnesota 179 178 (99.4) 3 (1.7)
Mississippi 100 100 (100.0) 9 (9.0)
Missouri 105 103 (98.1) 4 (3.9)
Montana 10 10 (100.0) 1 (10.0)
Nebraska 35 35 (100.0) 2 (5.7)
Nevada 107 107 (100.0) 6 (5.6)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 460 (99.8) 32 (7.0)
New Mexico 39 33 (84.6) 1 (3.0)
New York State2 287 286 (99.7) 11 (3.8)
New York City 943 897 (95.1) 85 (9.5)
North Carolina 309 307 (99.4) 42 (13.7)
North Dakota 6 4 (66.7) — —
Ohio 241 239 (99.2) 25 (10.5)
Oklahoma 125 125 (100.0) 14 (11.2)
Oregon 99 94 (94.9) 8 (8.5)
Pennsylvania 312 312 (100.0) 7 (2.2)
Rhode Island 44 44 (100.0) 0 (0.0)
South Carolina 235 233 (99.1) 28 (12.0)
South Dakota 16 16 (100.0) 1 (6.3)
Tennessee 277 277 (100.0) 37 (13.4)
Texas 1,424 1,423 (99.9) 96 (6.7)
Utah 25 25 (100.0) 0 (0.0)
Vermont 7 7 (100.0) 1 (14.3)
Virginia 330 330 (100.0) 5 (1.5)
Washington 247 240 (97.2) 11 (4.6)
West Virginia 27 27 (100.0) 3 (11.1)
Wisconsin 72 70 (97.2) 5 (7.1)
Wyoming 0 0 — — —
American Samoa3 5 5 (100.0) 0 (0.0)
Fed. States of Micronesia3 63 27 (42.9) — —
Guam3 53 51 (96.2) 1 (2.0)
Marshall Islands3 60 60 (100.0) 2 (3.3)
N. Mariana Islands3 55 55 (100.0) 0 (0.0)
Puerto Rico3 108 108 (100.0) 21 (19.4)
Republic of Palau3 9 9 (100.0) 0 (0.0)










Table 34. Tuberculosis Cases and Percentages by Excess Alcohol Use,1 Age >15: Reporting
Areas, 2005
1Excess alcohol use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 13,234 12,908 (97.5) 1,789 (13.9)
Alabama 201 201 (100.0) 33 (16.4)
Alaska 52 52 (100.0) 8 (15.4)
Arizona 244 222 (91.0) 29 (13.1)
Arkansas 105 105 (100.0) 4 (3.8)
California 2,753 2,672 (97.1) 263 (9.8)
Colorado 84 82 (97.6) 13 (15.9)
Connecticut 93 93 (100.0) 8 (8.6)
Delaware 25 25 (100.0) 3 (12.0)
District of Columbia 55 55 (100.0) 11 (20.0)
Florida 1,037 1,030 (99.3) 224 (21.7)
Georgia 463 447 (96.5) 73 (16.3)
Hawaii 109 73 (67.0) — —
Idaho 21 16 (76.2) 2 (12.5)
Illinois 550 491 (89.3) 74 (15.1)
Indiana 137 137 (100.0) 38 (27.7)
Iowa 51 51 (100.0) 6 (11.8)
Kansas 57 57 (100.0) 8 (14.0)
Kentucky 118 118 (100.0) 19 (16.1)
Louisiana 241 222 (92.1) 46 (20.7)
Maine 16 16 (100.0) 2 (12.5)
Maryland 266 266 (100.0) 17 (6.4)
Massachusetts 252 246 (97.6) 18 (7.3)
Michigan 238 237 (99.6) 21 (8.9)
Minnesota 179 177 (98.9) 13 (7.3)
Mississippi 100 100 (100.0) 20 (20.0)
Missouri 105 103 (98.1) 16 (15.5)
Montana 10 10 (100.0) 6 (60.0)
Nebraska 35 35 (100.0) 4 (11.4)
Nevada 107 107 (100.0) 7 (6.5)
New Hampshire 4 4 (100.0) 0 (0.0)
New Jersey 461 461 (100.0) 35 (7.6)
New Mexico 39 32 (82.1) 11 (34.4)
New York State2 287 286 (99.7) 22 (7.7)
New York City 943 898 (95.2) 144 (16.0)
North Carolina 309 308 (99.7) 46 (14.9)
North Dakota 6 5 (83.3) 0 (0.0)
Ohio 241 240 (99.6) 43 (17.9)
Oklahoma 125 125 (100.0) 25 (20.0)
Oregon 99 97 (98.0) 15 (15.5)
Pennsylvania 312 312 (100.0) 21 (6.7)
Rhode Island 44 44 (100.0) 5 (11.4)
South Carolina 235 234 (99.6) 59 (25.2)
South Dakota 16 16 (100.0) 3 (18.8)
Tennessee 277 277 (100.0) 57 (20.6)
Texas 1,424 1,423 (99.9) 251 (17.6)
Utah 25 25 (100.0) 2 (8.0)
Vermont 7 7 (100.0) 1 (14.3)
Virginia 330 330 (100.0) 6 (1.8)
Washington 247 240 (97.2) 34 (14.2)
West Virginia 27 27 (100.0) 2 (7.4)
Wisconsin 72 71 (98.6) 12 (16.9)
Wyoming 0 0 — — —
American Samoa3 5 4 (80.0) 0 (0.0)
Fed. States of Micronesia3 63 31 (49.2) — —
Guam3 53 53 (100.0) 1 (1.9)
Marshall Islands3 60 53 (88.3) 1 (1.9)
N. Mariana Islands3 55 55 (100.0) 5 (9.1)
Puerto Rico3 108 108 (100.0) 14 (13.0)
Republic of Palau3 9 9 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
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Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen: Reporting Areas,
2005
1Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages
shown only for reporting areas with information reported for >75% of cases.
2I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.
3 Streptomycin is no longer considered a first-line drug.  CDC.  Treatment of Tuberculosis. American Thoracic Society, CDC, and
Infectious Diseases Society of America.  MMWR 2003;52(No.RR-11): 1–77.
4Excludes New York City.
5Not included in U.S. totals.
Note: Excluding cases with no information on drug regimen, 406 (2.9%) persons were not started on any drugs, 7 (<0.1%) were started
on one drug, and 1,189 (8.4%) had an initial multidrug regimen other than IR, IRZ, or IRZ,E/S.




Cases with Information on
Initial Drug Regimen







United States 14,097 13,802 13,772 (99.8) (1.2) (5.5) (83.5) (83.4)
Alabama 216 213 213 (100.0) (0.5) (4.7) (87.8) (86.9)
Alaska 59 59 59 (100.0) (3.4) (10.2) (81.4) (81.4)
Arizona 281 276 270 (97.8) (0.4) (5.2) (84.8) (84.8)
Arkansas 114 109 109 (100.0) (15.6) (39.4) (29.4) (29.4)
California 2,904 2,860 2,859 (100.0) (1.1) (2.8) (87.4) (87.2)
Colorado 101 98 98 (100.0) (0.0) (5.1) (79.6) (79.6)
Connecticut 95 93 93 (100.0) (1.1) (8.6) (81.7) (81.7)
Delaware 26 26 26 (100.0) (0.0) (0.0) (100.0) (100.0)
District of Columbia 56 55 55 (100.0) (0.0) (3.6) (85.5) (85.5)
Florida 1,094 1,067 1,067 (100.0) (0.6) (6.5) (83.4) (83.3)
Georgia 505 503 503 (100.0) (0.4) (4.8) (77.3) (77.3)
Hawaii 112 111 111 (100.0) (4.5) (8.1) (74.8) (74.8)
Idaho 23 23 22 (95.7) (0.0) (18.2) (81.8) (81.8)
Illinois 596 588 585 (99.5) (0.3) (6.2) (83.8) (83.8)
Indiana 146 145 145 (100.0) (1.4) (11.0) (80.7) (80.7)
Iowa 55 55 54 (98.2) (0.0) (7.4) (88.9) (88.9)
Kansas 60 59 59 (100.0) (5.1) (1.7) (83.1) (83.1)
Kentucky 124 120 120 (100.0) (0.8) (9.2) (82.5) (82.5)
Louisiana 257 246 245 (99.6) (0.4) (5.7) (88.6) (88.6)
Maine 17 17 17 (100.0) (0.0) (5.9) (88.2) (88.2)
Maryland 283 278 278 (100.0) (2.2) (1.8) (91.7) (91.7)
Massachusetts 265 260 260 (100.0) (0.4) (2.3) (86.9) (86.9)
Michigan 246 240 240 (100.0) (5.0) (19.6) (65.0) (65.0)
Minnesota 199 197 197 (100.0) (0.0) (6.6) (87.3) (87.3)
Mississippi 103 95 95 (100.0) (1.1) (8.4) (77.9) (77.9)
Missouri 108 103 103 (100.0) (1.9) (1.9) (75.7) (75.7)
Montana 10 9 9 (100.0) (0.0) (0.0) (77.8) (77.8)
Nebraska 35 33 33 (100.0) (0.0) (6.1) (81.8) (81.8)
Nevada 112 110 110 (100.0) (0.0) (0.0) (94.5) (94.5)
New Hampshire 4 4 4 (100.0) (0.0) (25.0) (75.0) (75.0)
New Jersey 485 471 470 (99.8) (0.6) (7.2) (82.3) (82.3)
New  Mexico 39 37 36 (97.3) (0.0) (11.1) (83.3) (83.3)
New York State3 305 298 298 (100.0) (1.0) (6.7) (82.6) (82.6)
New York City 984 968 968 (100.0) (0.4) (2.8) (86.7) (86.7)
North Carolina 329 322 322 (100.0) (0.3) (2.2) (90.1) (89.8)
North Dakota 6 6 6 (100.0) (0.0) (0.0) (100.0) (100.0)
Ohio 260 251 251 (100.0) (0.8) (9.6) (81.3) (81.3)
Oklahoma 144 139 138 (99.3) (10.9) (15.9) (61.6) (61.6)
Oregon 103 103 103 (100.0) (0.0) (2.9) (93.2) (93.2)
Pennsylvania 325 319 319 (100.0) (0.9) (4.1) (62.1) (62.1)
Rhode Island 47 46 46 (100.0) (0.0) (2.2) (76.1) (76.1)
South Carolina 261 252 252 (100.0) (0.8) (12.7) (77.8) (77.8)
South Dakota 16 16 16 (100.0) (0.0) (18.8) (75.0) (75.0)
Tennessee 298 291 291 (100.0) (0.3) (5.5) (82.8) (82.8)
Texas 1,535 1,491 1,479 (99.2) (1.8) (5.3) (84.5) (84.5)
Utah 29 29 29 (100.0) (0.0) (0.0) (93.1) (93.1)
Vermont 8 8 8 (100.0) (0.0) (75.0) (25.0) (25.0)
Virginia 355 349 348 (99.7) (0.9) (5.5) (88.2) (88.2)
Washington 256 250 249 (99.6) (0.0) (2.8) (90.8) (90.8)
West Virginia 28 28 28 (100.0) (10.7) (3.6) (67.9) (67.9)
Wisconsin 78 76 76 (100.0) (2.6) (6.6) (80.3) (80.3)
Wyoming 0 0 0 — — — — —
American Samoa4 5 5 5 (100.0) (0.0) (0.0) (100.0) (100.0)
Fed. States of Micronesia4 74 74 74 (100.0) (1.4) (16.2) (73.0) (73.0)
Guam4 64 63 63 (100.0) (0.0) (3.2) (87.3) (87.3)
Marshall Islands4 66 66 66 (100.0) (0.0) (1.5) (93.9) (93.9)
N. Mariana Islands4 56 56 56 (100.0) (0.0) (0.0) (98.2) (98.2)
Puerto Rico4 113 101 99 (98.0) (0.0) (3.0) (91.9) (91.9)
Republic of Palau4 10 10 10 (100.0) (0.0) (20.0) (80.0) (80.0)
U.S. Virgin Islands4 ... ... ... ... ... ... ... ...
IRZE3
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1Patients tested to at least isoniazid
2Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
3Patients tested to at least isoniazid and rifampin
4Excludes New York City.
5Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 10,943 10,355 (94.6) 804 (7.8) 121 (1.2)
Alabama 165 158 (95.8) 9 (5.7) 0 (0.0)
Alaska 54 54 (100.0) 4 (7.4) 0 (0.0)
Arizona 206 162 (78.6) 21 (13.0) 1 (0.6)
Arkansas 71 63 (88.7) 3 (4.8) 0 (0.0)
California 2,282 2,142 (93.9) 208 (9.7) 33 (1.5)
Colorado 69 69 (100.0) 3 (4.3) 0 (0.0)
Connecticut 80 79 (98.8) 7 (8.9) 0 (0.0)
Delaware 23 23 (100.0) 0 (0.0) 0 (0.0)
District of Columbia 51 51 (100.0) 5 (9.8) 3 (6.0)
Florida 850 813 (95.6) 65 (8.0) 10 (1.2)
Georgia 397 389 (98.0) 22 (5.7) 1 (0.3)
Hawaii 89 84 (94.4) 3 (3.6) 0 (0.0)
Idaho 19 16 (84.2) 1 (6.3) 0 (0.0)
Illinois 450 412 (91.6) 28 (6.8) 0 (0.0)
Indiana 118 118 (100.0) 8 (6.8) 1 (0.8)
Iowa 40 40 (100.0) 3 (7.5) 0 (0.0)
Kansas 46 38 (82.6) 1 (2.6) 0 (0.0)
Kentucky 111 107 (96.4) 4 (3.7) 1 (0.9)
Louisiana 199 148 (74.4) — — — —
Maine 10 9 (90.0) 0 (0.0) 0 (0.0)
Maryland 221 218 (98.6) 19 (8.7) 0 (0.0)
Massachusetts 192 188 (97.9) 22 (11.7) 7 (3.7)
Michigan 200 195 (97.5) 10 (5.1) 1 (0.5)
Minnesota 150 150 (100.0) 14 (9.3) 4 (2.7)
Mississippi 88 80 (90.9) 3 (3.8) 0 (0.0)
Missouri 89 83 (93.3) 4 (4.8) 1 (1.2)
Montana 9 9 (100.0) 1 (11.1) 0 (0.0)
Nebraska 32 32 (100.0) 3 (9.4) 0 (0.0)
Nevada 92 88 (95.7) 6 (6.8) 0 (0.0)
New Hampshire 4 4 (100.0) 0 (0.0) 0 (0.0)
New Jersey 387 380 (98.2) 40 (10.5) 10 (2.6)
New Mexico 34 34 (100.0) 5 (14.7) 0 (0.0)
New York State2 238 237 (99.6) 21 (8.9) 3 (1.3)
New York City 751 701 (93.3) 74 (10.6) 22 (3.1)
North Carolina 271 261 (96.3) 22 (8.4) 3 (1.1)
North Dakota 4 4 (100.0) 0 (0.0) 0 (0.0)
Ohio 188 188 (100.0) 9 (4.8) 1 (0.5)
Oklahoma 88 88 (100.0) 5 (5.7) 1 (1.1)
Oregon 86 86 (100.0) 5 (5.8) 0 (0.0)
Pennsylvania 270 224 (83.0) 17 (7.6) 2 (0.9)
Rhode Island 19 19 (100.0) 1 (5.3) 0 (0.0)
South Carolina 183 179 (97.8) 8 (4.5) 3 (1.7)
South Dakota 14 14 (100.0) 1 (7.1) 0 (0.0)
Tennessee 239 226 (94.6) 14 (6.2) 2 (0.9)
Texas 1,159 1,135 (97.9) 45 (4.0) 4 (0.4)
Utah 21 21 (100.0) 0 (0.0) 0 (0.0)
Vermont 6 6 (100.0) 0 (0.0) 0 (0.0)
Virginia 275 233 (84.7) 17 (7.3) 2 (0.9)
Washington 208 203 (97.6) 26 (12.8) 3 (1.5)
West Virginia 28 27 (96.4) 3 (11.1) 0 (0.0)
Wisconsin 67 67 (100.0) 10 (14.9) 2 (3.0)
Wyoming 0 0 — — — — —
American Samoa3 4 4 (100.0) 0 (0.0) 0 (0.0)
Fed. States of Micronesia3 21 18 (85.7) 1 (5.6) 1 (5.6)
Guam3 39 35 (89.7) 4 (11.4) 1 (2.9)
Marshall Islands3 46 45 (97.8) 1 (2.2) 0 (0.0)
N. Mariana Islands3 25 18 (72.0) — — — —
Puerto Rico3 99 94 (94.9) 2 (2.1) 0 (0.0)
Republic of Palau3 3 3 (100.0) 0 (0.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ... ... ...
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility










Isoniazid1 Isoniazid and Rifampin3
No. No.(%) (%)
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United States 4,743 3,083 (65.0) — —
Alabama 55 51 (92.7) 6 (11.8)
Alaska 15 12 (80.0) 0 (0.0)
Arizona 96 81 (84.4) 12 (14.8)
Arkansas 30 25 (83.3) 1 (4.0)
California 916 0 (0.0) — —
Colorado 21 19 (90.5) 3 (15.8)
Connecticut 44 35 (79.5) 8 (22.9)
Delaware 8 7 (87.5) 1 (14.3)
District of Columbia 20 20 (100.0) 7 (35.0)
Florida 375 345 (92.0) 103 (29.9)
Georgia 187 177 (94.7) 40 (22.6)
Hawaii 24 5 (20.8) — —
Idaho 6 3 (50.0) — —
Illinois 203 166 (81.8) 22 (13.3)
Indiana 44 36 (81.8) 5 (13.9)
Iowa 22 17 (77.3) 1 (5.9)
Kansas 26 25 (96.2) 5 (20.0)
Kentucky 30 26 (86.7) 2 (7.7)
Louisiana 71 58 (81.7) 17 (29.3)
Maine 6 5 (83.3) 1 (20.0)
Maryland 118 112 (94.9) 28 (25.0)
Massachusetts 102 75 (73.5) — —
Michigan 92 66 (71.7) — —
Minnesota 72 65 (90.3) 5 (7.7)
Mississippi 27 27 (100.0) 4 (14.8)
Missouri 33 27 (81.8) 1 (3.7)
Montana 1 1 (100.0) 0 (0.0)
Nebraska 9 6 (66.7) — —
Nevada 38 37 (97.4) 7 (18.9)
New Hampshire 3 3 (100.0) 0 (0.0)
New Jersey 186 125 (67.2) — —
New Mexico 7 7 (100.0) 0 (0.0)
New York State3 115 93 (80.9) 13 (14.0)
New York City 385 303 (78.7) 79 (26.1)
North Carolina 106 102 (96.2) 21 (20.6)
North Dakota 2 2 (100.0) 1 (50.0)
Ohio 80 73 (91.3) 9 (12.3)
Oklahoma 40 40 (100.0) 4 (10.0)
Oregon 44 42 (95.5) 1 (2.4)
Pennsylvania 98 68 (69.4) — —
Rhode Island 17 15 (88.2) 4 (26.7)
South Carolina 71 63 (88.7) 11 (17.5)
South Dakota 5 4 (80.0) 0 (0.0)
Tennessee 90 86 (95.6) 14 (16.3)
Texas 539 311 (57.7) — —
Utah 10 10 (100.0) 2 (20.0)
Vermont 2 2 (100.0) 0 (0.0)
Virginia 143 107 (74.8) — —
Washington 72 61 (84.7) 7 (11.5)
West Virginia 4 4 (100.0) 0 (0.0)
Wisconsin 33 33 (100.0) 3 (9.1)
Wyoming 0 0 — — —
American Samoa4 2 1 (50.0) — —
Fed. States of Micronesia4 24 5 (20.8) — —
Guam4 19 18 (94.7) 0 (0.0)
Marshall Islands4 21 13 (61.9) — —
N. Mariana Islands4 24 24 (100.0) 0 (0.0)
Puerto Rico4 32 29 (90.6) 20 (69.0)
Republic of Palau4 6 6 (100.0) 0 (0.0)
U.S. Virgin Islands4 ... ... ... ... ...
Table 37. Tuberculosis Cases and Percentages Among Persons Aged 25–44 by HIV Status:
Reporting Areas, 2005
1Includes only those cases in persons with negative, positive, or indeterminate HIV test results.
2Counts and percentages shown only for reporting areas with information reported for >75% of cases. All 2005 California cases had an
unknown HIV status because CA HIV data for 2005 were not available at time of publication.
3Excludes New York City.
4Not included in U.S. totals.




Cases with Information on HIV Status1 Cases in Persons with HIV-Positive Results2
No. (%) No. (%)
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United States 14,097 13,544 (96.1) (56.7) (3.1) (0.1) (1.1) (38.8) (0.2)
Alabama 216 214 (99.1) (65.0) (0.9) (0.0) (0.0) (34.1) (0.0)
Alaska 59 54 (91.5) (61.1) (0.0) (0.0) (0.0) (38.9) (0.0)
Arizona 281 240 (85.4) (78.3) (0.4) (0.0) (2.1) (19.2) (0.0)
Arkansas 114 98 (86.0) (68.4) (2.0) (0.0) (0.0) (29.6) (0.0)
California 2,904 2,773 (95.5) (57.8) (3.0) (0.0) (2.1) (37.1) (0.1)
Colorado 101 99 (98.0) (65.7) (2.0) (0.0) (1.0) (31.3) (0.0)
Connecticut 95 95 (100.0) (47.4) (2.1) (0.0) (0.0) (50.5) (0.0)
Delaware 26 26 (100.0) (30.8) (7.7) (0.0) (7.7) (53.8) (0.0)
District of Columbia 56 56 (100.0) (83.9) (1.8) (0.0) (0.0) (14.3) (0.0)
Florida 1,094 1,090 (99.6) (45.1) (2.8) (0.1) (2.8) (48.5) (0.6)
Georgia 505 427 (84.6) (47.1) (2.8) (0.5) (1.4) (48.2) (0.0)
Hawaii 112 101 (90.2) (65.3) (2.0) (0.0) (0.0) (32.7) (0.0)
Idaho 23 19 (82.6) (73.7) (0.0) (0.0) (5.3) (21.1) (0.0)
Illinois 596 504 (84.6) (63.3) (4.4) (0.0) (0.0) (32.3) (0.0)
Indiana 146 146 (100.0) (59.6) (4.1) (0.7) (0.0) (35.6) (0.0)
Iowa 55 55 (100.0) (41.8) (5.5) (0.0) (0.0) (52.7) (0.0)
Kansas 60 60 (100.0) (28.3) (5.0) (0.0) (0.0) (66.7) (0.0)
Kentucky 124 124 (100.0) (60.5) (2.4) (0.0) (6.5) (30.6) (0.0)
Louisiana 257 238 (92.6) (63.4) (2.9) (0.8) (0.4) (32.4) (0.0)
Maine 17 17 (100.0) (64.7) (11.8) (0.0) (0.0) (23.5) (0.0)
Maryland 283 279 (98.6) (48.7) (3.9) (0.0) (0.0) (47.0) (0.4)
Massachusetts 265 252 (95.1) (54.8) (4.4) (0.4) (0.4) (40.1) (0.0)
Michigan 246 246 (100.0) (59.8) (5.7) (0.0) (0.8) (33.7) (0.0)
Minnesota 199 197 (99.0) (58.9) (2.5) (0.0) (1.0) (37.1) (0.5)
Mississippi 103 85 (82.5) (58.8) (2.4) (0.0) (0.0) (38.8) (0.0)
Missouri 108 106 (98.1) (60.4) (0.9) (1.9) (0.9) (35.8) (0.0)
Montana 10 10 (100.0) (70.0) (0.0) (0.0) (0.0) (30.0) (0.0)
Nebraska 35 35 (100.0) (60.0) (0.0) (0.0) (2.9) (37.1) (0.0)
Nevada 112 112 (100.0) (50.0) (0.9) (0.0) (0.0) (49.1) (0.0)
New Hampshire 4 4 (100.0) (25.0) (0.0) (0.0) (0.0) (75.0) (0.0)
New Jersey 485 485 (100.0) (52.8) (5.6) (0.0) (0.6) (40.8) (0.2)
New Mexico 39 36 (92.3) (63.9) (2.8) (0.0) (0.0) (33.3) (0.0)
New York State2 305 303 (99.3) (43.6) (6.3) (0.0) (0.0) (50.2) (0.0)
New York City 984 913 (92.8) (58.8) (4.6) (0.1) (0.0) (36.5) (0.0)
North Carolina 329 327 (99.4) (54.1) (2.1) (0.0) (1.2) (42.5) (0.0)
North Dakota 6 4 (66.7) — — — — — —
Ohio 260 259 (99.6) (51.7) (5.4) (0.4) (0.4) (41.7) (0.4)
Oklahoma 144 144 (100.0) (70.8) (0.0) (0.0) (0.0) (28.5) (0.7)
Oregon 103 103 (100.0) (57.3) (3.9) (0.0) (1.9) (35.9) (1.0)
Pennsylvania 325 325 (100.0) (35.7) (3.4) (0.0) (0.0) (60.9) (0.0)
Rhode Island 47 47 (100.0) (59.6) (0.0) (0.0) (0.0) (40.4) (0.0)
South Carolina 261 254 (97.3) (60.6) (3.9) (0.0) (0.4) (35.0) (0.0)
South Dakota 16 16 (100.0) (81.3) (0.0) (0.0) (0.0) (18.8) (0.0)
Tennessee 298 298 (100.0) (55.4) (1.7) (0.0) (0.3) (42.3) (0.3)
Texas 1,535 1,528 (99.5) (64.7) (2.6) (0.3) (0.9) (31.5) (0.1)
Utah 29 29 (100.0) (62.1) (0.0) (3.4) (0.0) (34.5) (0.0)
Vermont 8 8 (100.0) (75.0) (0.0) (0.0) (0.0) (25.0) (0.0)
Virginia 355 355 (100.0) (55.5) (1.7) (0.0) (1.1) (41.7) (0.0)
Washington 256 246 (96.1) (50.4) (4.1) (0.4) (2.0) (41.9) (1.2)
West Virginia 28 28 (100.0) (71.4) (0.0) (0.0) (0.0) (25.0) (3.6)
Wisconsin 78 74 (94.9) (48.6) (0.0) (0.0) (1.4) (48.6) (1.4)
Wyoming 0 0 — — — — — — —
American Samoa3 5 5 (100.0) (20.0) (0.0) (0.0) (0.0) (80.0) (0.0)
Fed. States of Micronesia3 74 60 (81.1) (58.3) (5.0) (0.0) (3.3) (33.3) (0.0)
Guam3 64 63 (98.4) (65.1) (0.0) (0.0) (0.0) (34.9) (0.0)
Marshall Islands3 66 64 (97.0) (37.5) (0.0) (1.6) (0.0) (60.9) (0.0)
N. Mariana Islands3 56 56 (100.0) (19.6) (1.8) (0.0) (0.0) (78.6) (0.0)
Puerto Rico3 113 112 (99.1) (83.0) (1.8) (0.0) (0.0) (15.2) (0.0)
Republic of Palau3 10 9 (90.0) (22.2) (0.0) (0.0) (0.0) (77.8) (0.0)
U.S. Virgin Islands3     ... ... ... ... ... ... ... ... ...
Table 38. Tuberculosis Cases and Percentages by Occupation, Age >15: Reporting Areas,
2005
1Occupation within past 24 months of TB diagnosis. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and
the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals.




















1Most recent year for which data are available.
2Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact
investigation and dispensing of medication) provided by non–health department providers; Both Health Department and Private/Other:
Both sectors involved in the care of the patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
3Excludes New York City.
4Not included in U.S. totals.
Note: Ellipses indicate data not available.
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Cases with Information on
Type of Health Care Provider
United States 14,840 14,506 14,282 (98.5) (57.8) (19.9) (22.3)
Alabama 258 253 252 (99.6) (65.5) (4.0) (30.6)
Alaska 57 55 55 (100.0) (16.4) (0.0) (83.6)
Arizona 295 285 264 (92.6) (65.5) (20.5) (14.0)
Arkansas 128 125 124 (99.2) (82.3) (2.4) (15.3)
California 3,220 3,177 3,134 (98.6) (53.7) (30.2) (16.1)
Colorado 111 110 110 (100.0) (66.4) (7.3) (26.4)
Connecticut 111 109 109 (100.0) (10.1) (40.4) (49.5)
Delaware 32 30 30 (100.0) (80.0) (6.7) (13.3)
District of Columbia 79 79 79 (100.0) (63.3) (32.9) (3.8)
Florida 1,041 1,011 1,008 (99.7) (74.6) (9.1) (16.3)
Georgia 532 522 499 (95.6) (72.5) (6.2) (21.2)
Hawaii 116 115 115 (100.0) (31.3) (20.0) (48.7)
Idaho 13 13 11 (84.6) (54.5) (9.1) (36.4)
Illinois 632 624 619 (99.2) (49.9) (24.6) (25.5)
Indiana 143 141 141 (100.0) (0.0) (18.4) (81.6)
Iowa 40 39 38 (97.4) (10.5) (2.6) (86.8)
Kansas 75 73 73 (100.0) (65.8) (5.5) (28.8)
Kentucky 138 133 132 (99.2) (68.9) (9.8) (21.2)
Louisiana 256 245 244 (99.6) (52.0) (11.1) (36.9)
Maine 24 23 23 (100.0) (100.0) (0.0) (0.0)
Maryland 269 263 263 (100.0) (87.1) (6.5) (6.5)
Massachusetts 261 258 254 (98.4) (54.3) (7.9) (37.8)
Michigan 243 233 228 (97.9) (63.2) (14.0) (22.8)
Minnesota 214 214 214 (100.0) (58.4) (39.7) (1.9)
Mississippi 131 127 126 (99.2) (100.0) (0.0) (0.0)
Missouri 130 125 124 (99.2) (18.5) (20.2) (61.3)
Montana 7 7 7 (100.0) (85.7) (0.0) (14.3)
Nebraska 28 27 27 (100.0) (0.0) (37.0) (63.0)
Nevada 106 101 101 (100.0) (92.1) (5.0) (3.0)
New Hampshire 15 14 14 (100.0) (0.0) (28.6) (71.4)
New Jersey 495 485 478 (98.6) (62.6) (31.2) (6.3)
New Mexico 49 47 47 (100.0) (63.8) (29.8) (6.4)
New York State3 340 332 330 (99.4) (49.4) (27.6) (23.0)
New York City 1,131 1,101 1,101 (100.0) (41.6) (19.9) (38.5)
North Carolina 374 365 362 (99.2) (43.4) (8.0) (48.6)
North Dakota 6 5 5 (100.0) (20.0) (40.0) (40.0)
Ohio 229 220 217 (98.6) (59.9) (24.9) (15.2)
Oklahoma 163 155 155 (100.0) (96.1) (1.9) (1.9)
Oregon 106 103 101 (98.1) (43.6) (11.9) (44.6)
Pennsylvania 336 326 326 (100.0) (71.2) (25.2) (3.7)
Rhode Island 46 45 44 (97.8) (90.9) (9.1) (0.0)
South Carolina 254 248 248 (100.0) (77.0) (3.2) (19.8)
South Dakota 20 19 19 (100.0) (63.2) (5.3) (31.6)
Tennessee 286 272 268 (98.5) (38.1) (6.7) (55.2)
Texas 1,580 1,540 1,454 (94.4) (63.8) (29.0) (7.2)
Utah 39 37 37 (100.0) (43.2) (2.7) (54.1)
Vermont 8 8 8 (100.0) (12.5) (0.0) (87.5)
Virginia 332 328 327 (99.7) (66.7) (11.3) (22.0)
Washington 250 249 249 (100.0) (59.0) (10.0) (30.9)
West Virginia 21 21 21 (100.0) (19.0) (19.0) (61.9)
Wisconsin 66 65 63 (96.9) (4.8) (6.3) (88.9)
Wyoming 4 4 4 (100.0) (0.0) (75.0) (25.0)
American Samoa4 ... ... 0 ... ... ... ...
Fed. States of Micronesia4  ... ... 0 ... ... ... ...
Guam4 61 61 58 (95.1) (96.6) (0.0) (3.4)
Marshall Islands4 ... ... 0 ... ... ... ...
N. Mariana Islands4 45 45 45 (100.0) (100.0) (0.0) (0.0)
Puerto Rico4 115 104 104 (100.0) (84.6) (11.5) (3.8)
Republic of Palau4 9 9 9 (100.0) (77.8) (22.2) (0.0)
U.S. Virgin Islands4     ... ... 0 ... ... ... ...
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Table 40. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): Report-
ing Areas, 20031
1Most recent year for which data are available.
2Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for
reporting areas with information reported for >75% of cases.
4Excludes New York City.
5Not included in U.S. totals.




Percentage of Cases by
Directly Observed Therapy3







Cases with Information on
Directly Observed Therapy
United States 14,840 14,382 14,155 (98.4) (56.6) (28.4)
Alabama 258 253 252 (99.6) (22.2) (77.4)
Alaska 57 55 55 (100.0) (96.4) (1.8)
Arizona 295 283 263 (92.9) (79.5) (8.7)
Arkansas 128 125 125 (100.0) (36.8) (28.8)
California 3,220 3,140 3,084 (98.2) (60.8) (19.6)
Colorado 111 110 110 (100.0) (87.3) (3.6)
Connecticut 111 107 107 (100.0) (11.2) (58.9)
Delaware 32 30 30 (100.0) (56.7) (36.7)
District of Columbia 79 79 79 (100.0) (35.4) (7.6)
Florida 1,041 1,005 1,002 (99.7) (52.5) (41.1)
Georgia 532 516 494 (95.7) (77.9) (18.4)
Hawaii 116 113 112 (99.1) (7.1) (71.4)
Idaho 13 13 12 (92.3) (58.3) (33.3)
Illinois 632 608 607 (99.8) (54.2) (21.1)
Indiana 143 139 139 (100.0) (71.9) (23.7)
Iowa 40 38 38 (100.0) (65.8) (28.9)
Kansas 75 70 69 (98.6) (92.8) (4.3)
Kentucky 138 132 132 (100.0) (54.5) (35.6)
Louisiana 256 244 244 (100.0) (84.0) (9.0)
Maine 24 23 23 (100.0) (100.0) (0.0)
Maryland 269 263 263 (100.0) (95.4) (1.5)
Massachusetts 261 256 255 (99.6) (39.6) (29.4)
Michigan 243 231 228 (98.7) (21.5) (36.8)
Minnesota 214 212 210 (99.1) (82.4) (11.4)
Mississippi 131 126 126 (100.0) (65.1) (30.2)
Missouri 130 123 122 (99.2) (42.6) (43.4)
Montana 7 7 7 (100.0) (100.0) (0.0)
Nebraska 28 27 27 (100.0) (59.3) (3.7)
Nevada 106 101 101 (100.0) (85.1) (5.9)
New Hampshire 15 14 14 (100.0) (64.3) (21.4)
New Jersey 495 485 479 (98.8) (25.7) (38.4)
New Mexico 49 47 47 (100.0) (80.9) (17.0)
New York State4 340 332 332 (100.0) (22.6) (70.5)
New York City 1,131 1,092 1,090 (99.8) (0.2) (67.5)
North Carolina 374 364 361 (99.2) (88.9) (10.0)
North Dakota 6 5 5 (100.0) (60.0) (0.0)
Ohio 229 217 216 (99.5) (66.7) (14.8)
Oklahoma 163 155 155 (100.0) (99.4) (0.0)
Oregon 106 103 101 (98.1) (71.3) (25.7)
Pennsylvania 336 323 313 (96.9) (66.1) (14.1)
Rhode Island 46 45 44 (97.8) (40.9) (59.1)
South Carolina 254 248 247 (99.6) (90.3) (6.9)
South Dakota 20 19 19 (100.0) (73.7) (5.3)
Tennessee 286 272 269 (98.9) (53.5) (45.4)
Texas 1,580 1,524 1,439 (94.4) (69.6) (26.5)
Utah 39 37 37 (100.0) (91.9) (8.1)
Vermont 8 8 8 (100.0) (12.5) (37.5)
Virginia 332 326 326 (100.0) (78.5) (8.0)
Washington 250 249 249 (100.0) (70.3) (19.3)
West Virginia 21 21 21 (100.0) (61.9) (9.5)
Wisconsin 66 63 63 (100.0) (36.5) (33.3)
Wyoming 4 4 4 (100.0) (25.0) (0.0)
American Samoa5 ... ... ... ... ... ...
Fed. States of Micronesia5     ... ... ... ... ... ...
Guam5 61 60 58 (96.7) (1.7) (96.6)
Marshall Islands5 ... ... ... ... ... ...
N. Mariana Islands5 45 45 45 (100.0) (100.0) (0.0)
Puerto Rico5 115 104 100 (96.2) (56.0) (0.0)
Republic of Palau5 9 9 9 (100.0) (0.0) (77.8)
U.S. Virgin Islands5      ... ... ... ... ... ...
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Table 41. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy
(COT): Reporting Areas, 20031
1Most recent year for which data are available.
2Initial isolate susceptible to rifampin (n=9,762) or susceptibility unknown (n=412); culture negative (n=2,309); culture status
unknown (n=720); age unknown (n=2).
3Initial isolate rifampin resistant, or pediatric patients (aged <15) with meningeal, bone, joint, or miliary disease.
4Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during
therapy. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages
shown only for reporting areas with information reported for >90% of cases.
5Excludes New York City.
6Not included in U.S. totals.





No.4 COT(%) No.4 COT(%)
Therapy <1 Year Indicated2
COT <1 Year(%)
Therapy >1 Year Indicated3
No.4 COT(%)
United States 14,840 13205 (81.5) (92.2) 195 (78.5) 13400 (92.0)
Alabama 258 235 (85.1) (94.9) 1 (100.0) 236 (94.9)
Alaska 57 52 (90.4) (98.1) 1 (100.0) 53 (98.1)
Arizona 295 260 (79.2) (82.7) 2 (0.0) 262 (82.1)
Arkansas 128 116 (87.1) (94.0) 1 (100.0) 117 (94.0)
California 3,220 2876 (80.0) (92.2) 57 (80.7) 2933 (92.0)
Colorado 111 102 (93.1) (96.1) 3 (100.0) 105 (96.2)
Connecticut 111 101 (73.3) (92.1) 0 ... 101 (92.1)
Delaware 32 28 (85.7) (100.0) 0 ... 28 (100.0)
District of Columbia 79 68 (91.2) (97.1) 0 ... 68 (97.1)
Florida 1,041 922 (85.4) (96.4) 12 (75.0) 934 (96.1)
Georgia 532 484 (77.9) (89.7) 3 (66.7) 487 (89.5)
Hawaii 116 99 (76.8) (93.9) 5 (20.0) 104 (90.4)
Idaho 13 13 — — 0 ... 13 —
Illinois 632 567 (80.4) (90.3) 8 (87.5) 575 (90.3)
Indiana 143 118 (95.8) (98.3) 2 (50.0) 120 (97.5)
Iowa 40 36 (91.7) (100.0) 1 (100.0) 37 (100.0)
Kansas 75 65 (76.9) (87.7) 2 (50.0) 67 (86.6)
Kentucky 138 120 (85.0) (95.0) 1 (100.0) 121 (95.0)
Louisiana 256 219 (79.9) (92.7) 1 (100.0) 220 (92.7)
Maine 24 23 (69.6) (95.7) 0 ... 23 (95.7)
Maryland 269 242 (86.8) (95.5) 3 (100.0) 245 (95.5)
Massachusetts 261 247 (76.5) (95.5) 0 ... 247 (95.5)
Michigan 243 211 (83.4) (92.4) 4 (75.0) 215 (92.1)
Minnesota 214 201 (88.6) (96.5) 4 (100.0) 205 (96.6)
Mississippi 131 112 (76.8) (92.9) 2 (100.0) 114 (93.0)
Missouri 130 107 (71.0) (90.7) 2 (100.0) 109 (90.8)
Montana 7 5 (100.0) (100.0) 1 (100.0) 6 (100.0)
Nebraska 28 26 (69.2) (76.9) 0 ... 26 (76.9)
Nevada 106 96 (91.7) (95.8) 3 (66.7) 99 (94.9)
New Hampshire 15 14 (85.7) (92.9) 0 ... 14 (92.9)
New Jersey 495 456 (80.0) (91.7) 7 (57.1) 463 (91.1)
New Mexico 49 37 (86.5) (100.0) 1 (100.0) 38 (100.0)
New York State5 340 301 (81.1) (95.0) 4 (100.0) 305 (95.1)
New York City 1,131 998 (85.6) (93.3) 21 (76.2) 1019 (92.9)
North Carolina 374 324 (89.2) (95.7) 1 (100.0) 325 (95.7)
North Dakota 6 4 (25.0) (75.0) 0 ... 4 (75.0)
Ohio 229 194 (88.7) (93.8) 2 (100.0) 196 (93.9)
Oklahoma 163 137 (69.3) (94.2) 1 (100.0) 138 (94.2)
Oregon 106 99 (81.8) (93.9) 1 (100.0) 100 (94.0)
Pennsylvania 336 290 (79.3) (91.0) 2 (0.0) 292 (90.4)
Rhode Island 46 40 (90.0) (95.0) 0 ... 40 (95.0)
South Carolina 254 234 (85.5) (93.6) 1 (100.0) 235 (93.6)
South Dakota 20 15 (73.3) (93.3) 1 (100.0) 16 (93.8)
Tennessee 286 238 (79.8) (91.2) 3 (100.0) 241 (91.3)
Texas 1,580 1411 (74.8) (84.9) 25 (76.0) 1436 (84.7)
Utah 39 34 (97.1) (97.1) 2 (100.0) 36 (97.2)
Vermont 8 8 (100.0) (100.0) 0 ... 8 (100.0)
Virginia 332 304 (84.9) (94.4) 2 (100.0) 306 (94.4)
Washington 250 235 (80.9) (95.3) 1 (100.0) 236 (95.3)
West Virginia 21 17 (70.6) (94.1) 0 ... 17 (94.1)
Wisconsin 66 61 (86.9) (93.4) 1 (100.0) 62 (93.5)
Wyoming 4 3 (100.0) (100.0) 0 ... 3 (100.0)
American Samoa6 ... ... ... ... ... ... ... ...
Fed. States of Micronesia6    ... ... ... ... ... ... ... ...
Guam6 61 58 (87.9) (96.6) 0 ... 58 (96.6)
Marshall Islands6 ... ... ... ... ... ... ... ...
N. Mariana Islands6 ... ... ... ... ... ... ... ...
Puerto Rico6 115 90 (70.0) (86.7) 2 (0.0) 92 (84.8)
Republic of Palau6 ... ... ... ... ... ... ... ...
U.S. Virgin Islands6    ... ... ... ... ... ... ... ...
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Table 42. Tuberculosis Cases and Percentages by Reason Therapy Stopped: Reporting
Areas, 20031
1Most recent year for which data are available.
2Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed. Percentage for U.S. based on
52 reporting areas (50 states, New York City, and the District of Columbia).
3Died = Died of any cause.
4Includes cases reported as Other, Missing, or Unknown.
5Excludes New York City.
6Not included in U.S. totals.
Note: Ellipses indicate data not available.
United States 14,382 12,328 85.7 324 2.3 353 2.5 83 0.6 982 6.8 312 2.2
Alabama 253 224 88.5 1 0.4 7 2.8 0 0.0 17 6.7 4 1.6
Alaska 55 52 94.5 0 0.0 0 0.0 0 0.0 2 3.6 1 1.8
Arizona 283 215 76.0 5 1.8 20 7.1 2 0.7 21 7.4 20 7.1
Arkansas 125 110 88.0 3 2.4 0 0.0 2 1.6 8 6.4 2 1.6
California 3,140 2,697 85.9 100 3.2 56 1.8 19 0.6 207 6.6 61 1.9
Colorado 110 101 91.8 1 0.9 3 2.7 0 0.0 5 4.5 0 0.0
Connecticut 107 93 86.9 5 4.7 3 2.8 0 0.0 6 5.6 0 0.0
Delaware 30 28 93.3 0 0.0 0 0.0 0 0.0 2 6.7 0 0.0
District of Columbia 79 66 83.5 0 0.0 2 2.5 0 0.0 11 13.9 0 0.0
Florida 1,005 898 89.4 14 1.4 17 1.7 0 0.0 71 7.1 5 0.5
Georgia 516 436 84.5 11 2.1 18 3.5 6 1.2 29 5.6 16 3.1
Hawaii 113 94 83.2 3 2.7 0 0.0 0 0.0 9 8.0 7 6.2
Idaho 13 11 84.6 0 0.0 0 0.0 0 0.0 0 0.0 2 15.4
Illinois 608 519 85.4 21 3.5 23 3.8 0 0.0 33 5.4 12 2.0
Indiana 139 117 84.2 1 0.7 1 0.7 1 0.7 19 13.7 0 0.0
Iowa 38 37 97.4 0 0.0 0 0.0 0 0.0 1 2.6 0 0.0
Kansas 70 58 82.9 4 5.7 1 1.4 1 1.4 3 4.3 3 4.3
Kentucky 132 115 87.1 1 0.8 3 2.3 0 0.0 11 8.3 2 1.5
Louisiana 244 204 83.6 6 2.5 6 2.5 1 0.4 24 9.8 3 1.2
Maine 23 22 95.7 1 4.3 0 0.0 0 0.0 0 0.0 0 0.0
Maryland 263 234 89.0 4 1.5 3 1.1 2 0.8 18 6.8 2 0.8
Massachusetts 256 236 92.2 8 3.1 2 0.8 0 0.0 9 3.5 1 0.4
Michigan 231 198 85.7 5 2.2 3 1.3 6 2.6 16 6.9 3 1.3
Minnesota 212 198 93.4 6 2.8 1 0.5 0 0.0 7 3.3 0 0.0
Mississippi 126 106 84.1 3 2.4 0 0.0 1 0.8 12 9.5 4 3.2
Missouri 123 99 80.5 4 3.3 3 2.4 3 2.4 14 11.4 0 0.0
Montana 7 6 85.7 0 0.0 0 0.0 0 0.0 1 14.3 0 0.0
Nebraska 27 20 74.1 1 3.7 4 14.8 0 0.0 1 3.7 1 3.7
Nevada 101 94 93.1 2 2.0 2 2.0 1 1.0 2 2.0 0 0.0
New Hampshire 14 13 92.9 0 0.0 0 0.0 0 0.0 0 0.0 1 7.1
New Jersey 485 422 87.0 2 0.4 36 7.4 0 0.0 22 4.5 3 0.6
New Mexico 47 38 80.9 0 0.0 0 0.0 0 0.0 9 19.1 0 0.0
New York State5 332 290 87.3 3 0.9 9 2.7 2 0.6 27 8.1 1 0.3
New York City 1,092 947 86.7 19 1.7 26 2.4 19 1.7 73 6.7 8 0.7
North Carolina 364 311 85.4 4 1.1 7 1.9 0 0.0 39 10.7 3 0.8
North Dakota 5 3 60.0 1 20.0 0 0.0 0 0.0 1 20.0 0 0.0
Ohio 217 184 84.8 3 1.4 1 0.5 4 1.8 21 9.7 4 1.8
Oklahoma 155 130 83.9 5 3.2 2 1.3 0 0.0 17 11.0 1 0.6
Oregon 103 94 91.3 0 0.0 3 2.9 0 0.0 3 2.9 3 2.9
Pennsylvania 323 264 81.7 7 2.2 4 1.2 3 0.9 31 9.6 14 4.3
Rhode Island 45 38 84.4 1 2.2 0 0.0 0 0.0 5 11.1 1 2.2
South Carolina 248 220 88.7 2 0.8 6 2.4 4 1.6 13 5.2 3 1.2
South Dakota 19 15 78.9 1 5.3 0 0.0 0 0.0 3 15.8 0 0.0
Tennessee 272 220 80.9 0 0.0 16 5.9 1 0.4 31 11.4 4 1.5
Texas 1,524 1,217 79.9 54 3.5 51 3.3 2 0.1 88 5.8 112 7.3
Utah 37 35 94.6 0 0.0 1 2.7 0 0.0 1 2.7 0 0.0
Vermont 8 8 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Virginia 326 289 88.7 7 2.1 8 2.5 1 0.3 20 6.1 1 0.3
Washington 249 225 90.4 3 1.2 4 1.6 1 0.4 13 5.2 3 1.2
West Virginia 21 16 76.2 0 0.0 1 4.8 0 0.0 4 19.0 0 0.0
Wisconsin 63 58 92.1 2 3.2 0 0.0 1 1.6 1 1.6 1 1.6
Wyoming 4 3 75.0 0 0.0 0 0.0 0 0.0 1 25.0 0 0.0
American Samoa6 ... ... ... ... ... ... ... ... ... ... ... ... ...
Fed. States of Micronesia6 ... ... ... ... ... ... ... ... ... ... ... ... ...
Guam6 60 56 93.3 1 1.7 0 0.0 0 0.0 2 3.3 1 1.7
Marshall Islands6 ... ... ... ... ... ... ... ... ... ... ... ... ...
N. Mariana Islands6 45 34 75.6 9 20.0 0 0.0 0 0.0 1 2.2 1 2.2
Puerto Rico6 104 78 75.0 0 0.0 8 7.7 3 2.9 12 11.5 3 2.9
Republic of Palau6 9 6 66.7 1 11.1 0 0.0 0 0.0 2 22.2 0 0.0
U.S. Virgin Islands6 ... ... ... ... ... ... ... ... ... ... ... ... ...
Reporting Area
Completed Moved Lost Refused Died3 Unknown4






Table 43. Completion of Tuberculosis Therapy (COT) Cases and Percentages1 by Hispanic
Ethnicity and Non-Hispanic Race: Reporting Areas, 20032
1Percentages shown only for reporting areas with information reported for >90% of cases, and indicate the percentage of those who
completed therapy within 1 year.
2Most recent year for which data are available.
3Therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not
die during therapy.
4Persons of Hispanic or Latino origin may be of any race.
5Excludes New York City.
6Not included in U.S. totals.
Note: Case counts and percentage for race categories do not include persons of Hispanic ethnicity.
Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation (page 9).
United States 13,205 3,771 (80.1) 150 (78.7) 3,230 (81.8) 3,646 (81.8) 2,339 (82.8) 69 (81.2)
Alabama 235 19 (84.2) 0 ... 10 (100.0) 127 (87.4) 79 (79.7) 0 ...
Alaska 52 2 (100.0) 36 (88.9) 9 (88.9) 0 ... 2 (100.0) 3 (100.0)
Arizona 260 162 (79.0) 13 (69.2) 24 (75.0) 9 (77.8) 52 (84.6) 0 ...
Arkansas 116 12 (75.0) 0 ... 17 (94.1) 32 (87.5) 55 (87.3) 0 ...
California 2,876 1,153 (79.4) 4 (75.0) 1,212 (80.5) 213 (78.4) 281 (80.4) 13 (84.6)
Colorado 102 49 (91.8) 0 ... 26 (92.3) 8 (100.0) 19 (94.7) 0 ...
Connecticut 101 31 (64.5) 0 ... 31 (80.6) 25 (68.0) 14 (85.7) 0 ...
Delaware 28 7 (100.0) 0 ... 5 (100.0) 8 (75.0) 8 (75.0) 0 ...
District of Columbia 68 8 (100.0) 0 ... 4 (75.0) 51 (92.2) 5 (80.0) 0 ...
Florida 922 231 (83.1) 0 ... 76 (81.6) 399 (86.0) 210 (87.6) 6 (100.0)
Georgia 484 84 (79.8) 0 ... 47 (68.1) 277 (78.7) 68 (79.4) 8 (75.0)
Hawaii 99 3 (100.0) 0 ... 91 (74.7) 0 ... 4 (100.0) 1 (100.0)
Idaho 13 8 (87.5) 2 (100.0) 0 ... 1 (100.0) 1 (0.0) 1 (100.0)
Illinois 567 141 (74.5) 4 (25.0) 144 (87.5) 201 (79.6) 74 (83.8) 3 (66.7)
Indiana 118 18 (83.3) 0 ... 17 (94.1) 46 (100.0) 37 (97.3) 0 ...
Iowa 36 10 (90.0) 0 ... 11 (90.9) 6 (100.0) 9 (88.9) 0 ...
Kansas 65 15 (60.0) 0 ... 18 (72.2) 15 (80.0) 17 (94.1) 0 ...
Kentucky 120 18 (88.9) 0 ... 6 (100.0) 17 (82.4) 79 (83.5) 0 ...
Louisiana 219 7 (85.7) 3 (100.0) 23 (78.3) 121 (78.5) 64 (81.3) 1 (100.0)
Maine 23 0 ... 1 (100.0) 2 (100.0) 9 (88.9) 11 (45.5) 0 ...
Maryland 242 42 (85.7) 0 ... 57 (91.2) 121 (82.6) 21 (100.0) 1 (100.0)
Massachusetts 247 40 (70.0) 1 (100.0) 87 (77.0) 65 (81.5) 53 (73.6) 1 (100.0)
Michigan 211 20 (85.0) 0 ... 45 (80.0) 79 (82.3) 66 (86.4) 1 (100.0)
Minnesota 201 19 (89.5) 5 (100.0) 57 (86.0) 105 (88.6) 13 (92.3) 2 (100.0)
Mississippi 112 8 (87.5) 0 ... 6 (66.7) 70 (78.6) 28 (71.4) 0 ...
Missouri 107 11 (72.7) 0 ... 14 (78.6) 33 (57.6) 47 (78.7) 2 (50.0)
Montana 5 0 ... 4 (100.0) 0 ... 0 ... 1 (100.0) 0 ...
Nebraska 26 12 (75.0) 1 (100.0) 5 (80.0) 2 (50.0) 5 (40.0) 1 (100.0)
Nevada 96 17 (100.0) 1 (100.0) 47 (93.6) 12 (91.7) 19 (78.9) 0 ...
New Hampshire 14 1 (100.0) 0 ... 9 (88.9) 3 (66.7) 1 (100.0) 0 ...
New Jersey 456 157 (80.9) 0 ... 133 (78.2) 106 (77.4) 60 (86.7) 0 ...
New Mexico 37 20 (90.0) 7 (85.7) 4 (75.0) 0 ... 6 (83.3) 0 ...
New York City 998 309 (86.7) 0 ... 300 (88.0) 324 (82.4) 62 (83.9) 3 (100.0)
New York State5 301 95 (83.2) 1 (100.0) 57 (75.4) 72 (79.2) 76 (84.2) 0 ...
North Carolina 324 64 (85.9) 6 (100.0) 29 (89.7) 150 (91.3) 74 (86.5) 1 (100.0)
North Dakota 4 0 ... 0 ... 0 ... 1 (0.0) 3 (33.3) 0 ...
Ohio 194 5 (60.0) 1 (100.0) 37 (86.5) 78 (93.6) 72 (86.1) 1 (100.0)
Oklahoma 137 16 (56.3) 30 (60.0) 15 (80.0) 24 (62.5) 52 (78.8) 0 ...
Oregon 99 33 (87.9) 2 (100.0) 35 (71.4) 4 (75.0) 25 (88.0) 0 ...
Pennsylvania 290 31 (80.6) 0 ... 86 (84.9) 83 (74.7) 88 (79.5) 2 (0.0)
Rhode Island 40 12 (91.7) 0 ... 9 (77.8) 9 (100.0) 10 (90.0) 0 ...
South Carolina 234 32 (87.5) 3 (100.0) 9 (77.8) 149 (85.9) 41 (82.9) 0 ...
South Dakota 15 0 ... 6 (83.3) 4 (100.0) 0 ... 5 (40.0) 0 ...
Tennessee 238 23 (69.6) 0 ... 22 (95.5) 95 (71.6) 94 (87.2) 4 (75.0)
Texas 1,411 700 (74.1) 3 (100.0) 148 (74.3) 358 (75.4) 198 (75.8) 4 (50.0)
Utah 34 11 (100.0) 1 (100.0) 10 (90.0) 7 (100.0) 5 (100.0) 0 ...
Vermont 8 0 ... 0 ... 4 (100.0) 3 (100.0) 1 (100.0) 0 ...
Virginia 304 62 (88.7) 0 ... 99 (81.8) 85 (84.7) 48 (87.5) 10 (80.0)
Washington 235 39 (89.7) 13 (61.5) 106 (79.2) 32 (78.1) 45 (84.4) 0 ...
West Virginia 17 1 (0.0) 0 ... 1 (100.0) 2 (100.0) 13 (69.2) 0 ...
Wisconsin 61 12 (91.7) 2 (50.0) 22 (86.4) 9 (88.9) 16 (87.5) 0 ...
Wyoming 3 1 (100.0) 0 ... 0 ... 0 ... 2 (100.0) 0 ...
American Samoa6 … … … … … … … … … … … … …
Fed. States of Micronesia6 … … … … … … … … … … … … …
Guam6 58 0 ... 0 ... 58 (87.9) 0 ... 0 ... 0 ...
Marshall Islands6 … … … … … … … … … … … … …
N. Mariana Islands6 42 0 ... 0 ... 42 (78.6) 0 ... 0 ... 0 ...
Puerto Rico6 90 88 (71.6) 0 ... 1 (0.0) 1 (0.0) 0 ... 0 ...
Republic of Palau6 7 0 ... 0 ... 7 (57.1) 0 ... 0 ... 0 ...











No. (%) No. No. No. No.(%) (%) (%) (%)No. (%)
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United States 15,208 79.9 14,259 (80.9) 14,061 (80.8) 13,271 (81.4) 13,205 (81.4)
Alabama 260 (80.4) 263 (88.2) 224 (79.5) 203 (89.7) 235 (85.1)
Alaska 59 (88.1) 104 (90.4) 50 (88.0) 45 (91.1) 52 (90.4)
Arizona 231 (82.3) 228 (78.1) 254 (81.9) 225 (79.1) 260 (79.2)
Arkansas 156 (82.7) 176 (84.1) 138 (92.0) 114 (86.8) 116 (87.1)
California 3,183 (79.8) 2,931 (79.5) 2,969 (80.1) 2,820 (81.8) 2,876 (79.9)
Colorado 80 (88.8) 83 (92.8) 128 (93.0) 96 (84.4) 102 (93.1)
Connecticut 108 (78.7) 90 (68.9) 113 (70.8) 90 (70.0) 101 (73.3)
Delaware 30 (80.0) 23 (78.3) 30 (93.3) 23 (91.3) 28 (85.7)
District of Columbia 57 (84.2) 71 (80.3) 63 (85.7) 77 (97.4) 68 (91.2)
Florida 1,075 (84.0) 1,004 (82.7) 1,018 (80.8) 945 (81.6) 922 (85.4)
Georgia 593 (77.6) 599 (80.6) 507 (81.3) 464 (78.2) 484 (77.9)
Hawaii 168 (67.9) 119 (73.1) 138 (73.9) 137 (69.3) 99 (76.8)
Idaho 14 (71.4) 13 (53.8) 7 (71.4) 12 (58.3) 13 (84.6)
Illinois 700 (81.3) 636 (83.3) 636 (77.8) 583 (76.3) 567 (80.4)
Indiana 133 (79.7) 119 (89.9) 97 (92.8) 107 (96.3) 118 (95.8)
Iowa 54 (83.3) 38 (89.5) 36 (77.8) 33 (81.8) 36 (91.7)
Kansas 62 (80.6) 70 (82.9) 70 (72.9) 76 (80.3) 65 (76.9)
Kentucky 177 (80.2) 117 (88.0) 131 (87.8) 129 (85.3) 120 (85.0)
Louisiana 310 (77.4) 285 (77.5) 259 (74.5) 207 (81.6) 219 (79.9)
Maine 19 (94.7) 22 (72.7) 19 (94.7) 18 (77.8) 23 (69.6)
Maryland 258 (86.0) 255 (83.5) 235 (88.9) 265 (86.4) 242 (86.8)
Massachusetts 248 (80.6) 261 (83.9) 250 (77.6) 255 (76.9) 247 (76.5)
Michigan 293 (83.6) 248 (83.1) 275 (81.1) 263 (81.4) 211 (83.4)
Minnesota 184 (87.5) 172 (84.9) 221 (84.6) 220 (85.5) 201 (88.6)
Mississippi 187 (84.5) 153 (83.7) 137 (83.9) 113 (83.2) 112 (76.8)
Missouri 174 (79.3) 183 (81.4) 138 (84.8) 114 (86.0) 107 (71.0)
Montana 10 (90.0) 19 (89.5) 17 (94.1) 10 (90.0) 5 (100.0)
Nebraska 18 (55.6) 22 (63.6) 31 (83.9) 24 (66.7) 26 (69.2)
Nevada 81 (77.8) 91 (84.6) 87 (80.5) 71 (97.2) 96 (91.7)
New Hampshire 17 (94.1) 20 (80.0) 19 (89.5) 18 (88.9) 14 (85.7)
New Jersey 490 (71.8) 480 (74.2) 458 (75.5) 475 (78.1) 456 (80.0)
New Mexico 48 (87.5) 38 (71.1) 46 (82.6) 50 (78.0) 37 (86.5)
New York City 1,252 (78.8) 1,122 (83.9) 1,067 (84.9) 927 (85.5) 998 (85.6)
New York State4 332 (75.6) 358 (79.6) 375 (81.6) 318 (76.4) 301 (81.1)
North Carolina 431 (88.6) 391 (90.3) 340 (88.5) 369 (90.5) 324 (89.2)
North Dakota 7 (57.1) 5 (100.0) 5 (100.0) 6 (100.0) 4 (25.0)
Ohio 262 (71.4) 298 (73.8) 258 (79.1) 219 (80.4) 194 (88.7)
Oklahoma 180 (73.9) 128 (82.8) 159 (80.5) 169 (84.6) 137 (69.3)
Oregon 114 (78.1) 110 (80.9) 113 (87.6) 104 (86.5) 99 (81.8)
Pennsylvania 370 (76.2) 337 (74.2) 280 (76.4) 306 (73.9) 290 (79.3)
Rhode Island 44 (68.2) 43 (74.4) 60 (73.3) 45 (68.9) 40 (90.0)
South Carolina 264 (69.7) 245 (76.3) 227 (85.0) 222 (80.2) 234 (85.5)
South Dakota 17 (76.5) 12 (75.0) 12 (66.7) 9 (88.9) 15 (73.3)
Tennessee 319 (84.0) 322 (80.4) 265 (84.2) 276 (83.7) 238 (79.8)
Texas 1,441 (79.8) 1,323 (78.9) 1,443 (75.8) 1,361 (75.6) 1,411 (74.7)
Utah 34 (73.5) 41 (73.2) 33 (81.8) 29 (96.6) 34 (97.1)
Vermont 2 (50.0) 2 (100.0) 7 (100.0) 8 (87.5) 8 (100.0)
Virginia 292 (85.6) 254 (86.2) 272 (80.9) 289 (86.5) 304 (84.9)
Washington 235 (81.3) 233 (82.0) 241 (84.6) 236 (83.5) 235 (80.9)
West Virginia 36 (69.4) 24 (50.0) 25 (64.0) 26 (65.4) 17 (70.6)
Wisconsin 96 (86.5) 75 (78.7) 75 (81.3) 67 (82.1) 61 (86.9)
Wyoming 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)
American Samoa5 … … … … … … … … … …
Fed. States of Micronesia5 … … … … … … … … … …
Guam5 65 (53.8) 47 (66.0) 56 (37.5) 79 (51.9) 58 (87.9)
Marshall Islands5 … … … … … … … … … …
N. Mariana Islands5 62 (82.3) 72 (83.3) 50 (88.0) 51 (68.6) 42 (78.6)
Puerto Rico5 148 (82.4) 128 (87.5) 92 (92.4) 93 (79.6) 90 (70.0)
Republic of Palau5 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 7 (57.1)
U.S. Virgin Islands5 … … … … … … … … … …
Reporting Area
1999 2000 2001 2002 2003
Year
No.2 No.2 No.2No.2(%)3 (%)3 (%)3 (%)3 (%)3
Table 44. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom
Therapy Was Indicated for One Year or Less: Reporting Areas, 1999–20031
1Most recent year for which data are available.
2Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs
prescribed, who did not die during therapy.
3Percentage of total cases in persons who completed therapy for whom therapy less than 1 year was indicated.
4Excludes New York City.
5Not included in U.S. totals.





Albuquerque, NM 9 14
Anaheim, CA 23 29
Arlington, TX 28 29
Atlanta, GA 38 52
Austin, TX 47 58
Baltimore, MD 68 58
Birmingham, AL 15 37
Boston, MA 57 70
Buffalo, NY 8 19
Charlotte, NC 46 47
Chicago, IL 332 307
Cincinnati, OH 20 22
Cleveland, OH 46 28
Colorado Springs, CO 8 8
Columbus, OH 74 49
Corpus Christi, TX 22 21
Dallas, TX 154 185
Denver, CO 48 45
Detroit, MI 84 98
El Paso, TX 44 66
Fort Worth, TX 81 67
Fresno, CA 45 64
Honolulu, HI 46 49
Houston, TX 344 433
Indianapolis, IN 45 31
Jacksonville, FL 77 69
Kansas City, MO 23 21
Las Vegas, NV 74 54
Long Beach, CA 53 54
Los Angeles, CA 350 386
Louisville, KY 25 27
Memphis, TN 87 83
Mesa, AZ 15 20
Miami, FL 97 127
Milwaukee, WI 22 27
Minneapolis, MN 54 63
Nashville, TN 53 46
Newark, NJ 47 61
New Orleans, LA 62 53
New York, NY 984 1,037
Norfolk, VA 22 13
Oakland, CA 45 53
Oklahoma City, OK 35 41
Omaha, NE 16 17
Philadelphia, PA 116 124
Phoenix, AZ 100 104
Pittsburgh, PA 11 5
Portland, OR 39 48
Sacramento, CA 124 117
St. Louis, MO 29 32
St. Paul, MN 30 26
San Antonio, TX 73 111
San Diego, CA 174 188
San Francisco, CA 132 135
San Jose, CA 126 149
Santa Ana, CA 34 39
Seattle, WA 74 93
Tampa, FL 69 57
Toledo, OH 11 4
Tucson, AZ 24 19
Tulsa, OK 21 30
Virginia Beach, VA 12 13
Washington, DC 56 81
Wichita, KS 18 15
TOTAL - 64 CITIES 5,146 5,528
San Juan, PR 13 13
Table 45. Tuberculosis Cases in Selected Cities1: 2005 and 2004
Cases2
2005 2004City
1Historical list of cities.
2Case counts are based on verified cases in persons residing within city limits. Residence
within city limits was determined by the health department.
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Table 46. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statisti-




Population Estimates 20052005 20052004 2004
Akron, OH 10 7 1.4 1.0 702,235
Albany-Schenectady, NY 16 14 1.8 1.6 897,847
Albuquerque, NM 13 15 1.7 2.0 780,439
Allentown, PA 9 13 1.3 1.9 680,159
Ann Arbor, MI 12 9 1.9 1.5 625,397
Atlanta, GA 295 317 6.2 6.8 4,768,685
Austin, TX 57 84 3.9 6.0 1,452,529
Bakersfield, CA 42 36 5.5 4.9 756,825
Baltimore, MD 122 118 4.6 4.5 2,655,675
Baton Rouge, LA 17 16 2.7 2.6 632,758
Bergen-Passaic, NJ 89 85 6.3 6.1 1,401,621
Birmingham, AL 36 62 3.8 6.5 956,749
Boise City, ID 10 ... 2.0 ... 509,320
Boston, MA 241 284 3.9 4.6 6,142,719
Buffalo, NY 13 26 1.1 2.3 1,147,711
Charleston, SC 44 41 7.4 7.0 594,899
Charlotte, NC 71 105 4.2 6.4 1,700,729
Chicago, IL 546 508 6.4 5.9 8,585,411
Cincinnati, OH 38 48 2.3 2.9 1,688,274
Cleveland, OH 75 55 3.4 2.5 2,229,539
Colorado Springs, CO 9 9 1.6 1.6 565,582
Columbia, SC 11 25 1.9 4.4 575,350
Columbus, OH 81 58 5.0 3.6 1,628,552
Dallas, TX 275 294 6.9 7.6 3,967,660
Dayton, OH 7 15 0.7 1.6 943,426
Daytona Beach, FL 9 15 1.6 2.7 566,465
Denver, CO 70 91 3.1 4.1 2,262,650
Detroit, MI 168 174 3.8 3.9 4,460,753
El Paso, TX 49 70 6.8 9.8 721,598
Fort Lauderdale, FL 99 88 5.6 5.0 1,777,638
Fort Myers, FL 16 21 2.9 4.1 544,758
Fort Wayne, IN 17 23 3.3 4.5 518,158
Fort Worth, TX 132 115 6.9 6.1 1,917,586
Fresno, CA 78 107 7.6 10.7 1,020,372
Gary, IN 20 15 3.1 2.3 651,069
Grand Rapids, MI 19 37 1.7 3.3 1,140,800
Greensboro, NC 51 49 3.8 3.7 1,325,671
Greenville, SC 25 22 2.5 2.2 1,017,125
Harrisburg, PA 25 18 3.9 2.8 647,390
Hartford, CT 25 24 2.1 2.0 1,188,241
Honolulu, HI 83 87 9.2 9.7 905,266
Houston, TX 423 512 9.1 11.2 4,673,106
Indianapolis, IN 53 43 3.1 2.5 1,718,892
Jacksonville, FL 92 90 7.5 7.5 1,223,802
Jersey City, NJ 69 68 11.4 11.2 603,521
Kansas City, MO 47 49 2.5 2.6 1,885,199
Knoxville, TN 15 20 2.0 2.8 734,682
Lakeland, FL 54 26 9.9 5.0 542,912
Las Vegas, NV 97 70 5.0 3.8 1,938,228
Lexington, KY 17 22 3.3 4.4 507,638
Little Rock, AR 21 15 3.4 2.5 615,456
Los Angeles, CA 973 995 9.8 10.0 9,935,475
Louisville, KY 36 38 3.4 3.6 1,056,070
McAllen, TX 92 82 13.6 12.5 678,275
Melbourne, FL 14 8 2.6 1.5 531,250
Memphis, TN 96 92 8.1 7.8 1,188,377
Miami, FL 229 271 9.6 11.5 2,376,014
Middlesex, NJ 65 73 5.2 5.9 1,239,820
Milwaukee, WI 35 35 2.3 2.3 1,512,855
Minneapolis-St. Paul, MN 167 157 5.3 5.0 3,142,779
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Table 46. (Cont’d) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan




Population Estimates 20052005 20052004 2004
Note: In 2005, there were 109 metropolitan statistical areas with a population of 500,000 or more.  In 2004, the Boise City, ID, and
Modesto, CA, metropolitan statistical areas had populations under 500,000.
2004 and 2005 population case counts and rates updated using U.S. Census Annual Estimates for the Population of Counties:  April 1,
2000–July 1, 2005 (http://www.census.gov/popest/counties/files/CO-EST2005-ALLDATA.csv)
Ellipses indicate data not calculated because MSA <500,000. See Technical Notes (page 9) for definition of MSA.
Mobile, AL 30 17 5.3 3.1 564,013
Modesto, CA 11 ... 2.2 ... 505,505
Monmouth-Ocean City, NJ 30 27 2.5 2.3 1,194,293
Nashville, TN 100 67 7.5 5.1 1,337,541
Nassau-Suffolk, NY 103 101 3.7 3.6 2,808,064
New Haven, CT 65 66 3.7 3.8 1,749,541
New Orleans, LA 116 101 8.7 7.5 1,340,517
New York, NY 1,070 1,123 11.3 11.8 9,477,427
Newark, NJ 150 171 7.2 8.2 2,076,613
Norfolk, VA 67 50 4.1 3.1 1,640,333
Oakland, CA 221 211 9.0 8.6 2,466,692
Oklahoma City, OK 57 60 5.0 5.3 1,143,404
Omaha, NE 19 21 2.5 2.8 761,544
Orange County, CA 241 228 8.1 7.6 2,988,072
Orlando, FL 121 125 6.3 6.7 1,933,255
Philadelphia, PA 218 216 4.2 4.2 5,202,429
Phoenix, AZ 194 211 5.0 5.7 3,865,077
Pittsburgh, PA 35 34 1.5 1.5 2,315,488
Portland, OR 73 70 3.5 3.4 2,085,197
Providence, RI 43 48 4.3 4.8 992,449
Raleigh-Durham, NC 65 94 4.7 7.1 1,368,651
Richmond, VA 47 44 4.4 4.2 1,064,821
Riverside-San Bern., CA 121 143 3.1 3.8 3,909,954
Rochester, NY 23 26 2.1 2.4 1,098,285
Sacramento, CA 154 164 8.3 9.0 1,857,351
St. Louis, MO 52 57 1.9 2.1 2,682,185
Salt Lake City, UT 22 24 1.5 1.7 1,427,108
San Antonio, TX 80 121 4.6 7.0 1,754,949
San Diego, CA 305 320 10.4 10.9 2,933,462
San Francisco, CA 205 204 12.2 12.1 1,685,996
San Jose, CA 199 202 11.7 12.0 1,699,052
Sarasota, FL 29 21 4.3 3.2 673,035
Scranton, PA 9 10 1.5 1.6 615,485
Seattle, WA 152 154 6.0 6.2 2,528,779
Springfield, MA 22 15 3.6 2.4 614,930
Stockton, CA 63 65 9.5 10.0 664,116
Syracuse, NY 20 13 2.7 1.8 733,217
Tacoma, WA 27 34 3.6 4.6 753,787
Tampa-St. Petersburg, FL 125 120 4.7 4.6 2,647,658
Toledo, OH 13 7 2.1 1.1 615,113
Tucson, AZ 33 21 3.6 2.3 924,786
Tulsa, OK 28 42 3.4 5.1 831,123
Vallejo, CA 44 50 8.1 9.2 544,357
Ventura, CA 55 72 6.9 9.0 796,106
Washington, DC 390 435 7.3 8.2 5,371,227
West Palm Beach, FL 92 99 7.3 8.0 1,268,548
Wichita, KS 23 17 4.1 3.0 562,258
Wilmington, DE 19 18 3.1 2.9 620,804
Youngstown, OH 10 10 1.7 1.7 584,498
Total - 109 Areas 11,011 11,415 5.7 6.0 192,639,077
San Juan, PR 53 47 2.6 2.3 2,015,050
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Table 47. Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: Metropolitan









Cases in Persons with Both Pulmo-
nary and Extrapulm. Disease
Miliary
Akron, OH 10 7 (70.0) 3 (30.0) 0 (0.0) 0
Albany-Schenectady, NY 16 10 (62.5) 5 (31.3) 1 (6.3) 0
Albuquerque, NM 13 7 (53.8) 4 (30.8) 2 (15.4) 1
Allentown, PA 9 6 (66.7) 2 (22.2) 1 (11.1) 1
Ann Arbor, MI 12 4 (33.3) 8 (66.7) 0 (0.0) 0
Atlanta, GA 295 210 (71.2) 64 (21.7) 21 (7.1) 3
Austin, TX 57 40 (70.2) 11 (19.3) 6 (10.5) 3
Bakersfield, CA 42 36 (85.7) 5 (11.9) 1 (2.4) 0
Baltimore, MD 122 84 (68.9) 24 (19.7) 14 (11.5) 4
Baton Rouge, LA 17 14 (82.4) 2 (11.8) 1 (5.9) 0
Bergen-Passaic, NJ 89 62 (69.7) 15 (16.9) 12 (13.5) 1
Birmingham, AL 36 26 (72.2) 9 (25.0) 1 (2.8) 1
Boise City, ID 10 8 (80.0) 1 (10.0) 1 (10.0) 0
Boston, MA 241 130 (53.9) 73 (30.3) 38 (15.8) 16
Buffalo, NY 13 10 (76.9) 2 (15.4) 1 (7.7) 0
Charleston, SC 44 26 (59.1) 12 (27.3) 6 (13.6) 0
Charlotte, NC 71 49 (69.0) 16 (22.5) 6 (8.5) 2
Chicago, IL 546 392 (71.8) 137 (25.1) 17 (3.1) 6
Cincinnati, OH 38 26 (68.4) 8 (21.1) 4 (10.5) 1
Cleveland, OH 75 39 (52.0) 24 (32.0) 12 (16.0) 2
Colorado Springs, CO 9 7 (77.8) 2 (22.2) 0 (0.0) 0
Columbia, SC 11 7 (63.6) 2 (18.2) 2 (18.2) 1
Columbus, OH 81 58 (71.6) 14 (17.3) 9 (11.1) 1
Dallas, TX 275 192 (69.8) 51 (18.5) 32 (11.6) 9
Dayton, OH 7 6 (85.7) 1 (14.3) 0 (0.0) 0
Daytona Beach, FL 9 7 (77.8) 2 (22.2) 0 (0.0) 0
Denver, CO 70 42 (60.0) 20 (28.6) 8 (11.4) 2
Detroit, MI 168 109 (64.9) 49 (29.2) 10 (6.0) 1
El Paso, TX 49 40 (81.6) 8 (16.3) 1 (2.0) 0
Fort Lauderdale, FL 99 82 (82.8) 16 (16.2) 1 (1.0) 0
Fort Myers, FL 16 15 (93.8) 1 (6.3) 0 (0.0) 0
Fort Wayne, IN 17 11 (64.7) 3 (17.6) 3 (17.6) 1
Fort Worth, TX 132 94 (71.2) 25 (18.9) 13 (9.8) 6
Fresno, CA 78 55 (70.5) 14 (17.9) 9 (11.5) 1
Gary, IN 20 13 (65.0) 7 (35.0) 0 (0.0) 0
Grand Rapids, MI 19 9 (47.4) 9 (47.4) 1 (5.3) 0
Greensboro, NC 51 33 (64.7) 10 (19.6) 8 (15.7) 5
Greenville, SC 25 23 (92.0) 0 (0.0) 2 (8.0) 1
Harrisburg, PA 25 18 (72.0) 6 (24.0) 1 (4.0) 0
Hartford, CT 25 14 (56.0) 8 (32.0) 3 (12.0) 0
Honolulu, HI 83 74 (89.2) 6 (7.2) 3 (3.6) 0
Houston, TX 423 301 (71.2) 79 (18.7) 43 (10.2) 19
Indianapolis, IN 53 33 (62.3) 12 (22.6) 8 (15.1) 4
Jacksonville, FL 92 80 (87.0) 12 (13.0) 0 (0.0) 0
Jersey City, NJ 69 47 (68.1) 17 (24.6) 5 (7.2) 1
Kansas City, MO 47 29 (61.7) 13 (27.7) 5 (10.6) 1
Knoxville, TN 15 12 (80.0) 3 (20.0) 0 (0.0) 0
Lakeland, FL 54 44 (81.5) 9 (16.7) 1 (1.9) 0
Las Vegas, NV 97 68 (70.1) 23 (23.7) 6 (6.2) 0
Lexington, KY 17 13 (76.5) 3 (17.6) 1 (5.9) 0
Little Rock, AR 21 16 (76.2) 2 (9.5) 3 (14.3) 0
Los Angeles, CA 973 658 (67.6) 224 (23.0) 91 (9.4) 19
Louisville, KY 36 31 (86.1) 5 (13.9) 0 (0.0) 0
McAllen, TX 92 71 (77.2) 8 (8.7) 13 (14.1) 2
Melbourne, FL 14 13 (92.9) 1 (7.1) 0 (0.0) 0
Memphis, TN 96 62 (64.6) 23 (24.0) 11 (11.5) 0
Miami, FL 229 165 (72.1) 58 (25.3) 6 (2.6) 2
Middlesex, NJ 65 39 (60.0) 22 (33.8) 4 (6.2) 1
Milwaukee, WI 35 23 (65.7) 11 (31.4) 1 (2.9) 0
Minneapolis-St. Paul, MN 167 75 (44.9) 74 (44.3) 18 (10.8) 1
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Table 47. (Cont’d) Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: Metro-









Cases in Persons with Both
Pulmonary and Extrapulm. Disease
Miliary
Mobile, AL 30 25 (83.3) 4 (13.3) 1 (3.3) 0
Modesto, CA 11 8 (72.7) 3 (27.3) 0 (0.0) 0
Monmouth-Ocean City, NJ 30 21 (70.0) 5 (16.7) 4 (13.3) 0
Nashville, TN 100 71 (71.0) 22 (22.0) 7 (7.0) 3
Nassau-Suffolk, NY 103 75 (72.8) 20 (19.4) 8 (7.8) 0
New Haven, CT 65 42 (64.6) 20 (30.8) 3 (4.6) 0
New Orleans, LA 116 98 (84.5) 12 (10.3) 6 (5.2) 5
New York, NY 1,070 703 (65.7) 241 (22.5) 126 (11.8) 4
Newark, NJ 150 100 (66.7) 28 (18.7) 22 (14.7) 2
Norfolk, VA 67 51 (76.1) 11 (16.4) 5 (7.5) 2
Oakland, CA 221 157 (71.0) 51 (23.1) 12 (5.4) 0
Oklahoma City, OK 57 43 (75.4) 4 (7.0) 10 (17.5) 2
Omaha, NE 19 11 (57.9) 7 (36.8) 1 (5.3) 0
Orange County, CA 241 177 (73.4) 49 (20.3) 15 (6.2) 2
Orlando, FL 121 109 (90.1) 6 (5.0) 6 (5.0) 1
Philadelphia, PA 218 144 (66.1) 51 (23.4) 23 (10.6) 5
Phoenix, AZ 194 158 (81.4) 23 (11.9) 13 (6.7) 2
Pittsburgh, PA 35 22 (62.9) 12 (34.3) 1 (2.9) 1
Portland, OR 73 49 (67.1) 15 (20.5) 9 (12.3) 1
Providence, RI 43 23 (53.5) 16 (37.2) 4 (9.3) 3
Raleigh-Durham, NC 65 44 (67.7) 16 (24.6) 5 (7.7) 2
Richmond, VA 47 36 (76.6) 9 (19.1) 2 (4.3) 0
Riverside-San Bern., CA 121 98 (81.0) 18 (14.9) 5 (4.1) 2
Rochester, NY 23 13 (56.5) 8 (34.8) 2 (8.7) 0
Sacramento, CA 154 121 (78.6) 22 (14.3) 11 (7.1) 2
St. Louis, MO 52 35 (67.3) 12 (23.1) 5 (9.6) 0
Salt Lake City, UT 22 13 (59.1) 6 (27.3) 3 (13.6) 2
San Antonio, TX 80 61 (76.3) 9 (11.3) 10 (12.5) 5
San Diego, CA 305 181 (59.3) 66 (21.6) 58 (19.0) 13
San Francisco, CA 205 141 (68.8) 49 (23.9) 15 (7.3) 0
San Jose, CA 199 122 (61.3) 65 (32.7) 12 (6.0) 2
Sarasota, FL 29 25 (86.2) 1 (3.4) 3 (10.3) 2
Scranton, PA 9 7 (77.8) 2 (22.2) 0 (0.0) 0
Seattle, WA 152 69 (45.4) 55 (36.2) 28 (18.4) 3
Springfield, MA 22 12 (54.5) 6 (27.3) 4 (18.2) 1
Stockton, CA 63 52 (82.5) 6 (9.5) 5 (7.9) 0
Syracuse, NY 20 15 (75.0) 3 (15.0) 2 (10.0) 0
Tacoma, WA 27 21 (77.8) 4 (14.8) 2 (7.4) 0
Tampa-St. Petersburg, FL 125 95 (76.0) 21 (16.8) 9 (7.2) 1
Toledo, OH 13 6 (46.2) 7 (53.8) 0 (0.0) 0
Tucson, AZ 33 29 (87.9) 3 (9.1) 1 (3.0) 0
Tulsa, OK 28 20 (71.4) 6 (21.4) 2 (7.1) 0
Vallejo, CA 44 30 (68.2) 11 (25.0) 3 (6.8) 0
Ventura, CA 55 45 (81.8) 7 (12.7) 3 (5.5) 0
Washington, DC 390 257 (65.9) 94 (24.1) 39 (10.0) 12
West Palm Beach, FL 92 70 (76.1) 20 (21.7) 2 (2.2) 0
Wichita, KS 23 13 (56.5) 7 (30.4) 3 (13.0) 0
Wilmington, DE 19 12 (63.2) 6 (31.6) 1 (5.3) 0
Youngstown, OH 10 8 (80.0) 2 (20.0) 0 (0.0) 0
Total - 109 Areas 11,011 7,613 (69.1) 2,419 (22.0) 978 (8.9) 199
San Juan, PR 53 44 (83.0) 9 (17.0) 0 (0.0) 0
1Includes cases in persons with pulmonary listed as major site of disease and no additional site of disease.
2Includes cases in persons with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as
major site of disease.
3Includes miliary cases.
Note: 1 (<0.1%) case had missing and/or unknown site of disease.
See Technical Notes (page 9) for definition of MSA.
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Table 48. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000
Population, 2005
Metropolitan
Statistical Area 5–14Under 5
Total
Cases 15–24 25–44 45–64 >65
Unknown or
Missing
Akron, OH 10 2 0 0 3 1 4 0
Albany-Schenectady, NY 16 0 1 0 4 3 8 0
Albuquerque, NM 13 0 0 0 5 3 5 0
Allentown, PA 9 0 0 1 4 3 1 0
Ann Arbor, MI 12 0 0 1 4 7 0 0
Atlanta, GA 295 20 8 46 129 63 29 0
Austin, TX 57 0 0 7 22 24 4 0
Bakersfield, CA 42 1 1 4 15 9 12 0
Baltimore, MD 122 2 2 14 49 35 20 0
Baton Rouge, LA 17 0 0 0 7 7 3 0
Bergen-Passaic, NJ 89 2 4 9 31 23 20 0
Birmingham, AL 36 0 0 1 13 10 12 0
Boise City, ID 10 0 1 0 3 6 0 0
Boston, MA 241 6 7 25 96 63 44 0
Buffalo, NY 13 0 0 0 6 6 1 0
Charleston, SC 44 3 0 5 13 17 6 0
Charlotte, NC 71 7 1 13 23 21 6 0
Chicago, IL 546 21 24 56 193 164 88 0
Cincinnati, OH 38 0 0 4 13 12 9 0
Cleveland, OH 75 3 3 8 19 23 19 0
Colorado Springs, CO 9 3 0 0 2 2 2 0
Columbia, SC 11 0 0 1 3 2 5 0
Columbus, OH 81 0 10 12 34 19 6 0
Dallas, TX 275 11 10 34 109 88 23 0
Dayton, OH 7 0 0 0 1 3 3 0
Daytona Beach, FL 9 1 0 0 1 4 3 0
Denver, CO 70 2 11 9 15 19 14 0
Detroit, MI 168 3 4 12 63 51 35 0
El Paso, TX 49 1 0 3 17 13 15 0
Fort Lauderdale, FL 99 4 2 12 34 35 12 0
Fort Myers, FL 16 0 0 4 3 5 4 0
Fort Wayne, IN 17 2 1 4 5 3 2 0
Fort Worth, TX 132 8 1 7 54 43 19 0
Fresno, CA 78 7 7 9 19 21 15 0
Gary, IN 20 1 0 3 6 6 4 0
Grand Rapids, MI 19 0 0 4 8 2 5 0
Greensboro, NC 51 2 1 2 14 23 9 0
Greenville, SC 25 4 0 1 8 7 5 0
Harrisburg, PA 25 0 0 1 7 8 9 0
Hartford, CT 25 1 1 1 12 5 5 0
Honolulu, HI 83 1 0 6 23 24 29 0
Houston, TX 423 23 10 47 168 125 50 0
Indianapolis, IN 53 2 0 6 19 14 12 0
Jacksonville, FL 92 2 1 9 34 32 14 0
Jersey City, NJ 69 1 1 12 28 19 8 0
Kansas City, MO 47 1 0 6 23 10 7 0
Knoxville, TN 15 0 0 2 2 8 3 0
Lakeland, FL 54 0 4 10 14 19 7 0
Las Vegas, NV 97 1 3 13 34 24 22 0
Lexington, KY 17 0 0 3 9 5 0 0
Little Rock, AR 21 1 0 1 2 9 8 0
Los Angeles, CA 973 26 14 93 338 295 207 0
Louisville, KY 36 0 0 2 8 15 11 0
McAllen, TX 92 9 2 12 21 26 22 0
Melbourne, FL 14 0 0 0 1 9 4 0
Memphis, TN 96 4 7 9 37 27 12 0
Miami, FL 229 12 11 16 83 82 25 0
Middlesex, NJ 65 2 1 8 32 15 7 0
Milwaukee, WI 35 1 0 7 13 8 6 0
Minneapolis-St. Paul, MN 167 9 9 53 62 18 16 0
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Table 48. (Cont’d) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with
>500,000 Population, 2005
Metropolitan





Mobile, AL 30 0 1 3 8 13 5 0
Modesto, CA 11 0 1 2 2 3 3 0
Monmouth-Ocean City, NJ 30 1 2 7 9 7 4 0
Nashville, TN 100 6 2 16 26 35 15 0
Nassau-Suffolk, NY 103 3 2 12 39 28 19 0
New Haven, CT 65 0 0 9 30 17 9 0
New Orleans, LA 116 6 5 14 25 47 19 0
New York, NY 1,070 25 21 132 423 288 181 0
Newark, NJ 150 5 3 18 54 40 30 0
Norfolk, VA 67 4 2 5 24 15 17 0
Oakland, CA 221 3 5 18 67 73 55 0
Oklahoma City, OK 57 5 4 6 16 19 7 0
Omaha, NE 19 0 0 3 5 7 4 0
Orange County, CA 241 4 2 22 70 52 91 0
Orlando, FL 121 0 1 10 44 42 24 0
Philadelphia, PA 218 3 11 16 83 55 50 0
Phoenix, AZ 194 21 14 19 65 47 28 0
Pittsburgh, PA 35 0 0 2 8 4 21 0
Portland, OR 73 0 2 8 32 17 14 0
Providence, RI 43 3 0 2 15 12 11 0
Raleigh-Durham, NC 65 2 3 5 33 12 10 0
Richmond, VA 47 3 1 4 18 14 7 0
Riverside-San Bern., CA 121 5 3 16 34 41 22 0
Rochester, NY 23 1 1 4 9 4 4 0
Sacramento, CA 154 6 5 14 43 56 30 0
St. Louis, MO 52 0 0 8 13 13 18 0
Salt Lake City, UT 22 1 2 2 8 6 3 0
San Antonio, TX 80 2 2 6 26 30 14 0
San Diego, CA 305 14 15 43 89 80 64 0
San Francisco, CA 205 4 3 15 55 60 68 0
San Jose, CA 199 3 1 17 79 46 53 0
Sarasota, FL 29 0 0 2 11 7 9 0
Scranton, PA 9 0 1 1 3 3 1 0
Seattle, WA 152 1 3 23 45 48 32 0
Springfield, MA 22 0 0 4 7 3 8 0
Stockton, CA 63 4 1 2 20 18 18 0
Syracuse, NY 20 0 3 0 10 3 4 0
Tacoma, WA 27 0 0 3 8 13 3 0
Tampa-St. Petersburg, FL 125 2 2 13 35 49 24 0
Toledo, OH 13 0 0 0 8 4 1 0
Tucson, AZ 33 0 0 4 11 11 7 0
Tulsa, OK 28 1 2 1 7 14 3 0
Vallejo, CA 44 0 2 2 12 18 10 0
Ventura, CA 55 0 1 4 21 14 15 0
Washington, DC 390 14 11 50 173 93 49 0
West Palm Beach, FL 92 3 1 10 37 28 13 0
Wichita, KS 23 0 1 3 9 7 3 0
Wilmington, DE 19 0 1 3 5 6 4 0
Youngstown, OH 10 1 0 1 2 3 3 0
Total - 109 Areas 11,011 368 306 1,212 3,894 3,168 2,063 0
San Juan, PR 53 2 1 4 9 21 16 0
Note: See Technical Notes (page 9) for definition of MSA.
5–14 25–44 45–64 >65
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Akron, OH 10 0 0 3 3 0 4 0 0
Albany-Schenectady, NY 16 0 0 6 1 0 9 0 0
Albuquerque, NM 13 5 1 3 3 0 1 0 0
Allentown, PA 9 3 0 1 1 0 4 0 0
Ann Arbor, MI 12 1 0 3 3 0 5 0 0
Atlanta, GA 295 58 0 30 172 2 32 0 1
Austin, TX 57 32 1 5 13 0 6 0 0
Bakersfield, CA 42 23 0 12 2 0 4 0 1
Baltimore, MD 122 16 0 24 68 0 14 0 0
Baton Rouge, LA 17 1 0 1 13 0 2 0 0
Bergen-Passaic, NJ 89 35 0 27 9 0 18 0 0
Birmingham, AL 36 4 0 3 15 0 14 0 0
Boise City, ID 10 2 0 0 1 0 6 1 0
Boston, MA 241 41 0 83 69 0 48 0 0
Buffalo, NY 13 0 0 5 3 0 5 0 0
Charleston, SC 44 4 0 1 28 0 11 0 0
Charlotte, NC 71 17 0 7 40 0 7 0 0
Chicago, IL 546 129 2 142 209 2 57 5 0
Cincinnati, OH 38 2 0 5 15 0 16 0 0
Cleveland, OH 75 5 0 11 41 0 18 0 0
Colorado Springs, CO 9 3 0 3 1 0 1 1 0
Columbia, SC 11 1 0 1 6 0 3 0 0
Columbus, OH 81 12 0 12 41 0 15 1 0
Dallas, TX 275 99 2 35 99 0 40 0 0
Dayton, OH 7 1 0 2 2 0 2 0 0
Daytona Beach, FL 9 2 0 0 0 0 7 0 0
Denver, CO 70 34 1 7 17 0 11 0 0
Detroit, MI 168 10 0 29 86 0 40 2 1
El Paso, TX 49 46 0 1 1 0 1 0 0
Fort Lauderdale, FL 99 16 0 13 48 0 21 1 0
Fort Myers, FL 16 7 0 0 3 0 6 0 0
Fort Wayne, IN 17 1 0 3 13 0 0 0 0
Fort Worth, TX 132 43 0 25 35 0 29 0 0
Fresno, CA 78 46 0 20 4 0 8 0 0
Gary, IN 20 4 0 3 9 0 4 0 0
Grand Rapids, MI 19 7 0 7 3 0 2 0 0
Greensboro, NC 51 6 0 10 25 0 10 0 0
Greenville, SC 25 1 0 3 10 0 11 0 0
Harrisburg, PA 25 1 0 8 3 0 13 0 0
Hartford, CT 25 4 0 9 4 0 8 0 0
Honolulu, HI 83 2 0 65 0 10 6 0 0
Houston, TX 423 181 0 61 122 0 59 0 0
Indianapolis, IN 53 16 0 8 14 1 14 0 0
Jacksonville, FL 92 8 0 13 48 0 23 0 0
Jersey City, NJ 69 29 0 30 5 0 5 0 0
Kansas City, MO 47 6 0 3 25 0 13 0 0
Knoxville, TN 15 1 0 1 3 0 10 0 0
Lakeland, FL 54 15 0 2 22 0 15 0 0
Las Vegas, NV 97 34 0 27 11 2 23 0 0
Lexington, KY 17 9 0 0 2 0 6 0 0
Little Rock, AR 21 1 0 0 13 0 7 0 0
Los Angeles, CA 973 451 1 347 102 2 67 1 2
Louisville, KY 36 3 0 4 5 0 24 0 0
McAllen, TX 92 88 0 2 0 0 2 0 0
Melbourne, FL 14 1 0 1 1 0 10 1 0
Memphis, TN 96 4 2 3 80 0 7 0 0
Miami, FL 229 109 0 14 95 0 11 0 0
Middlesex, NJ 65 13 0 40 5 0 7 0 0
Milwaukee, WI 35 6 1 10 9 0 9 0 0
Minneapolis-St. Paul, MN 167 12 4 47 95 0 9 0 0
Table 49. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan























Table 49. (Cont’d) Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metro-
politan Statistical Areas with >500,000 Population, 2005
1Persons of Hispanic or Latino origin may be of any race or multiple race.
2Indicates two or more races reported for a person.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race
does not include persons of Hispanic ethnicity.






















Mobile, AL 30 2 0 4 13 0 11 0 0
Modesto, CA 11 4 0 4 0 1 2 0 0
Monmouth-Ocean City, NJ 30 10 0 9 2 0 9 0 0
Nashville, TN 100 18 0 5 42 0 35 0 0
Nassau-Suffolk, NY 103 43 0 24 20 0 16 0 0
New Haven, CT 65 16 0 14 21 0 14 0 0
New Orleans, LA 116 10 0 5 80 1 20 0 0
New York, NY 1,070 320 0 303 327 5 103 7 5
Newark, NJ 150 35 0 16 78 0 21 0 0
Norfolk, VA 67 4 0 15 36 0 12 0 0
Oakland, CA 221 37 0 143 25 1 12 3 0
Oklahoma City, OK 57 10 9 9 9 0 17 3 0
Omaha, NE 19 5 0 0 3 1 9 1 0
Orange County, CA 241 67 0 146 6 0 21 0 1
Orlando, FL 121 25 0 15 47 0 32 2 0
Philadelphia, PA 218 24 0 70 83 0 41 0 0
Phoenix, AZ 194 124 1 18 16 0 35 0 0
Pittsburgh, PA 35 0 0 10 5 0 20 0 0
Portland, OR 73 15 1 33 5 3 15 1 0
Providence, RI 43 16 0 8 5 0 14 0 0
Raleigh-Durham, NC 65 16 0 7 30 0 12 0 0
Richmond, VA 47 7 0 10 24 0 6 0 0
Riverside-San Bern., CA 121 60 0 34 7 1 19 0 0
Rochester, NY 23 6 0 3 11 0 3 0 0
Sacramento, CA 154 25 0 77 22 2 26 0 2
St. Louis, MO 52 2 0 10 17 1 21 1 0
Salt Lake City, UT 22 11 0 3 2 0 6 0 0
San Antonio, TX 80 59 0 5 6 0 10 0 0
San Diego, CA 305 161 0 94 19 0 31 0 0
San Francisco, CA 205 38 3 128 15 3 18 0 0
San Jose, CA 199 37 0 135 11 0 13 2 1
Sarasota, FL 29 8 0 1 5 0 15 0 0
Scranton, PA 9 4 0 1 1 0 3 0 0
Seattle, WA 152 13 5 66 38 2 26 2 0
Springfield, MA 22 3 0 6 5 0 8 0 0
Stockton, CA 63 23 0 34 2 0 4 0 0
Syracuse, NY 20 1 0 2 13 0 4 0 0
Tacoma, WA 27 3 1 12 3 1 7 0 0
Tampa-St. Petersburg, FL 125 23 0 13 49 0 40 0 0
Toledo, OH 13 1 0 5 4 0 3 0 0
Tucson, AZ 33 15 6 1 2 0 9 0 0
Tulsa, OK 28 7 3 3 5 0 8 2 0
Vallejo, CA 44 7 0 25 6 0 6 0 0
Ventura, CA 55 32 0 18 0 0 5 0 0
Washington, DC 390 96 0 119 151 0 24 0 0
West Palm Beach, FL 92 25 0 5 49 0 12 1 0
Wichita, KS 23 4 0 6 7 0 6 0 0
Wilmington, DE 19 8 0 3 5 0 3 0 0
Youngstown, OH 10 0 0 0 1 0 9 0 0
Total - 109 Areas 11,011 3,191 44 2,918 3,109 41 1,656 38 14
San Juan, PR 53 53 0 0 0 0 0 0 0
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Table 50. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Per-
sons: Metropolitan Statistical Areas with >500,000 Population, 2005
Metropolitan
Statistical Area




Akron, OH 10 7 (70.0) 3 (30.0) 0 (0.0)
Albany-Schenectady, NY 16 9 (56.3) 7 (43.8) 0 (0.0)
Albuquerque, NM 13 6 (46.2) 7 (53.8) 0 (0.0)
Allentown, PA 9 5 (55.6) 4 (44.4) 0 (0.0)
Ann Arbor, MI 12 7 (58.3) 5 (41.7) 0 (0.0)
Atlanta, GA 295 151 (51.2) 144 (48.8) 0 (0.0)
Austin, TX 57 23 (40.4) 34 (59.6) 0 (0.0)
Bakersfield, CA 42 12 (28.6) 30 (71.4) 0 (0.0)
Baltimore, MD 122 70 (57.4) 52 (42.6) 0 (0.0)
Baton Rouge, LA 17 15 (88.2) 2 (11.8) 0 (0.0)
Bergen-Passaic, NJ 89 23 (25.8) 66 (74.2) 0 (0.0)
Birmingham, AL 36 27 (75.0) 9 (25.0) 0 (0.0)
Boise City, ID 10 4 (40.0) 6 (60.0) 0 (0.0)
Boston, MA 241 49 (20.3) 192 (79.7) 0 (0.0)
Buffalo, NY 13 7 (53.8) 6 (46.2) 0 (0.0)
Charleston, SC 44 39 (88.6) 5 (11.4) 0 (0.0)
Charlotte, NC 71 41 (57.7) 30 (42.3) 0 (0.0)
Chicago, IL 546 297 (54.4) 248 (45.4) 1 (0.2)
Cincinnati, OH 38 28 (73.7) 10 (26.3) 0 (0.0)
Cleveland, OH 75 51 (68.0) 24 (32.0) 0 (0.0)
Colorado Springs, CO 9 5 (55.6) 4 (44.4) 0 (0.0)
Columbia, SC 11 9 (81.8) 2 (18.2) 0 (0.0)
Columbus, OH 81 27 (33.3) 54 (66.7) 0 (0.0)
Dallas, TX 275 146 (53.1) 129 (46.9) 0 (0.0)
Dayton, OH 7 4 (57.1) 3 (42.9) 0 (0.0)
Daytona Beach, FL 9 7 (77.8) 2 (22.2) 0 (0.0)
Denver, CO 70 25 (35.7) 45 (64.3) 0 (0.0)
Detroit, MI 168 116 (69.0) 52 (31.0) 0 (0.0)
El Paso, TX 49 12 (24.5) 37 (75.5) 0 (0.0)
Fort Lauderdale, FL 99 47 (47.5) 52 (52.5) 0 (0.0)
Fort Myers, FL 16 7 (43.8) 9 (56.3) 0 (0.0)
Fort Wayne, IN 17 12 (70.6) 5 (29.4) 0 (0.0)
Fort Worth, TX 132 70 (53.0) 62 (47.0) 0 (0.0)
Fresno, CA 78 21 (26.9) 52 (66.7) 5 (6.4)
Gary, IN 20 13 (65.0) 7 (35.0) 0 (0.0)
Grand Rapids, MI 19 6 (31.6) 13 (68.4) 0 (0.0)
Greensboro, NC 51 30 (58.8) 21 (41.2) 0 (0.0)
Greenville, SC 25 21 (84.0) 4 (16.0) 0 (0.0)
Harrisburg, PA 25 15 (60.0) 10 (40.0) 0 (0.0)
Hartford, CT 25 8 (32.0) 17 (68.0) 0 (0.0)
Honolulu, HI 83 21 (25.3) 62 (74.7) 0 (0.0)
Houston, TX 423 228 (53.9) 195 (46.1) 0 (0.0)
Indianapolis, IN 53 26 (49.1) 27 (50.9) 0 (0.0)
Jacksonville, FL 92 74 (80.4) 18 (19.6) 0 (0.0)
Jersey City, NJ 69 17 (24.6) 52 (75.4) 0 (0.0)
Kansas City, MO 47 25 (53.2) 22 (46.8) 0 (0.0)
Knoxville, TN 15 12 (80.0) 3 (20.0) 0 (0.0)
Lakeland, FL 54 42 (77.8) 12 (22.2) 0 (0.0)
Las Vegas, NV 97 31 (32.0) 66 (68.0) 0 (0.0)
Lexington, KY 17 8 (47.1) 9 (52.9) 0 (0.0)
Little Rock, AR 21 19 (90.5) 2 (9.5) 0 (0.0)
Los Angeles, CA 973 214 (22.0) 755 (77.6) 4 (0.4)
Louisville, KY 36 27 (75.0) 9 (25.0) 0 (0.0)
McAllen, TX 92 38 (41.3) 54 (58.7) 0 (0.0)
Melbourne, FL 14 11 (78.6) 3 (21.4) 0 (0.0)
Memphis, TN 96 90 (93.8) 6 (6.3) 0 (0.0)
Miami, FL 229 72 (31.4) 157 (68.6) 0 (0.0)
Middlesex, NJ 65 9 (13.8) 56 (86.2) 0 (0.0)
Milwaukee, WI 35 16 (45.7) 19 (54.3) 0 (0.0)
Minneapolis-St. Paul, MN 167 23 (13.8) 144 (86.2) 0 (0.0)
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Table 50. (Cont’d) Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born
Persons: Metropolitan Statistical Areas with >500,000 Population, 2005
Metropolitan
Statistical Area




Mobile, AL 30 23 (76.7) 7 (23.3) 0 (0.0)
Modesto, CA 11 3 (27.3) 8 (72.7) 0 (0.0)
Monmouth-Ocean City, NJ 30 10 (33.3) 20 (66.7) 0 (0.0)
Nashville, TN 100 62 (62.0) 38 (38.0) 0 (0.0)
Nassau-Suffolk, NY 103 28 (27.2) 75 (72.8) 0 (0.0)
New Haven, CT 65 22 (33.8) 43 (66.2) 0 (0.0)
New Orleans, LA 116 104 (89.7) 12 (10.3) 0 (0.0)
New York, NY 1,070 301 (28.1) 762 (71.2) 7 (0.7)
Newark, NJ 150 72 (48.0) 78 (52.0) 0 (0.0)
Norfolk, VA 67 42 (62.7) 25 (37.3) 0 (0.0)
Oakland, CA 221 46 (20.8) 175 (79.2) 0 (0.0)
Oklahoma City, OK 57 38 (66.7) 19 (33.3) 0 (0.0)
Omaha, NE 19 11 (57.9) 8 (42.1) 0 (0.0)
Orange County, CA 241 34 (14.1) 206 (85.5) 1 (0.4)
Orlando, FL 121 67 (55.4) 54 (44.6) 0 (0.0)
Philadelphia, PA 218 102 (46.8) 116 (53.2) 0 (0.0)
Phoenix, AZ 194 68 (35.1) 123 (63.4) 3 (1.5)
Pittsburgh, PA 35 21 (60.0) 14 (40.0) 0 (0.0)
Portland, OR 73 19 (26.0) 54 (74.0) 0 (0.0)
Providence, RI 43 13 (30.2) 30 (69.8) 0 (0.0)
Raleigh-Durham, NC 65 38 (58.5) 27 (41.5) 0 (0.0)
Richmond, VA 47 30 (63.8) 17 (36.2) 0 (0.0)
Riverside-San Bern., CA 121 33 (27.3) 87 (71.9) 1 (0.8)
Rochester, NY 23 11 (47.8) 12 (52.2) 0 (0.0)
Sacramento, CA 154 49 (31.8) 102 (66.2) 3 (1.9)
St. Louis, MO 52 32 (61.5) 20 (38.5) 0 (0.0)
Salt Lake City, UT 22 3 (13.6) 19 (86.4) 0 (0.0)
San Antonio, TX 80 51 (63.8) 29 (36.3) 0 (0.0)
San Diego, CA 305 87 (28.5) 218 (71.5) 0 (0.0)
San Francisco, CA 205 47 (22.9) 158 (77.1) 0 (0.0)
San Jose, CA 199 22 (11.1) 175 (87.9) 2 (1.0)
Sarasota, FL 29 16 (55.2) 13 (44.8) 0 (0.0)
Scranton, PA 9 5 (55.6) 4 (44.4) 0 (0.0)
Seattle, WA 152 38 (25.0) 114 (75.0) 0 (0.0)
Springfield, MA 22 8 (36.4) 14 (63.6) 0 (0.0)
Stockton, CA 63 12 (19.0) 51 (81.0) 0 (0.0)
Syracuse, NY 20 5 (25.0) 15 (75.0) 0 (0.0)
Tacoma, WA 27 10 (37.0) 17 (63.0) 0 (0.0)
Tampa-St. Petersburg, FL 125 74 (59.2) 51 (40.8) 0 (0.0)
Toledo, OH 13 7 (53.8) 6 (46.2) 0 (0.0)
Tucson, AZ 33 15 (45.5) 18 (54.5) 0 (0.0)
Tulsa, OK 28 18 (64.3) 9 (32.1) 1 (3.6)
Vallejo, CA 44 11 (25.0) 33 (75.0) 0 (0.0)
Ventura, CA 55 10 (18.2) 45 (81.8) 0 (0.0)
Washington, DC 390 97 (24.9) 293 (75.1) 0 (0.0)
West Palm Beach, FL 92 38 (41.3) 54 (58.7) 0 (0.0)
Wichita, KS 23 11 (47.8) 12 (52.2) 0 (0.0)
Wilmington, DE 19 6 (31.6) 13 (68.4) 0 (0.0)
Youngstown, OH 10 10 (100.0) 0 (0.0) 0 (0.0)
Total - 109 Areas 11,064 4,402 (39.8) 6,634 (60.0) 28 (0.3)
San Juan, PR 53 47 (88.7) 6 (11.3) 0 (0.0)
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S.
Virgin Islands, and U.S. minor and outlying Pacific islands.
Note: See Technical Notes (page 9) for definition of MSA.
82




Tuberculosis in the U.S.-affiliated Pacific Island Jurisdictions (USAPI), 2005
The U.S.-affiliated Pacific Islands consist of six jurisdictions that cover an area within the Pacific
Ocean that is larger than the continental United States. Three are U.S. flag territories: Guam,
American Samoa, and the Commonwealth of the Northern Mariana Islands (CNMI). The other three
—the Federated States of Micronesia (FSM), the Republic of the Marshall Islands (RMI), and the
Republic of Palau—are independent countries but are also affiliated with the United States. These
independent countries have Compacts of Free Association with the United States; under these
compacts, the countries are fully sovereign in domestic and foreign affairs, but give responsibility for
their health, education, defense, and other essential operations to the United States. Through these
agreements, citizens residing in these three countries are able to immigrate to the United States
without the usual overseas screening for health conditions that is required of those permanently
resettling from other countries.
As a result of their affiliations with the United States, the USAPIs are among the recipients of U.S.
federal government funding, including CDC cooperative agreement funding for domestic TB control
program activities.
How do the USAPI TB programs differ from the 50 U.S. state programs?
· Geographically, the USAPIs include 104 inhabited islands spread out over 3 million square miles
in the Pacific Ocean. See Surveillance Slide 1-USAPI.
· There is a consistent shortage of health care providers in all job classes in the USAPIs, and
continuing education opportunities are limited, often requiring staff to travel off-island for
significant amounts of time. These challenges impact the delivery of health care.
· The USAPIs are faced with health problems common to developed countries (e.g., diabetes) as
well as developing countries (e.g., high infant mortality rates).
· While case counts in this region are similar to those in low-incidence U.S. states, the burden of
disease and case rates are much greater when compared to U.S. areas with similar case counts.
The burden of TB in the region far exceeds that of any U.S. metropolitan statistical area with a
population of 500,000 or greater.  The USAPI regional TB case rate (55.6/100,000) is 6 times
greater than that of the State of Hawaii (8.8/100,000) and almost 12 times greater than the U.S.
national rate (4.8/100,000).
86
Table 1: Cases and Case Rates for USAPIs, Hawaii, and the U.S., 2005
Jurisdiction Cases Rate Population
American Samoa 5 8.6 57,881
Guam 64 38.0 168,564
Palau 10 49.3 20,303
Micronesia 74 68.5 108,105
N. Mariana Islands (CNMI) 56 69.7 80,362
Marshall Islands 66 111.7 59,071
USAPI Regional 275 55.6 494,286
Hawaii 112 8.8 1,275,194
United States 14,097 4.8 296,410,404
USAPI TB Surveillance Data Highlights, 2005 (N=275)
• 28 (10%) under 15 years of age
• 96 (35%) 25–44 years of age
• 142(52%) male
• 73 (26%) not born in the USAPI jurisdictions or the United States
o 54 (74%) emigrated from the Republic of the Philippines (RP);
o Within CNMI, 44 (79%) reported patients were born outside the region,
predominately from RP (28, 64%) and from China (12, 16%)
• 231 (84%) diagnosed with pulmonary disease
• 138 (50%) positive culture for Mycobacterium tuberculosis
• 4 (3.3%) with MDR TB; 2 MDR TB cases occurred in persons born outside of the USAPI
jurisdictions, of 125 cases with positive culture and initial susceptibility testing done
• 75 (33%) of the work-eligible population aged 15–65 were unemployed
The data reported here reflect cases reported to the CDC National TB Surveillance System using the
Report of a Verified Case of TB.  TB case reports received as of January 2006 were used for this





This page intentionally left blank
88



















< 3.5 (year 2000 target)
3.6–4.8
> 4.8 (national average)
D.C.
Surveillance Slide #1-USAPI
Reported TB Cases by Age Group 
U.S.-Affiliated Pacific Islands, 2005













TB Case Rates* by Age Group and Sex, 










Anti-TB Drug Susceptibility, 
U.S.-Affiliated Pacific Islands, 2005
MDR 













*INH, RIF, PZA, EMB
**Other resistance (not MDR or INH resistant) or missing testing to at least one first-
line drug
Note: Data reflect results for 125 of 138 culture-positive isolates for which drug 
sensitivity testing results were available.
Surveillance Slide #4-USAPI
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Slide Narratives for U.S.- Affiliated Pacific Islands:
Slide 1-USAPI. TB Case Rates, U.S-Affiliated Pacific Islands, 2005. This map shows TB rates for
the U.S. Pacific Islands for reported cases in 2005. The case rate map for the 50 U.S. states and
District of Columbia is superimposed in the lower right. The case rate ranged from 8.6 per 100,000
persons in American Samoa to 111.7 per 100,000 persons in the Republic of the Marshall Islands,
with a regional case rate of 55.6 per 100,000 persons.
Slide 2-USAPI. Reported TB Cases by Age Group, U.S.-Affiliated Pacific Islands, 2005. This
pie chart shows the age distribution of persons reported with TB in the U.S. Pacific Islands in 2005.
Ten percent were children under 15 years of age and 21% were 15- to 24-year-olds, whereas 35%
were 25 to 44 years of age, 25% were 45- to 64-year-olds, and 9% were at least 65 years old.
Slide 3-USAPI. TB Case Rates by Age Group and Sex, U.S.-Affiliated Pacific Islands, 2005.
This slide graphs the case rates in 2005 of persons reported with TB in the U.S. Pacific Islands in
2005 by age group and sex. It shows that case rates increase with age, ranging from a low of 16 per
100,000 in female children to a high of approximately 153 per 100,000 in men 65 years and older.
Slide 4-USAPI. Anti-TB Drug Susceptibility, U.S.-Affiliated Pacific Islands, 2005.  This pie chart
shows the level of drug susceptibility for culture-positive cases in the U.S. Pacific Islands in 2005.
Data were available for approximate 90% of culture-positive cases for which drug susceptibility
testing was available for 2005. Any isoniazid resistance that was not multidrug resistance was 5%.
Resistance to at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), was 3%.
Other resistance (not MDR or INH resistant) or missing testing to at least one first-line drug was 9%.
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*Cases per 100,000, updated as of March 29, 2006.
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TB Case Rates,* United States, 2005
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TB Case Rates by Age Group 




































TB Case Rates by Race/Ethnicity* 
United States, 1993–2005**
* All races are non-Hispanic. In 2003, Asian/Pacific Islander category includes    
persons who reported race as Asian only and/or Native Hawaiian or Other   
Pacific Islander only.
** Updated as of March 29, 2006.







Reported TB Cases by Race/Ethnicity* 
United States, 2005
Hispanic or Latino








Other Pacific Islander 
(<1%)
*All races are non-Hispanic. Persons reporting two or more races accounted 
for less than 1% of all cases.
Surveillance Slide #9
TB Case Rates by Age Group and 
Race/Ethnicity,* United States, 2005
*All races are non-Hispanic. Persons reporting two or 
more races accounted for less than 1% of all cases.
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Black or African American
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*Updated as of March 29, 2006.
Surveillance Slide #11
Trends in TB Cases in Foreign-born 
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*Updated as of March 29, 2006.
Surveillance Slide #12
Reported TB Cases by Origin and 
Race/Ethnicity,* United States, 2005
*All races are non-Hispanic. Persons reporting two or more races accounted for 
less than 1% of all cases.
**American Indian or Alaska Native and Native Hawaiian or Other Pacific  
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*Updated as of March 29, 2006.
Surveillance Slide #14
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*Updated as of March 29, 2006.
Surveillance Slide #15
TB Case Rates in 
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*Includes the same data as slide 15, but rates presented on a logarithmic scale.
**Updated as of March 29, 2006.
Surveillance Slide #16
Countries of Birth of Foreign-born 



















Percent of Foreign-born with TB 
by Time of Residence in U.S. 
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*Data exclude foreign-born TB patients for when length of residence in the  
U.S. prior to diagnosis was unknown.
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*Updated as of March 29, 2006.
Note: Based on initial isolates from persons with no prior history of TB.




*Updated as of March 29, 2006.
Note: Based on initial isolates from persons with no prior history of TB.  
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Primary Isoniazid Resistance in 














*Updated as of March 29, 2006.
Note: Based on initial isolates from persons with no prior history of TB.
Surveillance Slide #21
Primary MDR TB in














*Updated as of March 29, 2006.
Note: Based on initial isolates from persons with no prior history of TB.











*Updated as of March 29, 2006.
Note:  Includes TB patients with positive, negative, or indeterminate HIV test 
results and persons from California reported with AIDS. 
(HIV test results are not reported from California)
Reporting of HIV Test Results 
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Estimated HIV Coinfection in Persons 
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*Updated as of March 29, 2006.
Note: Minimum estimates based on reported HIV-positive status 
among all TB cases in the age group.
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Mode of Treatment Administration 
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*Updated as of March 29, 2006. 
Directly observed therapy (DOT); Self-administered therapy (SA)
Surveillance Slide #25
Completion of TB Therapy 
United States, 1993–2003*
* Updated as of March 29, 2006.
** Healthy People 2010 target: 90% completed in 1 yr or less.
Note: Persons with initial isolate resistant to rifampin and children under 
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Tuberculosis in the United States
National Tuberculosis Surveillance System Highlights from 2005
Slide 1 (title slide). Tuberculosis in the United States—National Tuberculosis Surveillance
System, Highlights from 2005.  This slide set was prepared by the Division of Tuberculosis
Elimination, Centers for Disease Control and Prevention (CDC), Department of Health and Human
Services (DHHS).  It provides trends for the recent past and highlights from data collected through
the National Tuberculosis Surveillance System for 2005.  Since 1953, through the cooperation of
state and local health departments, CDC has collected information on the newly reported cases of
tuberculosis (TB) disease in the United States.  The data presented here were primarily collected via
the expanded TB case report introduced in 1993.  Currently, each individual TB case report (Report
of Verified Case of Tuberculosis, or RVCT) is submitted electronically to CDC.  The data for this
slide set are based on updates received by CDC as of March 29, 2006.  All case counts and rates for
years 1993–2004 have been updated.
Slide 2. Reported TB Cases, United States, 1982–2005.  The resurgence of TB in the mid-1980s
was marked by several years of increasing case counts until its peak in 1992.  Case counts began
decreasing again in 1993, and 2005 marked the thirteenth year of decline in the total number of TB
cases reported in the United States since the peak of the resurgence.  From 1992 until 2002, the total
number of TB cases decreased 5%–7% annually.  From 2002 to 2003, however, the total number of
TB cases decreased by only 1.4%.  In 2005, a total of 14,097 cases were reported from the 50 states
and the District of Columbia.  This represents a decline of 2.9% from 2004 and of 47% from 1992.
(Note:  A provisional total of 14,093 was reported in the MMWR in March 2006.)
Slide 3. TB Morbidity, United States, 2000–2005.   This slide provides the total number of reported
U.S. TB cases and the associated TB rates for each of the past 6 years.  Rate is defined as cases per
100,000 population.  The number of TB cases decreased from 16,309 in 2000 to 14,097 in 2005, and
the TB rate also decreased, from 5.8 in 2000 to 4.8 in 2005.
Slide 4. TB Case Rates, United States, 2005.  This map shows TB rates for 2005.  Twenty-six states
had a rate of less than or equal to 3.5 TB cases per 100,000, the interim goal for the year 2000
established by the Advisory Council for the Elimination of Tuberculosis.  This group of states has
remained fairly constant over the last decade; five states (CT, MI, NM, OR, and PA) joined the group
in 2000, one state (MO) joined the group in 2001 (also in 1998 for one year only), and one state
(KY) joined the group in 2003. Twelve states and the District of Columbia (DC) reported a rate
above the 2005 national average of 4.8 cases per 100,000: AK, CA, FL, GA, HI, LA, MD, NJ, NY,
SC, TN, and TX.  These 12 states and DC accounted for 65% of the national total and experienced
substantial overall decreases in cases and rates from 1992 through 2005.
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Slide 5. TB Case Rates by Age Group, United States, 1993–2005.  This slide shows the last 13
years’ declining trend in TB rates by age group.  The largest declines occurred in persons 65 years
and older (from 17.7 per 100,000 in 1993 to 7.7 in 2005), in adults aged 45 to 64 years (from 12.4 to
5.7), in adults aged 25 to 44 years (from 11.5 to 5.6), and in children under 15 years of age (from 2.9
to 1.4), each group having decreased approximately 50%.  The rate declined by 26% in those 15 to
24 years of age (from 5.0 to 3.7).
Slide 6. Reported TB Cases by Age Group, United States, 2005.  This pie chart shows the age
distribution of persons reported with TB in 2005.  Six percent were children under 15 years of age
and 11% were 15- to 24-year-olds, whereas 34% were 25 to 44 years of age, 29% were 45- to 64-
year-olds, and 20% were at least 65 years old.
Slide 7. TB Case Rates by Age Group and Sex, United States, 2005.  This slide graphs the TB
rates in 2005 by age group and sex.  It shows that rates increased with age, ranging from a low of
less than 2 per 100,000 in children to a high of approximately 11.0 per 100,000 in men 65 years and
older.  The rates in men 45 years and older were approximately twice those in same-age women.
Slide 8. TB Case Rates by Race/Ethnicity, United States, 1993–2005.  This slide shows the
declining trend in TB rates by race/ethnicity during the last 13 years.  Asians and Pacific Islanders
had the highest TB rates, which declined from 44.1 per 100,000 in 1993 to 25.5 in 2005, and had the
smallest percentage decline over the time period (42.2).  Rates declined by approximately 50% or
more over the time period in the other racial/ethnic groups: among non-Hispanic blacks or African-
Americans, from 28.5 in 1993 to 10.9 in 2005; among Hispanics, from 19.9 to 9.5; among American
Indians and Alaska Natives, from 13.9 to 6.9; and among non-Hispanic whites, from 3.6 to 1.3.
Since 2003, the Asian and Pacific Islander race category has included persons who reported race as
either 1) Asian only or 2) Native Hawaiian or Other Pacific Islander only.  Although these categories
were reported separately beginning in 2003, they were merged for this slide to allow for continuity in
reporting trends.
Several important factors likely contribute to the disproportionate burden of TB in minorities.  In
persons who were born in countries where TB is common, TB disease may result from infection
acquired in the country of origin.  Unequal distribution of TB risk factors, such as HIV infection,
may also contribute to increased exposure to TB or to an increased risk of developing TB once
infected with M. tuberculosis.
Slide 9. Reported TB Cases by Race/Ethnicity, United States, 2005.  In 2005, 82% of all reported
TB cases occurred in racial and ethnic minorities (29% in Hispanics, 28% in non-Hispanic blacks or
African- Americans, 23% in Asians, 1% in American Indians or Alaska Natives, and  <1% in Native
Hawaiians or Other Pacific Islanders), whereas 18% of cases occurred in non-Hispanic whites.
Persons reporting two or more races totaled less than 1% of all cases.  This is the second year that
Hispanics have constituted the single largest percentage of TB cases among all racial/ethnic groups.
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Slide 10. TB Case Rates by Age Group and Race/Ethnicity, United States, 2005.   This slide
presents TB rates in 2005 by age group and race/ethnicity.  Risk increased with age across racial and
ethnic groups, and rates were consistently higher in minority racial and ethnic groups than in non-
Hispanic whites.  Rates were the highest in Asians and Native Hawaiians and Other Pacific
Islanders, particularly in adult age groups.  The impact of foreign birth is a consideration in
interpreting rate variations by race/ethnicity.  For example, 96% of cases in the Asian group occurred
in foreign-born persons, compared with 75% of cases in Hispanics and 27% of cases in non-Hispanic
blacks or African-Americans.  Persons reporting two or more races totaled less than 1% of all cases.
Slide 11. Number of TB Cases in U.S.-born vs. Foreign-born Persons, United States, 1993–
2005. This graph plots the number of U.S.-born vs. foreign-born persons reported with TB each year,
from 1993 through 2005.  It illustrates the increase in the percentage of cases occurring in foreign-
born persons during this period, from 29% in 1993 to 55% in 2005.  Overall, the number of cases in
foreign-born persons remained virtually level, with approximately 7,000–8,000 cases each year,
whereas the number in U.S.-born persons decreased from more than 17,000 in 1993 to less than
6,500 in 2005.
Slide 12. Trends in TB Cases in Foreign-born Persons, United States, 1986–2005.  This slide
shows trends in TB cases in foreign-born persons in the United States from 1986, when information
on country of birth was first reported by all areas submitting reports to CDC, through 2005.  The
number of TB cases in foreign-born persons increased from nearly 5,000 in 1986 to 7,000–8,000
each year since 1991.  The percentage of TB cases accounted for by foreign-born persons increased
from 22% in 1986 to 55% in 2005.
Slide 13.  Reported TB Cases by Origin and Race/Ethnicity, United States, 2005.  Among U.S.-
born persons with TB in 2005, 45% were non-Hispanic black or African-American, 34% were non-
Hispanic white, 15% were Hispanic or Latino, 2% were American Indian or Alaska Native, 2% were
Asian, and <1% were Native Hawaiian or Other Pacific Islander.  Among the foreign-born, 40%
were Asian, 40% were Hispanic or Latino, 14% were non-Hispanic black or African-American, and
6% were non-Hispanic white.  Cases among American Indians or Alaska Natives and among Native
Hawaiians or Other Pacific Islanders constituted less than 1%, respectively, of the cases among the
foreign-born and are not shown.  Persons reporting two or more races totaled less than 1% of all
cases.
Slide 14.  Percentage of TB Cases Among Foreign-born Persons, United States, 1995 and 2005.
The percentage range of the total number of TB cases that occurred in foreign-born persons in each
state is highlighted for 1995 and 2005 in these side-by-side maps.  The number of states with at least
50% of cases in the foreign-born increased from eight in 1995 to 22 in 2005. The number of states
with at least 70% of cases in the foreign-born increased from one (HI) in 1995 to six (CA, HI, MA,
MN, NH, and UT) in 2005 (not shown on slide).
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Slide 15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2005.TB
rates in foreign-born persons remain higher than those in the U.S.-born population.  From 1993
through 2005, the rates in U.S.-born persons decreased from 7.4 per 100,000 to 2.5, whereas the
rates in foreign-born persons decreased from 34.0 per 100,000 to 21.9.
Slide 16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2005. This
is the same as Slide 15, but the rates are presented on a logarithmic scale to better illustrate the trend
in TB rates among the U.S.-born and foreign-born. The lines show a greater rate of decline among
the U.S.-born compared with the foreign-born during this period.
Slide 17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2005.
This slide shows the overall distribution of the countries of birth of foreign-born persons reported
with TB in 2005, with the top seven highlighted.  The list of countries has remained relatively
constant since 1986, when information on country of birth was first reported by all areas submitting
reports to CDC.  However, for 2005, Guatemala replaced Republic of Korea in the list of countries
contributing the highest percentages of foreign-born patients.  The seven top countries accounted for
62% of the total, with Mexico accounting for 25%; the Philippines, 11%; Viet Nam, 8%; India, 7%;
China, 5%; Haiti, 3%; and Guatemala, 3%.  Persons from more than 135 other countries each
accounted for 2% or less of the total, but altogether accounted for 38% of foreign-born persons
reported with TB.
Slide 18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis,
2005.  The length of U.S. residence among foreign-born persons prior to their TB diagnosis in 2005
is shown in these stacked bars.  Overall, 20% had been in the United States for less than 1 year, 25%
between 1 and 4 years, and 55% for at least 5 years.  The distribution is also shown for the top three
countries of birth: Mexico, the Philippines, and Viet Nam.  Among persons born in Mexico, 18% had
been in the United States for less than 1 year, 24% between 1 and 4 years, and 58% for at least 5
years. Among persons born in the Philippines, 26% had been in the United States for less than 1 year,
17% between 1 and 4 years, and 57% for at least 5 years.  Among persons born in Viet Nam, 21%
had been in the United States for less than 1 year, 11% between 1 and 4 years, and 68% for at least 5
years.
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2005.  Primary drug resistance
is shown for the past 13 years.  The graph starts in 1993, the year in which the individual TB case
reports submitted to the national surveillance system began collecting information on initial
susceptibility test results for patients with culture-positive TB.  Data were available for more than
85% of culture-positive cases for each year.  Primary resistance was calculated by using data from
persons with no reported prior TB episode. Resistance to at least isoniazid remained between 7.0%
and 8.4%.  However, resistance to at least isoniazid and rifampin, known as multidrug-resistant TB
(MDR TB), decreased from 2.5% in 1993 to approximately 1.0% in 1997, and remained at this level
up to and including 2005.
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Slide 20. Primary MDR TB, United States, 1993–2005.  This graph focuses on trends in primary
MDR TB (based on initial isolates from persons with no prior history of TB) in the United States
from 1993 through 2005.  The number of MDR TB cases, represented by bars, steadily declined from
410 in 1993 to 115 in 2001.  Since then the total number of MDR TB cases has fluctuated from 91 to
125 cases, with 95 cases reported for 2005.  Primary MDR TB, shown by the line, decreased from
2.5% in 1993 to approximately 1.0% in 1997, and remained at this level up to and including 2005.
Slide 21. Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States,
1993–2005.  This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons.
Based on initial isolates from persons with no prior history of TB, the percentage of isoniazid
resistance was approximately two times higher among foreign-born persons than among U.S.-born
persons.  In foreign-born persons, the percentage declined from 12.3% in 1993 to 9.8% in 2005.  In
U.S.-born persons, the percentage decreased from 6.8% in 1993 to 4.1% in 2005.
Slide 22.  Primary MDR TB in U.S.-born vs. Foreign-born Persons, United States, 1993–2005.
This graph highlights primary MDR TB in U.S.-born versus foreign-born persons.  The percentage
with primary MDR TB has declined among both groups, although the decline in the U.S.-born has
been greater.  As a result, the proportion of primary MDR TB cases reported in foreign-born persons
increased from approximately 26% of all MDR TB cases in 1993 to approximately 75% of all MDR
TB cases in 1999, and continued at this proportion through 2005 (not shown on slide).  Among the
U.S.-born, the percentage with MDR TB remained between 0.5% and 0.7% from 1998 through 2004
and dropped to 0.4% in 2005.  The percentage among foreign-born persons has fluctuated year by
year, while averaging approximately 1.4% from 1998 through 2005.
Slide 23. Reporting of HIV Test Results in Persons with TB by Age Group, United States,
1993–2004.  This slide shows the completeness of reporting of HIV test results in persons with TB
by age group from 1993 through 2004.  The percentage of TB patients for whom test results were
reported increased from 30% among all ages in 1993 to 56% in 2004, the latest year with available
data.  Among adults aged 25–44 years, the percentage increased from 46% to 67% in 2004.  The
numerator includes TB patients with positive, negative, or indeterminate HIV test results and persons
from California reported with AIDS (HIV test results are not reported to CDC from California).
Slide 24. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993–2004.
This slide provides minimum estimates of HIV coinfection among persons reported with TB from
1993 through 2004, the latest year with available data.  Since the addition of the request for HIV
status to the individual TB case report in 1993, incomplete reporting has provided a challenge to
calculating reliable estimates.  Results from the cross-matching of TB and AIDS registries have been
used to supplement reported HIV test results.  For all ages, the estimated percentage of HIV
coinfection in persons reported with TB decreased from 15% to 8% overall and from 29% to 14% in
persons aged 25 to 44 years during this period.
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Slide 25. Mode of Treatment Administration in Persons Reported with TB, United States,
1993–2003.  In 1993, the reporting areas began providing information about mode of treatment
administration on the individual TB case report form.  Treatment administered as only directly
observed therapy (DOT) increased from 22% in 1993 to 57% in 2003, the latest year with available
data.  There was also an increase in the proportion of patients who received at least some portion of
their treatment as DOT (based on combining the percentage of patients who received only DOT and
the percentage for whom some portion was self-administered).  In 2003, 85% of patients received at
least some portion of their treatment as DOT.
Slide 26. Completion of TB Therapy, United States, 1993–2003.  The reporting areas began
providing information on completion of therapy in 1993 through the individual TB case report form.
The calculations exclude patients with an initial isolate resistant to rifampin as well as children with
meningeal, bone or joint, or miliary disease.  Overall completion of therapy has remained at
approximately 92% from 1998 through 2003. Completion in 1 year or less increased from 64% in
1993 to approximately 80% in 1998–2003, the latest year with available data.  The current DHHS
Healthy People 2010 objective is completion of therapy in 1 year or less in 90% of patients.  CDC is
working with state and local health departments to determine and evaluate reasons for apparently





Tuberculosis Case Definition for Public Health Surveillance1
Tuberculosis (Revised 9/96)
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized pathologically by
the formation of granulomas. The most common site of infection is the lung, but other organs may be
involved.
Clinical case definition
A case that meets all of the following criteria:
• A positive tuberculin skin test result
• Other signs and symptoms compatible with tuberculosis, such as an abnormal, unstable (i.e.,
worsening or improving) chest radiograph, or clinical evidence of current disease
• Treatment with two or more antituberculosis medications
• A completed diagnostic evaluation
Laboratory criteria for diagnosis
• Isolation of M. tuberculosis from a clinical specimen,* or
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplification test,†
or
• Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or cannot
be obtained
Case classification
Confirmed: a case that meets the clinical case definition or is laboratory confirmed
Comment
Only one case should be counted in a person within any consecutive 12-month period. However, a
case in a patient who had previously had verified disease should be reported again if more than 12
months have elapsed since the patient was discharged from treatment. A case should also be
reported again if the patient was lost to supervision for >12 months and disease can be verified
again. Mycobacterial diseases other than those caused by M. tuberculosis complex should not be
counted in tuberculosis morbidity statistics unless there is concurrent tuberculosis.
1CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No.
RR-10):40- 41.
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic acid high-
pressure liquid chromatography performed on a culture from a clinical specimen) are acceptable
under this criterion.
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria species.
However, for surveillance purposes, CDC will accept results obtained from NAA tests approved by




Recommendations for Counting Reported Tuberculosis Cases
(Revised July 1997)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in
January 1977, numerous changes have occurred and many issues have been raised within the
field of tuberculosis (TB) surveillance.  This current version updates and supersedes the previous
version; it clarifies the parameters for counting TB cases among (a) immigrants, resident aliens,
and border crossers, (b) military personnel stationed in the United States and abroad, and (c)
persons diagnosed within the Indian Health Service and correctional facilities.
A distinction should be made between reporting TB cases to a health department and counting
TB cases for determining incidence of disease.  Throughout each year, TB cases and suspected
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories,
and health care providers.  From these reports, the state or local TB control officer must
determine which cases meet the current surveillance definition for TB disease.  These verified TB
cases are then counted and reported to the Centers for Disease Control and Prevention (CDC).
I. Reporting TB Cases. CDC recommends that health care providers and laboratories be
required to report all TB cases or suspected cases to state and local health departments
based on the current “Case Definition for Public Health Surveillance.”2 This notification
is essential in order for TB programs to
• Ensure case supervision
• Ensure completion of appropriate therapy
• Ensure completion of timely contact investigations
• Evaluate program effectiveness
• Assess trends and characteristics of TB morbidity
II. TB Surveillance. For purposes of surveillance, a case of TB is defined on the basis of
           laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.*
 ________________________________
* Because most laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis from very closely
related species, these laboratories report culture results as being positive or negative for “Mycobacterium tuberculosis
complex.” Although in almost all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M.
tuberculosis, other species are possible. For example, one study in San Diego found that 6% of human tuberculosis was
caused by Mycobacterium bovis; cultures from these cases would be reported by most laboratories as being positive for
M. tuberculosis complex. Other species in the Mycobacterium tuberculosis complex include M. africanum, M. microti,
M. canetii, M. caprae, and M. pinnipedii. Although M.  microti , M. canetii , M. caprae, and M. pinnipedii are newly
described species, their inclusion in M. tuberculosis complex should not impact public health laboratories or programs
because only a few laboratories identify to the species level. These seven species are almost identical in DNA homology
studies. In terms of their ability to cause clinical disease and be transmissible from person to person, M. bovis, M.
africanum, M. microti, and M. canetti behave like M. tuberculosis; therefore, disease caused by any of the organisms
should be reported as TB, using the Report of Verified Case of Tuberculosis (RVCT). The only exception is the BCG
strain of M. bovis, which may be isolated from persons who have received the vaccine for protection against TB or as
cancer immunotherapy; disease caused by the BCG strain of M. bovis should not be reported as TB because the
transmission is iatrogenic (treatment-induced), rather than person-to-person or communicable.
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a. Laboratory Case Definition
• Isolation of M. tuberculosis complex from a clinical specimen.  The use of rapid
identification techniques for M. tuberculosis performed on a culture from a clinical
specimen, such as DNA probes and high-pressure liquid chromatography (HPLC), is
acceptable under this criterion.
OR
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplification
(NAA) test.  NAA tests must be accompanied by cultures of mycobacterial species.
However, for surveillance purposes, CDC will accept results obtained from NAA tests
that are approved by the Food and Drug Administration (FDA).
OR
• Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not been
or cannot be obtained; historically this criterion has been most commonly used to
diagnose TB in the postmortem setting.
b. Clinical Case Definition. In the absence of laboratory confirmation of M. tuberculosis
complex after a diagnostic process has been completed, persons must have all of the
following criteria for clinical TB:
• Evidence of TB infection based on a positive tuberculin skin test result
     AND
• One of the following:
(1) Signs and symptoms compatible with current TB disease, such as an abnormal,
unstable (worsening or improving) chest radiograph, or
(2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight
loss, hemoptysis)
    AND
• Current treatment with two or more anti-TB medications
NOTE: The case definition described herein was developed for use in this document and is not
intended to replace the case definition for TB as stated in the current “Case Definitions for
Infectious Conditions Under Public Health Surveillance.”
In addition, the software for TB surveillance developed by CDC includes a calculated variable
called “Vercrit,” for which one of the values is “Provider Diagnosis.”  “Provider Diagnosis” is
selected when the user chooses to override a “Suspect” default value in the case verification screen
as “Verified by Provider Diagnosis.”  Thus, “Provider Diagnosis” is not a component of the case
definition for TB in the current “Case Definitions for Infectious Conditions Under Public Health
Surveillance” publication.  CDC’s national morbidity reports have traditionally included all cases
that are considered verified by the reporting areas, without a requirement that cases meet the
published case definition.
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III.    Counting TB Cases. Cases that meet the current CDC surveillance case definition for
verified TB are counted by 52 reporting areas with count authority (50 states, District
of Columbia, and New York City) to determine annual incidence for the United
States.  The remaining 7 reporting areas (American Samoa, Federated States of
Micronesia, Guam, Northern Mariana Islands, Puerto Rico, Republic of Palau, and
U.S. Virgin Islands) report cases to CDC but are not included in the annual incidence
for the United States. The laboratory and clinical case definitions are the two
diagnostic categories used by the CDC “Case Definitions for Infectious Conditions
Under Public Health Surveillance.”
Most verified TB cases are accepted for counting based on laboratory confirmation
of M. tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB.  If
disease recurs in a person within any 12-consecutive-month period, count only one
episode as a case for that year.  However, if TB disease recurs in a person, and if
more than 12 months have elapsed since the person was discharged from or lost to
supervision, the TB is considered a separate episode and should be counted as a new
case.  Note: Discharged from supervision implies completion of therapy.
Mycobacterial diseases other than those caused by M. tuberculosis complex should
not be counted in TB morbidity statistics unless there is concurrent TB.
a. Verified TB Cases
      COUNT
Count only verified TB cases that meet the laboratory or clinical case definitions
(see Section II).  The diagnosis of TB must be verified by the TB control officer or
designee.  The current CDC surveillance case definition for TB describes and
defines the criteria to be used in the case definition for TB disease.
     DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for
confirmation of disease.  Do not count a case for which two or more anti-TB
medications have been prescribed for preventive therapy for exposure to multidrug-
resistant (MDR) TB, or while the diagnosis is still pending.
b. Nontuberculous Mycobacterial Diseases (NTM)
     COUNT
     An episode of TB disease diagnosed concurrently with another nontuberculous
     mycobacterial disease should be counted as a TB case.
     DO NOT COUNT
     Disease attributed to or caused by nontuberculous mycobacteria alone should not be
                 counted as a TB case.
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c. TB Cases Reported at Death
      COUNT
TB cases first reported to the health department at the time of a person’s death are
counted as incident cases, provided the person had current disease at the time of
death.  The TB control officer should verify the diagnosis of TB.
      DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of
death or at autopsy.
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign
Visitors3
     COUNT
Immigrants and refugees who have been screened overseas for TB and
• have been classified as Class B (B1, B2, or B3)4 or resident aliens,
• are not already on anti-TB medications for treatment of TB disease, and
• are examined after arriving in the United States and diagnosed with clinically
active TB requiring anti-TB medications
should be counted by the locality of their current residence at the time of diagnosis
regardless of citizenship status.
Border crossers* and permanent resident aliens who are diagnosed with TB and
plan to receive anti-TB therapy from a locality in the United States for 90 days or
more should be counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic
personnel) who are diagnosed with TB, are receiving anti-TB therapy, and plan to
remain in the United States for 90 days or more should be counted by the locality of
current residence.
*Border crosser — defined, in part, by the U.S. Citizenship and  Immigration
Services (USCIS)3  as “a nonresident alien entering the United States across the
Mexican border for stays of no more than 72 hours.”  Border crossers may go back
and forth across the border many times in a short period.
      DO NOT COUNT
      TB cases in immigrants or refugees who have been classified as Class A with a waiver
      (TB, Infectious, Noncommunicable for travel purposes)4 should not be counted as new
                  cases even if the persons receive routine initial work-ups in the United States.  TB in
                  persons who are temporarily (<90 days) in the United States, for whom therapy may have
                  been started but who plan to return to their native country to continue therapy, should not
                  be counted in the United States.
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e. Out-of-State or Out-of-Area Residents
      COUNT
A person’s TB case should be counted by the locality in which he or she resides at
the time of diagnosis.  TB in a person who has no address should be counted by the
locality that diagnosed and is treating the TB.  The TB control officer should notify
the appropriate out-of-state or out-of-area TB control officer of the person’s home
locality to (1) determine whether the case has already been counted to avoid “double
counting,” and (2) agree on which TB control office should count the case if it has
not yet been counted.
      DO NOT COUNT
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident
and whose TB has already been counted by the out-of-area TB control office.
f. Migrants and Other Transients
      COUNT
Persons without any fixed U.S. residence are considered to be the public health
responsibility of their present locality and their TB case should be reported and
counted where diagnosed.
      DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that
they have already been counted by another locality.
g. Federal Facilities (e.g., Military and Veterans Administration Facilities)
      COUNT
Cases in military personnel, dependents, or veterans should be reported and counted
by the locality where the persons are residing in the United States at the time of
diagnosis and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a
military base outside the United States but are referred elsewhere for treatment (e.g.,
a military base located within the United States), the TB case should be reported
and counted where treated and not where the diagnosis was made.
     DO NOT COUNT
     Do not count if the case was already counted by another locality in the United States.
h. Indian Health Service
COUNT
TB should be reported to the local health authority (e.g., state or county) and counted where
diagnosed and treatment initiated.  However, for a specific group such as the Navajo Nation,
which is geographically located in multiple states, health departments should discuss each
case and determine which locality should count the case.
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     DO NOT COUNT
     Do not count if the case was already counted by another locality.
i. Correctional Facilities (e.g., Local, State, Federal, and Military)
      COUNT
Persons who reside in local, state, federal, or military correctional facilities may
frequently be transferred or relocated within and/or between various correctional
facilities. TB in these persons should be reported to the local health authority and
counted by the locality where the diagnosis was made and treatment plans were
initiated.
      DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere
by another locality or correctional facility, even if treatment continues at another
locale or correctional facility.
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United
       States
      DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted.  TB in
these persons should be counted by the country in which they are residing regardless
of their plans to return to the United States for further work-up or treatment.
IV. Suggested Administrative Practices
To promote uniformity in TB case counting, the following administrative procedures
are recommended:
(a)  All TB cases verified by the 52 reporting areas with count authority (50 states,
District of Columbia, and New York City) during the calendar year (by December 31)
will be included in the annual U.S. incidence count for that year.  All tuberculosis
cases verified during the calendar year by a reporting area with count authority from
one of the remaining 7 reporting areas (American Samoa, Federated States of
Micronesia, Guam, Northern Mariana Islands, Puerto Rico, Republic of Palau, and
U.S. Virgin Islands) are also counted but are not included in the annual incidence for
the United States.  Cases for which bacteriologic results are pending or for which
confirmation of disease is questionable for any other reason should not be counted
until their status is clearly determined; they should be counted at the time they meet
the criteria for counting.  This means that a case reported in one calendar year could be
included in the morbidity count for the following year.  The reporting area with count
authority should ensure that there is agreement between final local and state TB
figures reported to CDC. Currently, some reporting areas may not use this suggested
protocol.  Some of these areas may wait until the beginning of the following year
when they have received and processed all of the TB cases for inclusion in the annual
case count for the previous year.  If reporting areas decide to revise their protocols,
they should be aware that their TB trends may change.
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(b)  TB is occasionally reported to health departments over the telephone, by letter
or fax, or on forms other than the Report of Verified Case of Tuberculosis (RVCT).
Such information should be accepted as an official morbidity report if sufficient
details are provided; otherwise, the notification should be used as an indicator of a
possible TB case (suspect) which should be investigated promptly for confirmation.
 V. TB Surveillance Definitions
Case - an episode of TB disease in a person meeting the laboratory or clinical
criteria for TB as defined in the document “Case Definitions for Infectious
Conditions Under Public Health Surveillance”2 (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., a
known contact to an active TB case or a person with signs or symptoms consistent
with TB) who is currently under evaluation for TB disease.
Verification of a TB case - the process whereby a TB case, after the diagnostic
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB
control official who is familiar with TB surveillance definitions; if all the criteria for
a TB case are met, the TB case is then verified and eligible for counting.
Counting of a TB case - the process whereby a reporting area with count authority
evaluates verified TB cases (e.g., assesses for case duplication).  These cases are
then counted for morbidity in that locality (e.g., state or county) and reported to
CDC for national morbidity counting.
Mycobacterium tuberculosis complex (M. tuberculosis complex) - Because most
laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis
from very closely related species, these laboratories report culture results as being
positive or negative for “Mycobacterium tuberculosis complex.” Although in almost
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M.
tuberculosis, other species are possible. For example, one study in San Diego found
that 6% of human tuberculosis was caused by Mycobacterium bovis; cultures from
these cases would be reported by most laboratories as being positive for M.
tuberculosis complex. Other species in the Mycobacterium tuberculosis complex
include M. africanum, M. microti, M. canetii, M. caprae, and M. pinnipedii.
Although M.  microti , M. canetii , M. caprae, and M. pinnipedii are newly
described species, their inclusion in M. tuberculosis complex should not impact
public health laboratories or programs because only a few laboratories identify to
the species level. These seven species are almost identical in DNA homology
studies. In terms of their ability to cause clinical disease and be transmissible from
person to person, M. bovis, M. africanum, M. microti, and M. canetti behave like M.
tuberculosis; therefore, disease caused by any of the organisms should be reported
as TB, using the Report of Verified Case of Tuberculosis (RVCT). The only
exception is the BCG strain of M. bovis, which may be isolated from persons who
have received the vaccine for protection against TB or as cancer immunotherapy;
disease caused by the BCG strain of M. bovis should not be reported as TB because
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the transmission is iatrogenic (treatment-induced), rather than person-to-person or
communicable.
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium
tuberculosis complex that can cause human infection or disease.  Common
nontuberculous mycobacteria include M. avium complex or MAC (M. avium, M.
intracellulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M.
fortuitum, and M. simiae.  Other terms have been used to represent NTM, including
MOTT (mycobacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verified TB cases to
CDC.  Currently there are 59 reporting areas: the 50 states, District of Columbia,
New York City, American Samoa, Federated States of Micronesia, Guam, Northern
Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands.  The
annual incidence of tuberculosis for the United States is based on 52 reporting areas
(the 50 states, District of Columbia, and New York City).
Alien - defined by the U.S. Citizenship and Immigration Services (USCIS)3  as “any
person not a citizen or national of the United States.”
Border crosser - defined, in part, by the USCIS3 as “a nonresident alien entering
the United States across the Mexican border for stays of no more than 72 hours.”
Border crossers may go back and forth across the border many times in a short
period.
Class A (TB, infectious) - defined by the Division of Global Migration and
Quarantine,4  CDC, as an alien “with an abnormal chest radiograph or series of chest
radiographs suggestive of current pulmonary TB and one or more positive sputum
smear examinations for acid-fast bacilli.” This person is not authorized to enter the
United States unless a waiver has been granted (see definition for Class A - TB,
infectious, noncommunicable for travel purposes).
Class A (TB, infectious, noncommunicable for travel purposes) - defined by the
Division of Global Migration and Quarantine,4 CDC, as an alien “with an abnormal
chest radiograph or series of chest radiographs suggestive of active TB, a history of
one or more positive sputum smear examinations for acid-fast bacilli, currently on
recommended treatment, and sputum smears that are negative for acid-fast bacilli
on 3 consecutive days.” This person is authorized to enter the United States if a
waiver has been granted.
Class B1 (TB, clinically active, not infectious) - defined by the Division of Global
Migration and Quarantine,4 CDC, as an alien “with an abnormal chest radiograph or
series of chest radiographs suggestive of active TB, and sputum smears that are
negative for acid-fast bacilli on 3 consecutive days.” This person may be on anti-TB
medications when entering the United States.
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Class B1 (Extrapulmonary TB, clinically active, not infectious) - defined by the
Division of Global Migration and Quarantine,4 CDC, as an alien “with radiographic
or other evidence of extrapulmonary TB, clinically active.” This person may be on
anti-TB medications when entering the United States.
    Class B2 (TB, not clinically active) - defined by the Division of Global Migration and
    Quarantine,4 CDC, as an alien “with an abnormal chest radiograph or series of chest
    radiographs suggestive of active TB, not clinically active (e.g., fibrosis, scarring, pleural
    thickening, diaphragmatic tenting, blunting of costophrenic angles.)  Sputum smears are
    not required.” Such a person who “completed the recommended course of anti-TB therapy
    and whose chest radiographs are stable should be reported as Class B2-TB, treatment
    completed.” This person may be on anti-TB medications when entering the United States.
Class B3 (consistent with TB, old or healed) - defined by the Division of Global
Migration and Quarantine,4 CDC as an alien “with an abnormal chest radiograph or
series of chest radiographs (the only abnormality is a calcified lymph node, calcified
primary complex, or calcified granuloma).  Sputum smears are not required.”
Immigrant - defined by the USCIS3  as “an alien admitted to the United States as a
lawful permanent resident.  Immigrants are those persons lawfully accorded the
privilege of residing permanently in the United States.  They may be issued
immigrant visas by the Department of State overseas or adjusted to permanent
resident status by the USCIS of the United States.”
Permanent Resident Alien - see Immigrant.
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1. Reference to details of FDA-approved labeling for NAA (IIa) was deleted from
this document in September 2002.
2.  A note of clarification was added to Section III, Counting TB Cases, in
September 2003.

